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General Introduction  
Tuberculosis is a disease that has been around since the dawn of humankind [1,2]. In 
1882, Robert Koch (3) first discovered and described mycobacterium tuberculosis (MTB), 
the bacteria that causes TB in humans. More than a century later, in 1993, the World Health 
Organization (WHO) declared TB infection to be  global public health problem [4,5]. TB 
continues to cause high morbidity and mortality rates, and is classified among the top ten 
causes of global mortality, particularly in developing countries (6).   
Since then, many efforts have been undertaken by experts in international 
organisations, for example the World Health Organisation (WHO) and the International 
Union against Tuberculosis and Lung Disease (IUATLD), to tackle this health crisis. Based 
on an expert evaluation of the National TB Control Programme (NTCP), the WHO launched 
the “Directly Observed Treatment; Short-course (DOTS)” strategy in 1994 as the essential, 
most cost-effective means of tuberculosis control. The targets for success set by the WHO 
for the NTCP were to achieve a detection rate of smear positive TB cases of 70% and a cure 
rate of 85% in the detected cases (7-9). The success of this strategy later underpinned the 
development and implementation of the “Stop TB Strategy” (2006–2015), put in place to 
accelerate the global expansion of tuberculosis care and control (10). This was incorporated 
in the subsequent “End TB Strategy”, launched by the WHO as a post-2015 global TB 
strategy. This post-2015 framework consists of three pillars and components, the first of 
which focuses on integrated, patient-centred care and prevention, and is based on the DOTS 
treatment strategy. The goal of this strategy is to end the global tuberculosis epidemic by 
the year 2030, and the overall vision is of a world that will be free of TB disease, with zero 






TB in Khartoum State  
TB continues to be a major public health problem in Sudan, particularly in Khartoum 
State, despite the fact that there has been a reduction in tuberculosis-related mortality, and 
a decline in incidence and prevalence (13). 
Sudan ranks the 3rd of the 10 highest burden countries in the Eastern Mediterranean 
region. It alone carries about 15% of TB burden in the region. In 2010, the estimated annual 
risk for TB in Sudan was 1.8%, with an estimated incidence rate of 119/100,000 population 
(37,072 new cases for a population of 30.894 million). The prevalence of all TB cases in 
Sudan was estimated to be 209/100,000 population, with an overall death rate - including 
HIV infected TB cases - of 24/100,000 population annually. In 2018, the total number of 
reported cases of TB in Sudan was 20117 with a total incidence rate of 71/100.000 
population; a multidrug-resistant TB (MDR-TB) incidence of 2.6/100.000 population; a TB 
incidence rate among people living with HIV of 2.3/100.000, and a mortality rate of 
17/100.000 population (14-17). 
Tuberculosis in Khartoum State remains a major public health problem. The total 
number of TB cases detected in 2010 was 6670; an incidence rate of 119/100.000 population 
(population of the state was 5.558.647 in the year 2010). The annual risk for TB was 1.8 %, 
hence the programme was able to detect 2196 new smear positive cases (83.5% of the target) 
and achieve a cure rate of 48.4% from the detected cases. Non-adherence was 12% (the 
same as in 2009). The treatment failure rate was 1.0%, up slightly from 2009 (0.7%). The 
case fatality rate was 2.0%, which is higher than in 2009 (1.3%). This may be due to the 
increased incidence of HIV, the emergence of multi-drug resistance to TB, treatment failure, 
and the high default rate (18). The treatment success rate increased from 66% in 2011 to 
reach 81.0% and 84.0% in 2017 and 2018, respectively (of all registered new smear positive 




are illustrated in Figures 1-3 (18-20). In 2018, around 50% of detected TB patients had new 
smear positive pulmonary TB (PTB), 35% had smear negative PTB, and 15% had extra 
pulmonary TB (EPTB). Five percent of these cases were among children. The prevalence 
of multidrug resistant/ rifampicin resistant(RR) was 2.6/100.000 population (17,19,20). The 
incidence of TB in Khartoum State is similar to the national incidence estimates reported by 
the National Tuberculosis Control Programme ( NTCP) in 2011, but it is higher than that 
reported in 2018, as mentioned above (19, 20).  
The estimated prevalence of multi drug resistant Tuberculosis ( MDRTB) and TB 
among HIV patients remains unclear as the NTCP does not have a well-established system 
in place to detect these patients. This is due to the fact that laboratory investigation is not 
implemented on a routine basis for HIV and drug resistant TB (i.e. TB that is resistant to 

















Figure 1: Prevalence of TB cases in Khartoum State 2010-2018 (18-20) 
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There are many organisms which can infect the lungs, including bacteria, viruses, and 
other parasites. However, Mycobacterium TB remains the most chronic infectious disease, 
and may require a treatment period exceeding six months (in contrast to other infections 
which may only require treatment for a few days) (21,22). Furthermore, for a TB patient to 
be considered non-infectious, s/he should be on regular treatment for a period of more than 
2 weeks (23). In some cases, a patient’s health condition may require hospital admission, 
and absence from work, resulting in a loss of up to 30% of annual household income, or the 
loss of a job. Furthermore, when an individual suffers from TB, s/he may not be able to 
perform routine household activities such as preparing food. In some societies, TB patients 
may not be able to get married.  Hence, TB infection can have a social, psychological and 

















TB shows high morbidity and mortality, and has proven difficult to eliminate, despite 
the fact that it is both curable and preventable (6,25,26). Many professionals reiterate that 
poor compliance associated with TB treatment remains a challenge for the national TB 
control programmes in developing countries and in Sudan, including Khartoum State 
(27,28). Treatment compliance is as crucial as the early detection of disease for achieving a 
high cure rate (26). Despite all of the efforts taken by the TB control programme, there is 
still a high TB treatment default rate (14%) in Khartoum State (29), as compared to the 
WHO benchmark (of less than 3%) (30). Irregular, interrupted or incomplete TB treatment 
increases the risk of disease spread, treatment failure, relapse of disease, acquisition of drug-
resistant TB, prolonged infectiousness, and death (27,28).   
It has been observed that the ratio of TB cases among males to females is 1:1 at a 
young age in Sudan. This ratio increases to 2:1 among males after the age of 50 years. This 
finding reflects the complexity of the sociodemographic factors influencing TB treatment 
compliance. One study in Sudan found that, in more than 80% of TB cases, the family 
income was less than 100 dollar per month. Moreover, 66% of TB patients were illiterate or 
had received less than 6 years of schooling (15). Health is no longer considered simply as a 
biomedical problem; rather, it is  influenced by social, cultural, physiological, economic and 
political factors that determine the decisions of the individuals concerned (31,32). Other 
influential factors have also been proposed, including exposure, accessibility of TB services 
for diagnosis and medical treatment, stigma, behavioural factors, patient knowledge, beliefs, 
patient movement or change of address during the treatment course, and the receptiveness 
of healthcare providers (33,34).  
Poverty, poor nutrition, illiteracy and lack of knowledge represent major factors 
associated with noncompliance to treatment for TB among displaced individuals and 




non-governmental organizations. These clinics are not fully equipped in terms of labs, 
trained health personnel, and the availability of medication for DR TB (18, 33-36). 
Since 1993, the Ministry of Health (MOH) in Khartoum State has therefore adopted 
the implementation of TB treatment under the DOTS programme, in order to offer the 
services (TB diagnosis and medication) free of charge. The purpose of the DOTS strategy 
is to enhance the accessibility of services through primary health care centres (PHCC) (37). 
However, there are still some challenges facing the implementation of the DOTS 
programme, such as the inequity of health services utilization, especially in rural areas (18). 
      Default from TB treatment may occur during the course of the patient’s referral pathway 
from one TB health unit to another. Treatment default can mainly be attributed to lack of 
reporting and close follow-up, as well as to an ineffective default tracing system. Problems 
with this system include a lack of transportation and communication methods, as the tracing 
team depends on land line telephones and irregular home visits (38).  
Accordingly, NTCP policy makers have been urged to pay more attention to obstacles 
facing TB treatment adherence and not merely the treatment factors. In order for this to 
happen, it is necessary to address the social and behavioural factors influencing treatment 
adherence. It is also important to increase patient (and family) awareness of and knowledge 
about TB. In addition, it is necessary to enhance the current capacity of TB clinics, which 
means focusing on the workforce, the building venue, equipment, medical supplies, 
communication methods, transportation, and health care provider training (to improve 
communication skills as well as attitudes/behaviours towards TB patients). Moreover, the 
default tracing system should be improved by encouraging the use of active communication 
methods and technology such as text messages, phone calls and home visits, as well as 
incentives, and increasing transportation facilities. Lastly, there is a need to strengthen the 




governmental organisations in order to streamline the socioeconomic support provided to 
families and patients, alongside the provision of treatment services.  
In Khartoum state, despite the well-established infrastructure, and the availability of 
treatment for recommended regimens, the most serious challenge facing the control program 
is the high default rate, which, as mentioned earlier, stands at approximately 14% (29). Only 
a few studies have addressed this problem and these studies have mainly focused on 
sociodemographic and treatment-related factors (39). In order to achieve a higher rate of 
treatment compliance among TB patients, further in-depth research needs to be carried out 
to identify the particular factors, which determine treatment default in Khartoum State. The 
results of this research could then be used to make recommendations to policy makers and 
health care providers with the aim of reducing treatment default and improving treatment 
adherence. We hope the results of this research will be of value to the TB control programme 
in Khartoum State, Sudan, and also relevant to other countries with similar health situations. 
We hope that this thesis will serve as resource document for the design of interventions 
targeted at achieving the objectives of these TB programmes.  
Population of Khartoum State 
Sudan it is the third-largest country in the continent of Africa. Located in the north 
east of Africa, Sudan is surrounded by Egypt, Libya, Chad, Central African Republic, South 
Sudan, Ethiopia, Eretria and the Red Sea. The surface area of Sudan is 1,882,000 km2, and 
it lies between latitudes 8° and 23°N. According to the last census taken in 2008, the 
population of Sudan is over 30.894.000. In 2018, the total population was estimated at 
41.984.514 with an annual growth rate of 2.49%; a birth rate of 33.0/1000; a life expectancy 
of 65 years (40-42), and a population density of 22.69/km2 in 2016 (43). 
The country is composed of 18 states. Khartoum is the capital of Sudan and is located 




state in the country, with an area of 28.1165 km2, it is the most populous state, with the 
population estimated at 7,687,542 (20, 44).    
The National TB Control Programme(NTCP) in Khartoum State: 
The National Tuberculosis Programme (NTP) was established in Sudan in 1974, and 
was based upon a system of specialist Chest Units situated in hospitals. With the support of 
the WHO and the International Union Against Tuberculosis and Lung Disease (IUATLD), 
the programme was reviewed and reformed in 1993, when it fully adopted the WHO 
promoted DOTS strategy (37). 
The TB control programme was established in Khartoum State in 1993. TB services are 
delivered in primary health care along with all other routine health services. The services 
are provided by TB health units in hospitals, health centres, non- governmental clinics and 
private clinics. The decentralized healthcare system in Khartoum is divided into seven 
districts and 19 health areas. Its health facilities include 52 hospitals, 242 health centres, 185 
NGOs centres, 235 dispensaries and 365 primary health care units. TB patients receive their 
treatment in 53 TB health units distributed all over the state [17]. A registered nurse is 
designated for treatment and follow-up (continuation of treatment) in the primary health 
care unit, which is the basic unit of management of the program and also the unit of 
reporting.  The healthcare team also includes a medical assistant, a laboratory technician, 
and a clerk.  As mentioned earlier, the program follows the DOTS strategy which consists 
of passive case detection, ongoing government political and financial commitment to TB 
control, access to a regular uninterrupted drug supply, the use of short-course chemotherapy, 
standardized evaluation and monitoring of case detection and individual treatment 













Symptoms and signs of Tuberculosis: 
Tuberculosis (TB) is caused by bacteria (Mycobacterium tuberculosis) whose 
principle reservoir is humans. TB most often affects the lungs, occurring in about 80% of 
TB cases. TB may affect organs other than the lungs (this is called Extra-Pulmonary 
Tuberculosis), such as pleura, lymph nodes, abdomen, genitourinary tract, skin, joints, 
bones, and meninges. TB is mainly spread from person to person through the air. When 
people with lung TB cough, sneeze or spit, they propel the TB germs into the air. Bovine 
TB is spread by the ingestion of unpasteurized cow’s milk. A person needs to inhale only a 
few of these germs to become infected. Of those who become infected, 10–12% may 
develop tuberculosis disease. Common symptoms of active lung TB are cough with sputum 
and occasionally blood, chest pains, weakness, weight loss, fever and night sweats (15). 
Treatment of tuberculosis 
  The treatment of drug-susceptible tuberculosis and the type of patient care provided 
is of importance in the context of the “End TB Strategy”. The use of a 6-month rifampicin-
based regimen 2HRZE/4HR remains the recommended TB treatment option. Moreover, the 
use of fixed daily dosing (rather than thrice-weekly dosing) is the recommended dosing 
frequency for all patients with pulmonary TB, in both the intensive and continuation phases 
of therapy. The drugs used for TB treatment include: Rifampicin (R); Isoniazid (INH), 
Ethambutol (E), Ppyrazinamide (Z), and Streptomycin (47). 
Multidrug-resistant TB (MDR-TB): 
Resistance to TB drugs is a formidable obstacle to effective TB care and prevention globally. 
Multidrug-resistant TB (MDR-TB) is multifactorial and is fuelled by improper treatment of 
patients, poor management of supply and quality of drugs, and airborne transmission of 




compounded by the catastrophic economic and social costs that patients incur while seeking 
help and while receiving treatment (48). 
Objectives of the thesis: 
The overall objective of this study was to identify the determinants of treatment 
default among TB patients in Khartoum State, so that relevant suggestions and 
recommendations can be made with the aim of reducing treatment default among 
tuberculosis patients. 
The following specific objectives were identified: 
- To identify the factors which influence treatment default among TB patients 
registered at TB health units in Khartoum state. 
- To identify patient-related determinants of treatment default among TB patients 
(including sociodemographic factors, disease- and treatment-related factors, 
behavioural factors, knowledge about TB, and awareness of available TB 
services).  
- To explore the views of health care providers and TB patients about the factors 
that prevent TB treatment adherence.  
- To explore the magnitude of TB treatment default in Khartoum State and to 
identify the response of defaulting patient to the default tracing method carried out 
by the TB programme. 
-  To assess the use of mobile phones in improving adherence and decreasing the 
default rate among patients receiving TB medication under the DOTS programme. 
- To provide advice and recommendations from the study findings to strengthen the 






Outline of the thesis 
This thesis investigates and describes the determinant factors leading to TB treatment 
default that need intervention by a TB control programme. 
Chapter 2 provides a systematic review of the patient characteristics associated with 
non-adherence to tuberculosis treatment. This study will increase existing knowledge about 
treatment default (and the factors affecting it) and help to promote adherence to TB 
treatment. The aim is to reinforce the surveillance system of TB control activities and to 
assist health care system designers, health service providers, patients, families and the 
community, who are all working towards the goal of eliminating TB at state, national and 
international levels.  
Chapter 3 describes patients’ non adherence to TB treatment in Sudan, zeroing in on 
the socio-demographic factors influencing non adherence to tuberculosis therapy in 
Khartoum State. Chapter 4 outlines the disease- and treatment-related factors associated 
with TB treatment default in Khartoum State. Chapter 5 investigates patient knowledge 
about TB and behavioural factors leading to non- adherence to TB treatment in Khartoum 
State. Chapter 6 presents the results of a qualitative study and explores the barriers leading 
to treatment default among TB patients in Khartoum State. Chapter 7 describes the results 
of an intervention study which investigated the use of mobile phones to improve adherence 
to tuberculosis treatment in Khartoum state. Finally, Chapter 8 presents a summary and 
discussion of the findings presented in the preceding chapters, and provides a foundation for 
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Chapter 2    Patient characteristics associated with non-adherence to  
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Background: A high level of adherence to treatment is essential for cure and prevention of 
tuberculosis (TB) treatment resistance. 
Methods: A Systematic review of 53 studies addressing the patient characteristics 
associated with TB medication non-adherence was performed. The publications were 
identified by searching the PubMed, World Health Organization (WHO), and Centers for 
Disease Control and Prevention (CDC) database, EmBase, Scopus database Arts, 
humanities, Social Science database and Google scholar. Only English language 
publications were eligible. Potentially eligible studies were retrieved and the full articles 
were assessed. The potentially eligible studies were included if they concerned patients 
treated for tuberculosis, reported non-adherence and reported on potential risk factors 
associated with non-adherence.  
Results:  Factors that were  most frequently consistently and statistically significantly 
related to non-adherence to tuberculosis treatment were: family income, 
patient  movement and changing address or giving wrong address, tuberculosis relapse or 
multidrug-resistant TB (MDRTB), during intensive phase of treatment, history of default, 
treatment regimen(long course), response to treatment,  homeless, stigma, seeking 
traditional healers, staff receptiveness, lack of directly observed therapy short course 
(DOTS), poor knowledge or lack of health education, side effects of drugs, feeling better, 
alcohol intake and lack of family and social support. 
Conclusions: Non- adherence to tuberculosis treatment was influenced by several factors.  
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Tuberculosis (TB) is among the top ten causes of global mortality [1-4]. It is estimated 
that approximately one-third of the world’s population (approximately two billion people)is 
infected with tuberculosis bacillus[5-7]. In 2015, globally 10.4 million new cases of TB and 
1.8 million deaths from TB occurred, of which 1.4 million among HIV-negative people and 
0.4 million deaths were in HIV-positive people and thus officially classified as HIV deaths 
in the International Statistical Classification of Diseases[8-10]. Approximately 80% of TB 
cases are found in 22 countries; the highest incidence rates being found in Africa and South-
East Asia[11].  
 TB has a high morbidity and mortality rate despite its status as a treatable 
disease[12,13]. A high level of adherence to treatment  is essential for cure and to avoid 
development of resistance [14,15]. Thus, completion of antituberculosis treatment is the 
foremost priority of tuberculosis (TB) control programs. Treatment that is taken irregular, 
interrupted for two months or longer or is incomplete increases the risk of treatment failure, 
relapse of disease, acquisition of drug-resistant TB, death, and prolonged infectiousness [16-
21]. In turn, treatment failure and relapse can increase transmission of TB. Poor adherence 
to treatment is common despite various interventions aimed at improving treatment 
completion [22]. Non-adherence to TB medication is a major barrier to its local and global 
control and worsen the treatment outcome. In addition, defaulting increases the risk of drug 
resistance, relapse and death, and may prolong infectiousness. The objective of this 
systematic review was to identify the patient characteristics that are consistently associated 
with TB medication non-adherence. This knowledge could be helpful for health care 
providers and health policy makers to improve treatment adherence. The patient 
characteristics that we studied were: socio-demographic factors; disease related factors; 






       This systematic review was conducted to answer the question: which patient 
characteristics are consistently and statistically significantly associated with TB treatment 
non-adherence. The study reviewed publications found on risk factors associated with 
defaulting tuberculosis treatment that were published in English between 1990 to 2017. The 
publications were identified by searching the PubMed database, WHO database, and CDC 
database, EmBase, Scopus database, Arts, humanities,  Social Science database and google 
scholar. Using the key words ‘tuberculosis', ‘mycobacterium tuberculosis’, 'adherence' ,'non 
adherence', 'defaulting', 'risk factors', 'compliance', 'determinant factors', 'outcome of 
tuberculosis treatment', 'predictors', leading', 'impact',  'noncompliance', ‘Anti tuberculosis 
treatment’, and ‘anti tuberculosis therapy’. Because of resource limitations, papers 
published in other languages were not considered. Additional reports were identified by 
manually reviewing the references of the studies found.  
The potentially eligible studies were included if the following criteria were all met: it 
concerned patients treated for tuberculosis (see definition below), it reported  on adherence 
and non adherence, it reported on potential risk factors associated with adherence and non 
adherence, if the type of study is observation (cohort, case-control, cross-sectional), RCT 
and community survey, if it is a quantitative study or  combined quantitative and qualitative, 
and if there is association (p value, odds ratio or relative risk and 95% confidence interval, 
or p value, odds ratio or relative risk, or p value). The papers were excluded if they did not 
meet the above criteria, and if only an abstract was available. Selected articles were reviewed 
for information on the country of study, sample size, population source, type of the study, 
the statistical association, and risk factors e.g age, sex, and other associated factors. 
For purpose of data review simple definition were used according to those of the 




A case of tuberculosis was defined as a patient in whom tuberculosis has been 
bacteriologically confirmed, or has been diagnosed by a clinician.  
 A bacteriologically confirmed TB case is one from whom a biological specimen is 
positive by smear microscopy, culture or WHO-approved rapid diagnostics (WRD) (such as 
Xpert MTB/RIF). All such cases should be notified, regardless of whether TB treatment has 
started. 
A clinically diagnosed TB case is one who does not fulfil the criteria for bacteriological 
confirmation but has been diagnosed with active TB by a clinician or other medical 
practitioner who has decided to give the patient a full course of TB treatment. This definition 
includes cases diagnosed on the basis of X-ray abnormalities or suggestive histology and 
extrapulmonary cases without laboratory confirmation. Clinically diagnosed cases 
subsequently found to be bacteriologically positive (before or after starting treatment) 
should be reclassified as bacteriologically confirmed.  
Pulmonary tuberculosis (PTB) refers to any bacteriologically confirmed or clinically 
diagnosed case of TB involving the lung parenchyma or the tracheobronchial tree. Miliary 
TB is classified as PTB because there are lesions in the lungs. Tuberculous intra-thoracic 
lymphadenopathy (mediastinal and/or hilar) or tuberculous pleural effusion, without 
radiographic abnormalities in the lungs, constitutes a case of extrapulmonary TB. A patient 
with both pulmonary and extrapulmonary TB should be classified as a case of PTB. 
Extrapulmonary tuberculosis (EPTB) refers to any bacteriologically confirmed or clinically 
diagnosed case of TB involving organs other than the lungs, e.g. pleura, lymph nodes, 
abdomen, genitourinary tract, skin, joints and bones, meninges. 
Potentially eligible studies were excluded if they did not report on potential risk 




review. Potentially eligible studies were retrieved and the full articles were assessed. Results 
are reported according to the PRISMA guidelines for systematic reviews[25]. 
  Data was extracted by A.A.Ali. For the purpose of data extraction a simple definition 
for treatment adherence and  nonadherence  was used according to that of the World Health 
organization  publication (WHO, 2002)[22,26]. Non - adherence (or Defaulter): A patient 
whose treatment was interrupted for 2 or more consecutive months.  
The following five categories of risk factors for TB treatment non-adherence were 
considered:  
1-Sociodemogaphic factors including; age , sex, ethnicity, marital status, educational level 
, occupation, employment status, family income, nationality, and residential locality,  
religion, patients moving or changing address, family size and  house size [11,27-40]. 
2-Disease related factors including; type of tuberculosis(first time to develop tuberculosis, 
relapse, multi- drug resistant tuberculosis), sputum smear result, severity of disease , and 
site of tuberculosis[41-51]. 
3- The treatment and services related factors including; treatment regimen, Time of 
defaulting, directly observation therapy short course(DOTS), drugs availability, drug cost, 
response to treatment, side effects of drugs, distance of residence from treatment center, 
waiting time, travelling time, travelling cost, satisfaction with treatment and services, staff 
receptiveness towards the patients, history of default, treatment (in patient or out-patient), 
type of clinic(governmental or private), hospital referral, and difficulties facing tracing 
system for defaults [31,42,52-61]. 
4-Selected behavioral factors including; smoking, alcohol intake, IVDU and HIV status, 




5- Other factors influencing defaulting including; presence or absence of social support such 
as family support, health education and patient knowledge, stigma, chronic diseases,  
traditional treatment, feeling better, and need incentive[13,67-76].  
 When possible we extracted odds ratios (ORs), relative risks (RRs), and their 95% 
confidence interval. Otherwise the direction of the association and statistical significance 
was used. The relationship was considered consistent if the variable was reported in 3 studies 
or more to be statistically significantly related with non-adherence to tuberculosis treatment 
and more often statistically significantly related to non-adherence than none related. Ethics 
approval was not required for this systematic review. 
Results:  
The database searching resulted in a total of 2131 identified citations. About 981 
records remained after removal of duplication. Out of these 894 were excluded because they 
did not focus on the TB treatment and risk factors. Of the 87 abstracts that were potentially 
eligible, 34 were excluded after the review of the full paper or abstract (see Figure 1). Hence 
53 eligible articles were finally included. 
  Of these 53 eligible studies, 21 were conducted  in Africa, 19 in Asia, five in North 
America, four in Europe and four in South America.  
The study design included 26 cohort studies, 17 case control studies, eight cross-
sectional studies, and two surveys. The main characteristics of each study are reported in 
table-1.  
The factors associated with non- adherence to tuberculosis treatment are given in table 
(2a-e). Factors that were most frequently, consistently and statistically significantly related 
to tuberculosis treatment non-adherence were; low family income reported odds ratio(OR: 
1.61 to 11.24), patient moving or giving wrong address reported relative risk( RR:2.36 




phase of treatment(OR:1.78 to117.21), history of default (OR 1.09 to8.2) , long course 
treatment regimen (OR:1.096 to 6.9), response to treatment(OR: 2.4 to 9.9), side effect of 
drugs(OR:1.1 to 13.3), alcohol intake(OR:1.3 to 4.9) homeless (OR: 2.0 to 3.2), stigma(OR: 
2.0 to 5.0), seeking traditional healers( OR:1.9 to 5.7) ,staff receptiveness (OR: 1.7 to 12.3 
), lack of DOTS (OR: 1.42 to 2.29),poor knowledge or lack of health education(OR: 1.88 to 
8.67 ), lack family and social support (OR:2.14-3.23) and feeling better (OR:5.28 to 21.0).  
Factors frequently but not consistently related to tuberculosis treatment non-
adherence were: male, residential locality, distance to tuberculosis treatment unit, HIV 
status, IVDU, prison, and smoking.  
All  studies reported the default rates. The reported default rates ranged between 3% 
and 55.7%. These default rates varied substantially among the studies as either cumulative 
or incremental percentages of all patients. Also it varied according to regimen of treatment, 
age, sex, ethnicity, and residential locality. 
 All the papers included in the systematic synthesis had reported the number of 
patients (the sample size) participated in the individual study. The total number of the 
participant subjects in all articles was 165842.  
Ninety eight percent of the studies included in the systematic review showed a 
significant effect of the 17 related factors on TB treatment default. 
The number of studies showed increased risk of TB treatment default for each of the 
17 significant variables varied from 5 to 16 studies: 5/52 for homeless and seeking 
traditional healers; 6/52 for feeling better; 7/52 for response to treatment and stigma; 8/52 
for low family income, patient moving or giving wrong address ,and lack of family and 
social support ; 11/52 for long course treatment regimen, lack of DOTS, and side effects of 




relapse or multidrug resistant (MDR) TB, staff receptiveness and history of default; and 
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Table (1): The design of the studies (Patient characteristics associated with non-adherence to tuberculosis treatment) 




 Study type Population 
1  VAN DER Werf TS 
(1990)(15) 
Ghana 569 10 Retrospective 
cohort study 
Sputum-smear positive pulmonary tuberculosis (PTB) patients 
registered between 1984 and 1987 in a rural ambulatory non-
supervised service program in Agogo Hospital in the hills of 
Ashanti, Ghana, 
2  Chuah SY 
(1991)(17) 
Malaysia  227 33 Retrospective 
cohort study 
Tuberculosis patients in Perak started treatment in 1982. 
3 Menzies R  
(1993)(18) 
Canada 352 16 Retrospective 
cohort study 
 
Adult Tuberculosis patients treated at the tuberculosis clinic of 
Montreal Chest Hospital in 1987-1988. 
4 Me´ndez A P (1997) 
(66) 
USA 184 48 Retrospective 
cohort study 
All patients in New York City with a first-time positive culture 
for Mycibacterium tuberculosis in April 1991 were selected 
5 Ngamvithayapong, J 
(1997)(22) 
 
Thailand 412 26 Prospective 
cohort 
(i)blood donors who had indicated a desire to know their HIV 
test result; (ii) persons attending the hospital's anonymous 
counselling and testing clinic; (iii) patients attending the 
hospital's outpatient clinics for other illnesses but found to be 
HIV-infected, and (iv) female commercial sex workers  
6 Jochem K 
(1997)(24) 
Nepal 693 14.8 Prospective 
cohort study 
New cases of Smear positive tuberculosis patients. 
7 William J  
(1997)(20) 
USA 294 18 Retrospective  
cohort study 
All patients treated with outpatient DOT from 1984 to 1994 
8 KATE C. 
 (1998)(67) 
USA,  2,576  5.5 Cohort  study Adult patients at least(15 yr of age) reported as having TB in 
California during 1993. 
9  Comolet T M 
(1998)(27) 
Madagascar 149 25.5 Case-control 
study 
Sputum positive tuberculosis patient 










Table (1): The design of the studies (Patient characteristics associated with non-adherence to tuberculosis treatment) 
NO Author  Country  N Default 
rate 
Study type Population 
11 Borgdorff MW J. 
 2000)(63) 
Netherland  7529 10 Cohort study  
 
Tuberculosis patient in the Netherlands in the period 1993-1997 
12  El-Sony A I 
(2002) (13) 
Sudan 1797 16.9 cross-sectional study All persons aged 15–49 years with respiratory symptoms seen in 
the general health services from March 1998 to March 2000, from 
eight states in Sudan 
13 Tekle B(2002) (76) Ethiopia 1367 11.3 A case control study New tuberculosis patients  on DOTS 




303 5.6 A descriptive study TB patients and community members in the rural Tintswalo 
district ofthe Northern Province of South Africa registered with 
tuberculosis in the 18-month period 






5757 8 Nested case- control 
study 
Patients registered for antituberculous drug therapy in 1996in 
Hong Kong 
17 Sophia V, (2003) 
(54) 
India,  483 25 Case control study New and re-treatment smear positive patients followed up till 
treatment outcome from March to December 1999 and March 
1999 to September 2000. 
18 Robert M. (2004) 
(21) 
USA  372 12.6 Prospective cohort 
study 
Culture-positive patients who were reported from 1998-2000 




408 8.5 Nested case-control 
study 
All tuberculosis patients registered at the Government 
chest clinics from 1 January 1999 to 31 March 1999, 
20  Hill PC(2005), (42) Gambia,  301 25.2 Prospective cohort 
study 
New cases of TB aged >15 years who started their treatment 
between 16 October 2002 and 26 November 2003. 
21  Pandit, N S.K. 
(2006) (70) 
India 274 6.2 Cross sectional study All the patients who registered for DOT treatment during last 
quarter (Oct-Nov-Dec) 2002,  in Anand district, state Gujarat, 
India 
22 .Daniel OJ (2006) 
(64) 
Nigeria 774 23 Retrospective cohort 
study 
Adult Tuberculosis patients age 15 years and above registered for 
anti-TB treatment DOTS  between January 1997-December 2003 , 




Table (1): The design of the studies (Patient characteristics associated with non-adherence to tuberculosis treatment) 





Study type Population 






20 Prospective cohort 
study 
Smear-positive tuberculosis patients in Hossana Hospital 
24 Gelmanova IY 
(2007 )  (43) 
Russia 23
7 
8.8 Retrospective cohort 
study 
Detected, smear and/or culture-positive adult TB patients 
initiating therapy in a DOTS programme in Tomsk between 1 
January and 31 December 2001 
25 Fahrettin T 
(2008  ) (44) 
Turkey 58
6 
5.1 Retrospective cohort 
study 
 Adult pulmonary tuberculosis patient age more than 15 years in 
Istanbul Eyup  tuberculosis Dispensary between year 1999-2004 
26  Franke M F(2008) (50) Peru 67
1 
10 Retrospective cohort Patients with multi drug resistant TB disease 






40 Cohort study Registered TB treatment (non Thai)from 1 October 2004 to 31 
September 2006. 
28 Xu L  (2010) (33) China,  50
1 
9 A patient-based 
study survey 
Rural smear-positive pulmonary TB patients registered with the 
county TB dispensaries at study sites who completed treatment 
during the period October 2006 to September 2007. 
29 Kliiman K(2010) (65) Estonia 11
07 
9.4 a retrospective 
cohort study 
Patients with culture-confirmed pulmonary TB who started 
treatment during 2003–2005 
30 Samuel A  B (2010) (72) Ghana 16
5 
55.7 Cross-sectional study TB patients who had  registered in New Juaben District from 
January 2003 to December 2005 (TB Registry) and had fully 
completed their treatment during the time of the study 
31  Muture BN (2011) (45) Kenya 197
8 
16.7 A Case-Control study TB patients (adults and children) registered during the period January 
2005 to March 2007 
32 Kelly E D(2011) (51)  Morocc
o 
291 13 A retrospective cohort 
study 
Patients with smear- or culture-positive pulmonary tuberculosis 




12 Retrospective case 
control study 
Adult persons ≥ 18 years old enrolled in treatment under DOTS at 
public health facilities in South Africa between January 1 and December 
31, 2002. 
34 Culqui D R(2012), (56) Peru 789 5 An unmatched - case–
control study 
Patients diagnosed with tuberculosis from 2004 to 2005 who completed 











Study type Population 
35 Garrido MDS(2012) (60) Brazilia 11321 10 Case control study TB patients from 2005-2010 in the Amazonas State. 
36 Tamhane A(2012) 
(75) 
India 150 29 Cross-sectional 
study 
Newly diagnosed sputum smear-positive pulmonary tuberculosis (TB) 
patients. 
37  Nezenega ZS(2013) (61) Ethiopia 531 26 Cross sectional 
study 
TB patients on anti TB treatment in 11 public health centers and one 
hospital of Sidama zone 
38 Lalor M K(2013) (49) Uzbekis
tan 
710 20 A retrospective 
cohort 
Multi and extensively drug-resistant tuberculosis patients who started 
treatment between 2003 and 2008 and thus had finished approximately 2 
years of treatment by the end of 2010. 
39 Slama K(2013) (39) Morocc
o 
320 33.8 Case–control study TB patients (new cases or relapsed) who were enrolled in treatment for TB 
between 1 January 2009 and 31 December 2010 
40 Alobu I(2014), (35) Nigeria 1668 9.9 A retrospective 
Cohort Study 
Adult tuberculosis patients treated during 2011 and 2012 in two large health 
facilities in Elbony state 
41 Vasudevan K(2014) (59) India 564 5.9 Retrospective 
cohort study 
TB patients registered at  RNTCP in Puducherry, Southern India. 
42 Cherkaoui I(2014) (48) Moroco 277 3 Case-control study Adult patients with definite or probable pulmonary or extrapulmonary TB 
who either defaulted from TB treatment (cases) or successfully completed it 
(controls) were enrolled. 
43 Abdelhadi. A.A(2015) (36) Sudan 306 11 Case control study Pulmonary TB patient  
44  Lackey B(2015) (38) Peru 1233 10 A Cohort 
Study 
New adult smear-positive cases of pulmonary TB in a high-Incidence Area 
of Lima district 
45 Roy N (2015), (55) India 158 15 A case-control 
study 
New sputum-positive (NSP) tuberculosis (TB) patients in Darjeeling 
District, West Bengal, India from August’2011 to December’2011. 
46 Basa S(2015), (74) India  550 7.5 Cross sectional 
study 
TB patients registered under DOTS from January to June 2005 and to study 
the reasons for default in Mayurbhanj district, Orissa, India. 
47 Thelma E.(2016) (37) Philippi
nes 
273 38 Case–control study  More than 18 years of age with confirmed MDR or rifampin-resistant TB 





Table (1): The design of the studies (Patient characteristics associated with non-adherence to tuberculosis treatment): 
 
 
NO Author Country 
and area  
N Default 
rate 
Study type Population 
48 Saibannavar A (2016),  
( 47) 
India 411 6 A retrospective 
cohort study 
TB  defaulters patients 
49 Ahmed A(2016),(57) Sudan 315 14 Case control study Tuberculosis patients registered at tuberculosis centers at all provinces in 
Khartoum state from May 2010 to May 2011. 




14 Case control 
study 
Tuberculosis patients registered at tuberculosis centers at all provinces in 
Khartoum state from May 2010 to May 2011. 





7.2 A retrospective 
cohort study 
Pulmonary TB cases older than 15 years of age with a recorded pre-
treatment smear result registered in the ETR.Net electronic register 
52 El –Muttalut M 
(2017),  (40) 
Sudan 36
6 
16.4 A cross-sectional 
study 
TB patient in Kassala  State 






Pulmonary tuberculosis treatment Al-muglad rural hospital, Al-Muglad 

















Factors not associated 
1 Age 
15,32,34,71,35,36,4














37, 39, 40, 49, 55, 57, 58, 
50, 60, 65, 66  
3 Ethnicity 47 20,63,54, 66 17,31,42,72,46 
4 Marital status 22,,47 45 
15,31,32,44,71,33,46, 36, 
38, 39, 40, 73,49, 55, 56, 
57, 51, 75 
5 Educational level 46, 36, 38, 40 ,47,60 
15,27,45, 48, 57, 
50, 75 
22,41,54,70,32,44,33,72,39
, 55, 56, 65, 66, 76 
6 Occupation 17,47, 48, 57 72 
69,41,31,42,32,71,33, 36, 
37, 40 
7 Employment status 73, 74, 65 48, 75 54,43,45,46, 39, 49, 55, 76 
8 Family income 
62,33,72,45, 40, 73 
,47, 56  
54, 39 ,48, 66 32, 37,57, 75, 76 
9 Nationality, 63 20,46 18, 36 ,57  
10 Residential locality 27, 40, 57, 58,50, 65 20,45,35,34, 37  17,63,31,32,71, 48,60 
11 Religion 59  27,72,46,47, 56, 57 
12 




49, 75 55 
13 Family size  48 45, 57 , 75 











Table 2 b: Behavioral factors consistently associated with non-adherence:   










1 Smoking 31,39,48 41, 37, 38, 55 49, 58, 51, 75 
2 Alcohol intake 20,67,41,45,46, 37, 39, 
73, , 74,55 ,60, 65 
43,66 27,62,31, 49, 
58, 51, 65 
3 IVDU 67,43, 38, 56, 50, 66 51 20,62,71, 37, 
58  
4 HIV status 45, 34, 38,60 67,62,31,64, 66 20,63,13,71, 
58 
5 Homelessness 20,67,62,63, 66 65  
6 Prison 67,63, 65  62, 38 49,38, 71 



















Table 2 c: Treatment and services related factors consistently associated with 
non-adherence: : 











1 Treatment regimen(long 
course) 
18,24,13,54,72, 35, 
74, 49, 59, 50, 66 
 17,67,71,47 
2 Time of defaulting (intensive 
phase or continuation phase 
17,18,53,54,31,42,64,
45,  36, 59, 61, 76 
41, 37,48   
3 DOTS 15,62,21,70,53,33,35, 
74,48,60, 66 
 31 
4 Drugs availability 29, 61 72  
5 Drug cost 68,75  70 
6 Response to treatment 24,20,,29,54,42,43, 66 50  
7 Side effects of drug 29,31,70,43,72,37, 
74,48, 55,56,  76 
22, 54,46,45 15,20,27, 39  
8 Distance of residence from 
treatment center 
15,29,32,33,72,47, 74, 45, 57 17,22,54, 37, 
73, 48, 50, 76 
9 Waiting time 29, 61 45 70,46, 58 
10 Travelling time 27,42, 39 37, 57  15,70,43, 73,75 
11 Travelling cost 29,42 32, 57  15,70 
12 Satisfaction with treatment and 
services 
 73, 61  58 
13 Staff receptiveness 18,27,29,33,72,46, 37, 
73 , 74, 55, 58, 75, 61 
45  
14 History of default 18,41,53,54,31,45,46, 
70, 71, 72, 73 ,76 
51 65 
15 Treatment (in patient or out-
patient) 
22,31  46 
16 Type of clinic(governmental or 
private) 
 35  
17 Hospital referral 17   
18 Difficulties facing tracing 
system for defaults 
 55   
19 access health-care services 
within office hours 
56   
20 Too many patients when 
visiting health center 
58   
22 health center appearance  
 





Table 2 d: Disease related factors consistently associated with non-adherence:  












1 Type of tuberculosis 
-first time to develop TB 
- relapse 
- multi- drug resistant 
67,,62,41,53,43,
44,46,34, 38, 39 
, 49, 65 , 66 
 63,71,45, 37 
2 Severity of disease 22, 51  15,17,53, 66  
3 Sputum smear result 18,24,35,50, 51 63,34 15,17,13,53,31,64,43, 
37,60 , 65, 66 
4 Site of tuberculosis 35 17,41, 48, 57 53,44, 39, 66 
 
Table 2 e: Other (miscellaneous) factors consistently associated with non-
adherence: 











1 social support 29,72, 37, 74,48, 57, 
58, 76 
  
2 Health education, 
counseling and patient 
knowledge 
18,27,,29,54,70,72,45,
46, 37, 39,48 , 55, 56, 
58, 75, 76 
42 36 
3 Stigma 22,29,70,72,46, 36, 73 45, 58  
4 Chronic diseases 53,60 38, 50 31,71, 48 
5 Traditional treatment 72,45,46, 74, 75 41  
6 Feeling better 46, 36, 39, 40  , 74, 48    











The results of this systematic review show that family income, moving of 
patient or giving wrong address, tuberculosis relapse or MDR TB, intensive phase 
of treatment, history of default, long course treatment regimen, response to 
treatment, homeless, stigma, seeking traditional healers, staff receptiveness, DOTS, 
poor knowledge or lack of health education were consistently and statistically 
significantly related to tuberculosis treatment non-adherence. Surprisingly some 
frequently cited factors which were traditionally thought to be related to tuberculosis 
treatment non-adherence appeared to be not consistently associated with non-
adherence, these include age, sex, marital status, occupation, employment status, 
level of education. 
The most important methodological aspect of this systematic review that 
requires explanation is the use of a qualitative approach, i.e. counting statistical 
results of the patient characteristics related to non-adherence to tuberculosis 
treatment. Ideally, numerical results of individual studies are combined. However, 
when reviewing eligible studies it was discovered that in most of these primary 
studies only numerators were given if a factor was statistically significant related to 
non-adherence. Hence, only including the results of a characteristic if full numerical 
data was given had the potential to lead to an extreme bias. Since studies dating back 
to 1990 were included we assumed that it was unlikely to get full responses of all 
authors. Hence, we resorted to, admittedly a less optimal qualitative approach.  
Some other methodological aspects of this systematic review require 
attention: First of all, we attempted to identify all relevant articles published up to 
date of this review and found a large number of relevant references. However, due 
to language restriction and lack of resources we only included articles in the English 




definitions in many relevant studies. In addition, many relevant factors for non- 
adherence were not taken into account in many studies. Thirdly, the majority of 
articles included in this study were conducted in developing countries; the findings 
are therefore most applicable to countries with low resources which carry the 
greatest burden of TB disease and where urgent interventions are needed to improve 
adherence to tuberculosis treatment. However, our findings may also be applicable 
to more developed countries. Fourthly, our review took many types of risk factors 
(social and biomedical) for non - adherence to TB treatment into account while many 
individual articles solely have focused on the factors related to health services 
provision. 
   Overall we trust that the factors identified as consistently related to TB 
treatment non-adherence are of truly associated with non- adherence. For the 
potential risk factors for non-adherence that were not consistently associated a 
numerical approach in large data set of new studies might still show an association. 
However, it is likely that these associations are of little importance. 
Exploration of the factors associated with non-adherence to tuberculosis 
treatment deserves some attention. Some of these factors identified can be changed 
and solved. These include factors associated with patient behavior: moving of patient 
or giving wrong address, homeless, stigma and seeking traditional healers, and 
factors related to treatment services: not on DOTS, long course treatment regimen, 
staff receptiveness and poor knowledge or lack of health education .Other factors 
related to non- adherence are difficult to change as they are not of patients or the 
treating physician control. Most of these factors are related to the treatment and the 
system of services provision and include: low family income, tuberculosis relapse 




treatment. Hence, the presence of these factors might guide to the targeting of extra 
attempts to stimulate treatment adherence. 
The doctor-patient-relationship offers good environment for communication 
giving patients comfort in expressing the obstacles they face during treatment 
course. This enables treating doctors and health worker staff to analyze patients’ 
problems and provide advice, counseling and health education regarding type of 
disease, side effect of drug, duration of treatment, implementation of DOT short 
course program. Moreover, it will enable health care workers to be more flexible 
with patients in giving them choices and options that maintain their autonomy in 
treatment compliance and to overcome obstacles related to health services provision. 
The doctors and health worker staff receptiveness and their effort in 
counseling and health education provision increases awareness of patients and their 
families and the whole community about Tuberculosis. The social support positively 
affects the patients’ knowledge to counteract the feeling of guilt and shame (stigma). 
This will be reflected on patients’ compliance with tuberculosis medication instead 
of seeking traditional medicine. Patients’ compliance assists the tuberculosis control 
program to achieve high cure rates and decrease the MDR prevalence in the 
community. 
 This synthesis suggests that governmental and nongovernmental 
organizations need to give more attention to support poor patients financially and 
offer accommodation for the homeless. Another cost effective suggestion is to 
consider even distribution of health services to improve its availability, accessibility 
and affordability to all tuberculosis patients. This, combined with good referral 
system from health unit to hospital, will result in reduction of the cost of travelling, 
waiting time at tuberculosis clinic, and patient movement. Besides, good counseling 




change of address to health worker staffs and therefore improve adherence to 
tuberculosis treatment. 
The review findings are important for the policy makers, medical 
practitioners, health worker staff and researchers to study the patient context as a 
whole (social, behavioral factors, believes and knowledge) and not to ignore their 
experience and opinion in treatment course. This will make the health care consumer 
share the responsibility of the treatment process and will combat non-adherence. 
Moreover, it helps in creating good relationship between the patients, health care 
providers and the whole community. This new approach in thinking will improve 
tuberculosis treatment adherence and will reinforce the surveillance system of 
tuberculosis control program at state, national and international levels. 
 In addition to the findings of this systematic review we believe that further 
studies are needed to be conducted to deeply understand different aspects of 
tuberculosis disease and its treatment (social and biomedical) aspects which is a 
complex process. These studies should include the experience of policy makers, the 
health personnel working in the field, nongovernmental organizations, patient 
support groups and the community leaders. Moreover, the patients’ knowledge about 
tuberculosis for example, patient satisfaction with health services provision and staff 
receptiveness. This will substantially help the health care system planners in 










Non adherence to tuberculosis treatment is a complex dynamic process which 
was influenced by multiple factors. Identifying and understanding the nature of these 
factors facilitates development of appropriate and effective intervention plans.  
The relationship between the identifiable variables and TB treatment default 
is important for the knowledge of policy makers and clinicians dealing with TB 
patients. Despite the fact that association of these variables with increased risk of 
TB treatment default had been reported in many individual studies, it had not 
received attention in terms of planning, training, guidelines, and research. This 
systematic review attempts to alter the current situation with the aim to increase 
Knowledge about treatment default and to promote adherence to TB treatment.  
The results of our review can help to find out the consistently statistically 
related factors to TB default treatment and assist the health care system designers, 
health service providers including clinicians, nurses, counselors, patients, families, 
and the community leading to high adherence to tuberculosis treatment, reinforcing 
the surveillance system of tuberculosis control program hence achieving the goal of 
tuberculosis elimination at state, national and international levels. 
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      Despite the Treatment pulmonary TB patients, defaulting from treatment may 
remain the major challenge to control TB. In addition, it increases the risk of drug 
resistance, relapse, and death and may prolong infectiousness. Our objective was to 
identify determinants of treatment defaulting among TB patients in Khartoum State, 
Sudan.  
Methods: 
We conducted a case control study where the  patients defaulting from treatment 
were considered as ‘cases’ and those completing treatment as ‘controls’ between 
May 2010 to May 2011.  
Results: 
  There were 2727 TB patients who attended TB treatment clinics during study 
period. Out of these 2399 patients (86%) had continued their treatment while 328 
patients (14%) had interrupted it. 105 cases were traced and interviewed. In addition 
210 patients who had continued their treatment were included (controls). In the 
multivariate analysis the variables that remained in the model were: residential 
locality (rural area) (OR 2.58; 95% CI 1.4 -4.67), patients moving or changing 
address(OR 5.47; 95% CI 2.90- 10.35), absence of family support (OR 2.14; 95% 
CI 1.12 - 4.11),and occupation (blue collar work) (OR 2.38; 95% CI 1.39 -4.10). 
Conclusions: 
The results of this study conclude some socio-demographic factors influence 
defaulting  of TB treatment. We believe that the findings are applicable to current 
situation of TB management and control in Sudan and other developing countries 
 





 Tuberculosis (TB) as a disease has been known ever since the dawn of man’s 
history [1].  In 1993 the World Health Organization (WHO) declared that TB was the 
major global public health problem [2]. It is estimated that one-third of the world’s 
population (approximately two billion people) have been affected by the 
mycobacterium tuberculosis[3-5].The WHO estimates that currently about 9.4 million 
new TB cases occur each year and that approximately 1.8 million deaths annually are 
related to TB[6-7].  
 In 2010, it was estimated that in Sudan there were 209 cases of active TB per 
100.000 of populace with an annual incidence of new cases of 119/100.000, resulting 
in approximately 37.000 new cases each year in Sudan. Hence, Sudan shoulders about 
15% of TB burden in the Eastern Mediterranean Region and has the second highest 
active TB prevalence of the countries in this region. In addition, the estimated death 
rate related to TB, including HIV infected TB patients, was 24/100.000 per year [8]. 
 Treatment of active pulmonary TB patients remains the most effective strategy 
to stop the spread of the disease [9,10]. Defaulting from treatment may remain the 
major challenge to control TB. In addition, it increases the risk of drug resistance, 
relapse, and death and may prolong infectiousness [11-15]. Non-compliance with 
therapy is considered a priority for researchers because it remains unclear how to 
identify patients at risk for non-compliance, or how to effectively intervene with such 
patients [16]. The high rate of patient defaulting TB treatment in Khartoum State makes 
the identification of risk factors leading to this default essential. The present study was 
conducted to identify determinants of treatment defaulting among TB patients. Such 
information could help to put forward suggestions and recommendations that can lead 





This was an observational case control study where the  patients defaulting from 
treatment were considered as ‘cases’ and those completing treatment as ‘controls’.  
Setting 
This study was conducted in Khartoum State. In 1993, the Ministry of Health in 
Khartoum State established a tuberculosis control program.  The decentralized 
healthcare system in Khartoum is divided into seven districts and 19 health areas. Its 
health facilities include 43 hospitals, 147 health centers, 185 NGOs centers, 235 
dispensaries and 365 primary health care units. TB services are delivered in primary 
health care along with all other routine health services. A registered nurse is 
designated responsible for treatment and follow up for continuation of treatment in 
the primary health care unit. This primary health care unit is the basic unit of 
management of the program and also the unit of reporting. Personnel at the primary 
health care unit responsible for tuberculosis services include a medical assistant, a 
laboratory technician and a clerk.  The program provides care through the DOTS 
strategy (Directly Observed Treatment with Short course chemotherapy) as 
recommended by WHO. TB patients receive their treatment through 53 TB treatment 
units distributed all over the state[17]. 
Population  
The reference population for this study comprised all tuberculosis patients registered 
at tuberculosis centers at all provinces in Khartoum state from May 2010 to May 
2011. The data collection was done from 1th of May 2011 to 15th of July 2011.  
The inclusion criteria for both cases and controls were; patients age more than 15 
years and clinically and laboratory diagnosed as tuberculosis, registered at the 
treatment units in Khartoum States. Cases were those patients identified as TB 




each case (defaulter) without exclusion criteria, the next 2 subsequent patients 
without exclusion criteria, who came for treatment or follow up, without defaulting, 
in the same TB treatment unit or the near one in the same area, were taken as control 
into the study. The patients were excluded from the study if they were: too ill for 
interview, had a psychiatric illness, or gave incorrect address and could not be traced.  
The following definitions were applied according to the World Health Organization 
(WHO, 2002). Treatment default: an interruption of TB treatment for two or more 
consecutive months during the intended treatment period. Pulmonary TB: a patient 
with tuberculosis disease involving the lung parenchyma. Extra-pulmonary TB: a 
patient with tuberculosis of organs other than the lungs (e.g. pleura, lymph nodes, 
abdomen, genitourinary tract, skin, joints and bones, meninges). Diagnosis should 
be based on a culture-positive specimen, histological evidence or strong clinical 
evidence consistent with active extra-pulmonary disease, followed by a decision by 
a clinician to treat with a full course of anti-tuberculosis chemotherapy. A patient in 
whom both pulmonary and extra-pulmonary TB has been diagnosed was classified 
as pulmonary TB[18-20]. 
Data Collection 
Information on disease related factors and treatment related factors were 
retrieved from patients' medical records. In addition, a face to face interview was 
held, using a standardized questionnaire by trained interviewers to elicited 
information on the various factors possibly associated with treatment defaulting. 
The following variables were collected: socio-demographic factors including; age, 
sex, ethnicity, marital status, educational level , occupation, employment status, 
family income, nationality,  residential locality,  distance of residence from treatment 




of transport to the  health center, travelling cost to health centre, waiting time, family 
support and site of tuberculosis[9,11,21-28]. 
Before the start of data collection the interviewers had been trained on how to 
interview the respondents, and had been given instructions on how to fill the 
questionnaire. After that, pretesting was conducted by interviewing few patients. 
Based on the pretesting results the questionnaire was used without any major 
changes. 
Statistics 
 The sample size was calculated according to Fleiss J.L(1981) [29]  using a 
two sided type one error of 0.05 and a power of 80% and the ability to detect an odds 
ratio of 2.0 with a exposure frequency of 30% in the control group and a ratio of 
cases to controls of 1:2. This yielded a sample size of 105cases and 210 controls.  
 Data were reviewed for consistency and completeness. Data analysis was 
performed in SPSS(Statistical package of Social Sciences) version 16. The 
Demographic characteristics of cases and controls were compared using test for 
qualitative  variables and student’s t tests for continuous variables.  Univariate and 
multivariate analysis were conducted. Descriptive statistics were calculated for all 
dependent variables. Logistic regression was used to calculate the odds ratio and its 
95% confidence interval. Variables that were related to treatment default with a p-
value less than 0.20 were entered in a multivariate model, using a backward approach 
[30, 31].  
 Ethical Considerations 
 Ethical approval was obtained from Ministry of Health Khartoum State ' 
ethical Committee. Permission was granted by public committee leaders in the 
localities through official letters. Informed verbal consent was secured from every 




confidentially was maintained. Prior to the arrival of the data collection team the 
respondents had been informed regarding all relevant aspects of the study , including 
the purpose of the study, interview process and potential benefits. The interviewers 
introduced themselves to respondents and outlined the scope of interview and its 
approximate length to the potential respondents at the beginning of each interview. 
the respondents had been informed that the participation was entirely voluntary, and 
that privacy and confidentially will be maintained during data processing and 
reporting. Potential respondents also were informed that they had the right to refuse 
to participate, or to end the interview at any time. 
Results 
Patients 
 There were 2727 TB patients who attended TB treatment clinics during study 
period. Out of these 2399 patients (86%) had continued their treatment while 328 
patients (14%) had interrupted it. Out of these, 185 patients had defaulted prior to 
the data collection period. Hence, 143 patients were potentially eligible as cases. Of 
these 15 had given a wrong address and 12 had moved out of Khartoum State and 
could not be interviewed. A further 11patients refused the interview. Hence, 105 
cases were traced and interviewed. In addition 210 patients who had continued their 
treatment were included (controls). The demographic and TB characteristics are 
given in table 1a and table1 b. Cases and controls were of similar age, but cases lived 
more often in a village and at a greater distance from the TB center. Also, they were 
more often illiterate, had less family support and were more liable to give a wrong 
address or to move during treatment period without informing the treatment center.  
Risk factors for defaulting 
In the univariate analysis the socio demographic factors found statistically 




(illiterate), distance to health center, residential locality (rural area), patients moving 
or changing address, time to clinic  >60minutes, no family support and, occupation 
(blue collar work) Table 2. 
In the multivariate analysis the variables that remained in the model were: 
residential locality (rural area), patients moving or changing address, absence of 
family support and occupation (blue collar work). The adjusted odds ratios with their 
corresponding 95% confidence intervals are given in Table 3. 
Discussion 
The results of present study showed that 14% of TB patients in Khartoum 
State were treatment defaulters. Also we identified several factors associated with 
TB treatment default which included:  educational level (illiterate), distance to health 
center (more than 5 kilometer), type of residential area (village), moving, absence of 
family support, and occupation (blue collar work). Surprisingly, the traditional 
factors thought to be related to TB treatment default (e.g. age, religion, family 
income, family size, house size and travelling cost) were found not statistically 
associated with default in this study. 
         The findings of this study are similar to results in developing countries with 
low resources in Africa and Asia which carry the highest burden of TB[22-28]. We 
observed that patients moving or giving wrong address were more likely to default 
their TB treatment. These findings are similar to results of other studies in 
developing (Uganda, South Africa) and developed countries (USA) [21,26,28]. 
However, in a recent study in Malaysia, changing of residence was not associated 
with TB default[22]. 
       We could confirm that rural residence, distance to health center (more than five 
kilometers), educational level (illiteracy), and absence of family support were 




defaulting TB treatment is well recognized as mentioned by Tatek in (Ethiopia), [23] 
Bernard N Muture in (Kenya) [9] and Samuel A (Ghana) [25]. However our findings 
were in contrast to those reported by Nyi and Chuah from Malysia the rural 
residence, distance to health center, and educational level were not associated with 
TB treatment default[11,22]. 
The present study showed no significant association between TB treatment 
default and the following socio-demographic factors: age, sex, ethnicity, marital 
status, nationality, means of transport to the  health center,  waiting time, religion, 
family income, family size, house size,  travelling cost the and site of tuberculosis. 
These findings are similar to those reported by Nyi from Malaysia, but differ from 
those  reported by  Jaggarajamma K. in India, Connoly C. in South Africa and Kelly 
E Dooley in Morocco  where  age (older more than 45 years/younger less than 45 
years) and female sex were related to  TB treatment default.   
The results of this study might help the policy maker in Khartoum state, Sudan 
and developing countries in planning and policy development to strengthen TB 
control programs in general. Attention for and exploring of the factors that are –even 
with the DOTS-approach – still strongly associated with TB treatment default could 
be done.  
An important issue seems health education and counseling provided by health 
workers for TB patients including their families. These efforts should encourage 
patients and their families to adhere to TB treatment and also help to ensure family 
support during the treatment period.  
Changing address and moving to other place continues to be a challenge for 
TB treatment adherence. TB patients and their families should give their home 




recording of the address of a (more distant) family member living at a different 
location could be used to increase tracking ability of the health care workers.  
This study showed that those who lived in the rural areas or if the distance of  
their residences is more than five kilometers from the TB treatment centre were more 
than two times likely of  being non compliance to TB treatment than those lived in 
urban areas or their residence is less  than 5 kilometers to TB treatment centers.  
Hence, the Provision of health services and accessibility in the rural areas and near 
to residence of TB patient will enhance the patients compliance to treatment.  For 
those who had no work or of low socioeconomic status. They need more attention 
from the governmental and nongovernmental organizations to support TB patients 
financially and socially. Overall the results of present study raise very important 
issues on TB default and socio-demographic predictors factors in Sudan since there 
were no previous details studies on this field. This results can help in decreasing the 
TB treatment default. Hence, decreasing treatment failure, multi drugs resistant, 
treatment relapse and spreading of tuberculosis in the community. 
There are some methodological aspects of this study need attention: firstly, 
this study was conducted in Khartoum State, capital of Sudan which is the most 
populated state in Sudan. The population in this state could be safely stated to 
represent the whole country as most of the inhabitants are drawn from various parts 
of Sudan. Hence, the results of this study apply to other parts of Sudan. In addition, 
the TB patients included in this study were selected from all tuberculosis treatment 
units (health centers and hospitals)  in the state . By this fact, the generalization of 
the study findings to total tuberculosis population in the state and Sudan could be 




Secondly, the recall bias was minimized by reviewing the patient medical 
records and cross checking for each study variables, and avoiding rush questioning 
during interview period. 
  Thirdly, the reliability and sensitivity of information gathered from each 
subject could not be counterchecked. Although questions about sensitive issues were 
carefully tackled using a warm approach and ensuring strict and uninterrupted 
communications, so as to maximize the validity of the responses obtained.   
Fourthly, possible confounders were taken into consideration in the design (by 
restricting the diagnosis criteria) and by using logistic regression. 
Lastly, the major problem we faced during this study was how to reach the 
defaulting patients (cases) for this study. This problem was tackled stepwise. Firstly, 
their medical records were traced and identified and all contact information was 
reviewed. Then, study personnel used the following sequence of contact attempts: 
calls – first to the patient and thereafter to known family members or friends -  and 
home visits - first to patient and thereafter to known family members or friends. 
Interestingly, it appeared during the study that many of the defaulting patients did 
not have access to mobile telephones, a risk factor not previously described. The 
interviewers made an average of three attempts to contact each defaulter before 
deciding that a defaulter was a non-respondent. Due to the proportion of defaulters 
who could not be traced and retrieved, the generalizability of the findings to the 
whole population of patients with tuberculosis should be done with caution. 
Conclusions: 
The results of this study conclude some socio-demographic factors (rural 
residence, occupation(blue colour work), those without family support and those 




treatment. We believe that the findings are applicable to current situation of TB 
management and control in Sudan and other developing countries.  
What is known about this topic? 
 TB is a major health problem in Sudan. 
 defaulting from treatment remain the major challenge to control TB 
disease. 
 Defaulting from treatment increases the risk of drug resistance, relapse, 
and death and may prolong infectiousness 
  
What this study adds 
 This study provides valuable information on risk factors leading to TB 
treatment default in Sudan. 
 The current study confirms the high default rate in Khartoum state which 
mentioned in previous studies. 
 Special attention should be given to TB patients and  their families and 
patients address to enhance treatment compliance.  
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Table 1. Demographic and social characteristics of the study population.  





Age – mean (SD*) 32.8 (14.4) 34.6 (14.9) 0.339 
   Between 15 and 30 years 56 (53.3%) 100 (47.6%)  
   Over 30 years 49 (46.7%) 110 (52.4)  
Sex   0.98 
  Male 74 (70.5%) 128 (60.9%)  
  Female 31 (29.5%) 82 (39.1%)  
Site of tuberculosis   0.39 
  Pulmonary 92 (87.6%) 180 (85.7%)  
  Extra-pulmonary 13 (12.4%) 30 (14.3%)  
Type of residential area   0.001 
  City 64 (61.0%) 169 (80.5%)  
  Village 41 (39.0%) 41 (19.5%)  
Distance to clinic   0.005 
  Between 1 and 5 kilometers 35 (33.3%) 105 (50.0.%)  
  More than 5 kilometers 70 (66.7%) 105 (50.0.%)  
Patient moving or giving wrong address   0.001 
   Yes 41 (39.0%) 23 (11.0%)  
    No 64 (61.0%) 187 (89.0%)  
Inform clinic when moving   0.002 
   Yes 7(17.1%) 10 (43.5%)  
    No 34 (82.9%) 13 (56.5%)  
Type of transport to get to clinic   0.103 
    On foot or by bicycle 7(6.7%) 25(11.9%)  
    With car or public transport 98(93.3%) 185(88.1%)  
Transportation cost   0.06 
   Less than 3 Sudanese pound(SD) 61(58.1%) 101(48.1%)  
   3 Sudanese pound(SD) or more 44(41.9%) 109(51.9%)  
Time to clinic   0.048 
    Up to 60minutes  83(79%) 184(87.6%)  
    More than 60minutes 22(21%) 26(22.4%)  















Table 1: Demographic and social characteristics of the study population. 





Marital status   0.178 
   Single 50 (47.6%) 87 (41.4%)  
   Married 55 (51.4) 123 (58.6)  
Family size   0.484 
   Less than 4 members 17(16.2%) 36 (17.1%)  
4 members or more 88(83.8%) 174 (82.9%)  
House size(room number)   1.00 
  Less than 3rooms 41 (39%) 82(39%)  
  3 rooms or more 64(61%) 128(61%)  
Family income =(mean, SD)     (1.14,  0.447  ) (1.24,  0.575  ) 0.07 
Less than 1000 Sudanese pound(SP) 93(88.6%) 171(81.4%)  
  1000(SP) or more 12(11.4%) 39 (18.6%)  
Family support   0.001 
 Those with family support 73(69.5%) 180(85.7%)  
 Those without family support 32(30.5%) 30(14.3%)  
Occupation   0.001 
  Blue collar work  66(62.9%) 91(43.3%)  
 White work 39(37.1%) 119(56.7%)  
Nationality   0.523 
 Sudanese 98(93.3%) 197(93.8%)  
 Non-Sudanese 7(6.7%) 13 (6.2%)  
Educational level   0.005 
  Illiterate 24 (22.9%) 23(11%)  
  Literate 81 (77.1%) 187(89%)  
Religion   0.370 
  Muslim 95(90.1%) 196(92.3%)  

















Table 2: Socio-demographic factors associated with TB treatment default 
Socio-demographic factor Odds ratio (OR)    95% C .I 
Age group   
  Between 15 and 30 years  vs.  Over 30 years 0.80 0.50 -1.27 
Sex   
   Male vs.   Female 1.53 0.93-2.53 
Site of tuberculosis   
    Pulmonary vs.    Extra-pulmonary 1.18 0.60-2.37 
Residential locality   
    Village  vs.      City    2.64 1.57-4.44 
Distance   
  More than 5 kilometers vs  Between 1 and 5 kilometers  2.000 1.23-3.26 
Patient movement   
Patient moving or giving wrong address vs.Those not moved 5.21 2.90-9.34 
Inform clinic when moving   
  Those not informed the clinic vs. 
  Those Inform clinic when moving  
6.31 1.98- 20.11 
Type of transport to get to clinic   
   On foot or by bicycle vs With car or public transport 1.89 0.80-4.53 
Transportation cost   
   Cheap vs    Expensive 0.67 0.42- 1.10 
Time to clinic   
  More than 60minutes vs Up to 60 minutes   1.88 1.01-3.50 
Marital status   
  Single vs   Married 1.29 0.80-2.06 
Family size   
 Less than 4 member vs  More than 4 members 0.93 0.50 -1.76  
House size(room number(   
 Less than 3rooms vs 3 rooms or more  1.00 0.62- 1.62 
Family income   
 Less than1000 Sudanese pound(SP) vs 1000(SP) or more 1.77 0.88- 3.54 
Family support   
 Those without family support vs. Those with family support 2.63 1.49-4.64 
Occupation   
  Blue collar work vs  White work     2.21  1.37- 3.58 
Nationality   
 Non-Sudanese vs.  Sudanese  1.08 0.42- 2.80 
Educational level   
  Illiterate vs  Literate 2.64 1.57-4.44 
Religion   





Table 3: Adjusted Odds Ratio (the model) factors associated with non- adherence 
 ( OR and 95% C,I): 
Socio-demographic factors Odds ratio 
(OR) 
  95% C .I 
Residence   
   (rural  versus urban) 2.58 1.43  -  4.67 
Occupation   
  (blue collar work vs white work) 2.38 1.39 -4.10 
Family support   
 those without family support vs those with family support 2.14 1.12 - 4.11 
Patient movement   
  those moving or giving wrong address vs  
  those not   moved during treatment period 
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 Defaulting on tuberculosis (TB) treatment remains a challenge to controlling 
TB. This case-control study aimed to identify determinants of treatment default 
among TB patients attending treatment clinics in Khartoum State from May to July 
2011. Cases were TB patients who defaulted on treatment and controls were those 
who completed treatment. Of the 2727 TB patients attending the clinics, 328 (14%) 
had defaulted. Of these, 185 had resumed treatment before data collection and 143 
had not and were eligible as cases. Of the 143, 27 could not be 
traced and 11 declined to participate. Thus, 105 cases and 210 controls were included 
and interviewed. The variables significantly associated with treatment default were: 
rural residence (OR: 2.68; 95% CI: 1.51–4.73), not being on a DOTS programme 
(OR: 2.53; 95% CI: 1.49–4.30), having side-effects from treatment (OR: 1.94; 95% 
CI: 1.14–3.29), and having a history of TB (relapse, multidrug-resistant TB or 
treatment failure) (OR: 5.11; 95% CI: 2.69–9.69). Attention should be paid to these 
groups at risk of defaulting to encourage treatment adherence and continuation. 
 









Tuberculosis (TB) has been known for a long time and is still a major public 
health problem (1). Worldwide TB kills more young and middle-aged adults than 
any other infectious disease, although it is a curable and preventable disease (2). The 
World Health Organization 
(WHO) estimates that currently about 9.6 million new TB cases occur each year and 
that about 1.5 million deaths annually are related to TB (3,4). 
In 2010, it was estimated that the prevalence of TB cases in Sudan was 209 
per 100 000 population with an annual incidence of new cases of 119 per 100 000, 
resulting in about 37 000 new cases each year in Sudan. Hence, Sudan has about 
15% of the TB burden in the WHO Eastern Mediterranean Region and the second 
highest active TB prevalence of the countries in this region. In addition, the 
estimated death rate related to TB, including HIV-infected 
TB patients, was 24 per100 000 per year (5). 
Successful treatment of TB involves taking anti-TB drugs for at least 6 months 
(6,7). The therapeutic regimens given under direct observation short course therapy 
(DOTS) as recommended by WHO have been shown to be highly effective for both 
preventing and treating TB (8,9). The health authority of Sudan follows the strategies 
for TB prevention and treatment recommended by WHO. Despite the efforts that 
had been made by health authorities, some patients still do not follow their TB 
treatment and do not complete the intensive stage of treatment. As defined by WHO, 
patients who fail to collect their TB treatment for 2 consecutive months are reported 
as defaulters (10). Defaulting on TB medication is a major barrier to its local and 
global control. In addition, defaulting increases the risk of drug resistance, relapse 
and death, and may prolong infectiousness (11–15). The TB patient treatment default 




default on TB treatment in Khartoum State makes the identification of the risk 
factors leading to patients to default essential. In a previous paper, we reported on 
the sociodemographic factors associated with non-adherence to TB  treatment (17). 
In the present paper we identify the disease- and treatment-related determinants of 
treatment default among TB patients in Khartoum State. This information could help 
to suggest actions that could lead to a reduction of TB treatment defaulting. 
Methods 
Study design 
This was an observational case control study. Cases were the patients who 
defaulted from treatment and controls were those who completed treatment. 
Setting 
This study was conducted in Khartoum State. In 1993, the Ministry of Health 
in Khartoum State established a TB control programme. The decentralized health 
care system in Khartoum is divided into 7 districts and 19 health areas. Its health 
facilities include 43 hospitals, 147 health centres, 185 centres run by 
nongovernmental organizations, 235 dispensaries and 365 primary health care units. 
TB services are available in 53 of the primary health care centres in Khartoum State 
and is where TB patients receive their treatment (16). A registered nurse is 
designated responsible for TB treatment and follow up of continuation of treatment 
in the primary health care unit. This primary health care unit is the basic unit of 
management and reporting of the TB programme. Staff at the primary health care 
unit responsible for TB services include a medical assistant, a laboratory technician 
and a clerk. The programme provides care through the DOTS strategy as 







Our cases and controls were drawn from all TB patients attending the 53 
treatment clinics in Khartoum State. The inclusion criteria for both cases and 
controls were: patients over 15 years who were clinically and laboratory diagnosed 
with TB and registered at the treatment units in Khartoum State. Cases were those 
patients identified as having defaulted on TB treatment during the data collection 
period. Following identification of each case (defaulter), without exclusion criteria, 
the next 2 patients who had completed their treatment without defaulting were 
included as controls, without exclusion criteria. They were attending the clinics 
because they had been requested to come for follow up, in the same TB treatment 
unit or the nearest one in the same area, either to do the final sputum smear or to 
collect the smear results. Patients were excluded from the study if they were too ill 
for interview, had a psychiatric illness or had given an incorrect address and could 
not be traced.  
The interview process was done from 1 May 2011 to 15 July 2011, but in 
order to reach the target defaulted group for the interviews, we used clinic records 
for the patients registered from May 2010 to May 2011. 
TB and treatment definitions 
The following definitions were applied. A pulmonary TB patient was one with 
TB disease involving the lung parenchyma. An extra-pulmonary TB patient was one 
with TB of organs other than the lungs (e.g. pleura, lymph nodes, abdomen, 
genitourinary tract, skin, joints and bones and meninges). A patient in whom both 
pulmonary and extrapulmonary TB were diagnosed was classified as pulmonary TB 
(10). 
Treatment default was defined as an interruption of TB treatment for 2 or more 




patient previously treated for TB who has been declared cured or has completed 
treatment and is diagnosed with bacteriologically positive (smear or culture) TB. 
Treatment failure was defined as a patient who is sputum smear positive at 5 months 
or later during treatment. Multidrug resistant (MDR) TB was defined as TB 
resistance to at least isoniazid and rifampicin. Side-effects of treatment were defined 
according to a patient’s  complaint and as identified by doctors and taken from the 
records (5,18–20). 
Drug regimen was defined as a drug or several drugs given in certain doses 
for a stated duration, as described by the treating doctor according to the national TB 
control programme. All new TB patients should receive the category 1 (CAT1) 
regimen for 6 months, which includes rifampicin, isoniazid, pyrazinamide and 
ethambutol. The category 2 (CAT2) treatment regimen is used for retreatment of TB 
patients; it lasts for 8 months and includes streptomycin in the first 2 months 
(5,10,19). 
DOTS is directly observed treatment, or watching the patient take his/ her 
medication to ensure medications are taken in the right combination and for the 
correct duration (10,19). 
Data collection 
Information on disease-related and treatment-related factors was retrieved 
from the medical records of the patients. In addition, face-to-face interviews were 
held, using a structured questionnaire, by trained interviewers to obtain information 
on the various factors possibly associated with treatment default. The questionnaire 
was pretested on 35 patients and, based on the results, was used without any major 
changes. All TB patients who had defaulted prior to the data collection period were 
identified and their address retrieved from patient records. Then, the interviewers 




and then to known family members or friends, and then home visits, first to patient 
and then to known family members or friends. If there was no telephone number on 
record, home visits were made.  
Data on the following variables were collected: sociodemographic 
characteristics including age, sex, residence (urban/rural); and disease- and 
treatment- related factors including BCG vaccination status, sputum smear result, 
treatment regimen, on a DOTS programme or not, chest X-ray, response to 
treatment, side-effects from treatment, sputum smear after 2 months, previous 
history of TB (including relapse, treatment failure and MDR-TB), other treatments 
sought, and other chronic diseases, e.g. diabetes mellitus (1,4,11,16,20–22). 
Statistical analysis 
The sample size was calculated according to Fleiss (1981) (23–25) assuming 
a two-sided type one error of 0.05, a power of 80% and the ability to detect an odds 
ratio (OR) of 2.0 with an exposure frequency of 30% in the control group and a ratio 
of cases to controls of 1:2. This gave a sample size of 105 cases and 210 controls.  
Data were reviewed for consistency and completeness. Data analysis was 
performed in SPSS, version 16. The demographic characteristics of the cases and 
controls were compared using the chi-squared test for qualitative variables and 
Student t-test for continuous variables. Univariate and multivariate analyses were 
done. Descriptive statistics were calculated for the dependent variable (treatment 
default). Logistic regression analysis was done to calculate the ORs and its 95% 
confidence intervals (CI). Variables that were related to treatment default with a P-








Ethical approval was obtained from the ethics committee of the Ministry of 
Health, Khartoum State. Permission was granted by public committee leaders (senior 
health officers at the locality: director of health services, health team coordinator and 
PHC director) in the localities through  official letters. Informed verbal consent was 
obtained from every eligible patient included in the study before the interview. Prior 
to the interview, all relevant aspects of the study were explained to the participants, 
including the purpose of the study, interview process and potential benefits. The 
interviews took place at the TB units in a suitable and separate room. The 
interviewers introduced themselves to the participants and outlined the scope of the 
interview and its approximate length at the beginning of each interview. The 
participants were informed that participation was entirely voluntary, and that privacy 
and confidentially would be maintained during data processing and reporting. 
Potential respondents also were informed that they had the right to decline to 
participate, or to end the interview at any time without jeopardizing their right for 
care and treatment.  
Privacy and confidentially were maintained and the information was used 
only for this study and will not be used by any other person for any other purposes. 
Results 
Cases and controls 
There were 2727 TB patients who attended the 53 TB treatment clinics in 
Khartoum State during the study period. Out of these, 2 399 patients (86%) had 
completed their treatment while 328 patients (14%) had interrupted treatment. The 
328 patients were divided into 2 categories: 1) 143 who had defaulted and never 




cases; and 2) 185 who had defaulted but were traced and came back to continue 
treatment before the start of data collection, who were excluded. 
Of the 143 eligible cases, 15 had given a wrong address and 12 had moved 
away from Khartoum State and could not be interviewed. A further 11 patients 
declined the interview. None of the cases was too ill for interview or had a 
psychiatric illness. Hence, 105 cases were traced and interviewed. In addition, 210 
patients who had completed their treatment were included as controls; none declined 
to participate. 
Demographic characteristics of the cases and controls 
The demographic characteristics of the cases and controls are given in Table1. 
Among the cases, 70.5% were males compared with 60.9% among the controls. The 
mean ages and standard deviations (SD) were 32.8 (SD14.4) years for the cases and 
34.6 (SD 14.9) years for the controls; 53.3% of the cases and 47.6% of the controls 
were aged 15 to 30 years. Among the cases, 61.0% were urban residents while 80.5% 
of the controls were urban residents. 
Disease and treatment characteristics of the cases and controls 
The disease and treatment characteristics of the cases and controls are given 
in Table 1. Cases and controls had a similar BCG vaccination status (61.9% and 
53.3% had had the BCG vaccination respectively) and sputum smear results at the 
beginning of treatment (71.4% and 74.8% were positive respectively) as well as after 
2 months (10.5% and 6.1% were positive respectively). However, more cases had a 
previous history of TB (37.1%), including relapse, failure and MDR-TB, compared 
with controls (10.0%). Hence, more cases (45.7%) received the CAT2 treatment 
regimen than controls (22.9%). Fewer cases were on DOTS (36.2%) than the 
controls (59.5%) and fewer had a good response to treatment (76.2%) compared with 




treatment than the controls (31.0%) and more also sought traditional remedies 
(28.6%) than the controls (12.9%) (Table1). 
Risk factors for defaulting 
In the univariate analysis the following disease- and treatment-related factors 
were statistically significant associated with defaulting (P < 0.01): rural residence 
(OR: 2.64; 95% CI: 1.57-4.44), CAT2 regimen (OR: 2.84; 95% CI: 1.72-4.69), not 
being on a DOTS programme (OR: 2.59; 95% CI: 1.59-4.201), poor response to 
treatment (OR: 2.42; 95% CI: 1.305-4.49), having side-effects from treatment (OR: 
2.45; 95% CI: 1.52-3.97), previous history of TB (relapse, treatment failure and 
MDR-TB) (OR: 5.32; 95% CI: 2.92-9.69) and seeking traditional remedies (OR: 
2.71; 95% CI : 1.51-4.87) (Table 1). 
The multiple logistic regression analysis and adjusted ORs (aOR) and 95% 
CIs are shown in Table 2. The variables that remained in the model were: rural 
residence (aOR: 2.68; 95% CI: 1.51-4.73), not being on a DOTS programme (aOR: 
2.53; 95% CI:1.49-4.30), having side-effects from treatment (aOR: 1.94; 95% 
CI:1.14-3.29) and previous history of TB (aOR: 5.11; 95% CI: 2.69-9.69) (Table 2). 
Discussion 
In our study, the overall prevalence of TB treatment default among the 
patients who attended TB treatment clinics during the study period was 14%, which 
is similar to that reported in other studies conducted in Khartoum State (5,16). A 
high default rate on TB treatment has also been reported in other developing 
countries in Africa and Asia, e.g. 22.88% in Ethiopia and 10.33% in India (26,27). 
Our study showed that DOTS reduced default rates as those not on a DOTS 
programme has 2.5-times higher odds of default. This agrees with the results of 





Rural residence was strongly associated with TB default which concurs with 
the findings of other studies in Ethiopia (31), and South Africa(32)  TB treatment 
default was also strongly associated with having side-effects from the TB medication 
and having a history of TB (relapse, failure and MDR-TB), which concurs with other 
studies (6,11,33-36). However our findings are in contrast to those reported from 
Malaysia where residence, medicine side-effects and history of TB were not 
associated with TB treatment default (20). Furthermore, in contrast to the findings 
of our study, a study in Estonia found that urban residence was positively associated 
with TB default (37). 
The findings of our study might help doctors and policy-makers in Khartoum 
State and other developing countries in planning and policy development to 
strengthen TB control programmes in general. Although we highlight the relation 
between disease and treatment-related factors and defaulting TB treatment, further 
exploration of precipitating factors for defaulting are needed. 
To combat the TB spread in communities, WHO launched the DOTS strategy 
in 1993. Since that time, DOTS implementation has achieved good results by 
increasing patient compliance to treatment and decreasing treatment interruption in 
communities of both low and high socioeconomic status (28,29). The Ministry of 
Health in Khartoum State adopted a DOTS strategy when it was recommended by 
the WHO in 1993 (5). To make the access of TB services available, the Ministry of 
Health set up more than 50 TB units (microscopic and treatment centres) distributed 
all over the State, according to geography and population density (16). Despite these 
efforts, TB treatment default remains high. 
In view of our findings, in order to reduce TB treatment default further, 
attention should be paid to more adequate follow-up of patients, treatment of their 




defaulters, particularly among rural patients who may face barriers to continuing 
treatment and among those with a history of TB (those who have relapsed, 
experienced treatment failure and those with MDR-TB). An objective of the TB 
control programme in Khartoum State is to provide tracing teams for defaulters in 
all TB units, which are responsible for contacting defaulting patients, encouraging 
them to come back to continue their treatment and visiting them at their home if they 
do not reply so as to identify the barriers and advise them on how to overcome them 
when they first start to default. The fact that this does not appear to be happening, at 
least up our study period, may indicate that the programme and its allocated 
resources need to be reassessed. The introduction of a revised retrieval system in 
Saudi Arabia significantly improved the retrieval of non-attenders and reduced the 
dropout rate (38). 
In terms of the generalizability of our findings, some methodological aspects 
of our study need to be considered. First, our study was conducted in Khartoum 
State, which is the most populated state in Sudan. Its population may be represent 
the whole country as most of the inhabitants come from various parts of Sudan. In 
addition, the TB patients included in this study were selected from all TB treatment 
units in the State. Thus, our findings can be generalized to the total TB population 
in the State and also Sudan as well as to communities with similar settings. Second, 
recall bias was minimized by using a standardized questionnaire during the interview 
and by cross-checking patients’ responses for each study variable against their 
medical records. Third, the reliability of the information gathered from each patient 
could not be counter-checked but questions about sensitive issues were carefully 
handled to maximize the accuracy of the responses obtained. Fourth, possible 
confounders were taken into consideration in the design (by restricting the diagnosis 




problem we faced during the study was how to reach the defaulting patients (cases). 
This problem was tackled in 3 steps. First, the patient medical records were traced 
and identified and all contact information was reviewed. Then, study personnel first 
tried to telephone the patient and, failing that, to telephone known family members 
or friends. If telephone contact failed or if there was no telephone number on record, 
home visits were made, first to the patient and then to known family members or 
friends. Interestingly, we found that many of the defaulting patients did not have 
access to any phone (mobile or landline), a risk factor not previously described nor 
evaluated in our study. The interviewers made an average of 3 attempts to contact 
each defaulter before recording a defaulter was a non-respondent. Due to the number 
of eligible cases who could not be traced and interviewed (27 of 143), generalizing 
the findings to the whole population of patients with TB should be done with caution.  
In conclusion, our study shows that living in a rural area, not being on a DOTS 
programme, developing side-effects to treatment, and having a history of TB 
(relapse, MDR-TB or treatment failure) increased the likelihood of defaulting on 
treatment. These findings may help guide improvement in the current TB treatment 
delivery in Sudan and similar developing countries. 
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 Cases (n = 
105) 
Controls (n = 210) P-value OR 95% CI 
  No. (%) No. (%)    
Age (years)       
1530 (ref)  56 (53.3) 100 (47.6)    
> 30  49 (46.7) 110 (52.4) 0.34 0.80 0.501.27 
Sex       
Male  74 (70.5) 128 (61.0) 0.098 1.53 0.932.53 
Female (ref)  31 (29.5) 82 (39.0)    
Residence       
Urban (ref)  64 (61) 169 (80.5)    
Rural  41 (39) 41 (19.5) < 0.0001 2.64 1.574.44 
Site of TB       
Pulmonary  92 (87.6) 180 (85.7) 0.643 1.18 0.602.37 
Extra-
pulmonary (ref) 




      
Positive  75 (71.4) 157 (74.8) 0.52 084 0.501.43 
Negative (ref)  30 (28.6) 53 (25.2)    
Chest X-ray       
Normal  80 (76.2) 173 (82.4) 0.19 0.68 0.391.21 






      
CAT1 (ref)  57 (54.3) 162 (77.1)    
CAT2  48 (45.7) 48 (22.9) < 0.0001 2.84 1.724.69 
On DOTS       
Yes (ref)  38 (36.2) 125 (59.5)    
No  67 (63.8) 85 (40.5) < 0.0001 2.59 1.594.21 
Response to 
treatment 
      
Good (ref)  80 (76.2) 186 (88.6)    
Poor  25 (23.8) 24 (11.4) 0.004 2.42 1.304.49 
Sputum smear 
after 2 months 
      
Positive  11 (10.5) 13 (6.1) 0.166 1.82 0.784.27 
Not done  23 (21.9) 44 (21.0) 0.686 1.13 0.632.01 
Negative (ref)  71 (67.6) 153 (72.9)    
Had side-
effects to TB 
treatment 
      
Yes  55 (52.4) 65 (31.0) < 0.0001 2.45 1.523.97 
No (ref)  50 (47.6) 145 (69.0)    
Previous 
history of TB 
      
No: new case 
(ref) 
 66 (62.9) 189 (90.0)    







      
Yes  30 (28.6) 27 (12.9) 0.001 2.71 1.514.87 
No (ref)  75 (71.4) 183 (87.1)    
Had BCG 
vaccine 
      
Yes  65 (61.9) 112 (53.3) 0.149 1.42 0.882.29 
No (ref)  40 (38.1) 98 (46.7)    
Have chronic 
diseases 
      
Yes  10 (9.5) 35 (16,7) 0.06 0.53 0.251.11 
No (ref)  95 (90.5) 175 (83.3)    
aIncluding relapse, treatment failure and multidrug-resistant TB. 
OR = odds ratio; CI = confidence intervals. 




Table 2 multivariate analysis of the disease and treatment risk factors for defaulting on tuberculosis 
(TB) treatment  
Disease and treatment 
related factors 
Adjusted OR 95% CI P-value 
Rural residence 2.68 1.514.73 0.001 
Not on DOTS 2.53 1.494.30 0.001 
Side-effects from TB 
treatment 
1.94 1.143.29 0.015 
Previous history of TBa 5.11 2.699.69 < 0.0001 
aIncluding relapse, treatment failure and multidrug-resistant TB. 






























Chapter 5  Patient knowledge and behavioral factors leading to non- 
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     Although tuberculosis is a curable and preventable disease, defaulting from 
treatment can prolong infectiousness leading to increased transmission, an increased 
risk of drug resistance, relapse and death. Our objective was to identify patient 
related determinants (including knowledge and awareness, opinion about TB 
services and behavioral factors) of treatment defaulting among TB patients in 
Khartoum State, Sudan. 
Methods: 
Between May 2010 to May 2011, we conducted a case control study where 
the  patients defaulting from treatment were considered as ‘cases’ and those 
completing treatment as ‘controls’.  
Results: 
 There were 2727 TB patients who attended TB treatment clinics during study 
period. Out of these 2399 patients (86%) had continued their treatment while 328 
patients (14%) had interrupted it. 105 cases were traced and interviewed. In addition 
210 patients who had continued their treatment were included as controls. In the 
multivariate analysis the variables that remained in the model were: rural residence 
(OR= 2.16; 95% CI= 1.19-3.90), “had never heard about TB before had it(OR= 1.81; 
95%CI=1.02-3.20 ), lack of knowledge on when to stop TB medication (OR= 2.00; 
95% CI= 1.10 -3.64), less support by families, friends and colleagues (OR= 3.23; 
95% CI= 1.62- 6-46), too many patients when visiting the TB center (OR= 2.24; 
95% CI =1.29 - 3.88), and lack of counseling about TB and its treatment (OR= 4.79; 
95% CI= 2.57 -8.95). 
Conclusions 
The results of this study show that patient’s knowledge about TB, its treatment 




continuation. Hence, adequate counseling of patients, including counseling of their 
peers for social support, and adequate training of the health care providers who have 
enough to time to attend to their patient’s need are potential measures to reduce TB 
treatment default.  
 





















Tuberculosis (TB), is a global health concern for both developing and 
developed countries (Nezenega et al., 2013). It has reached epidemic proportions in 
many developing countries, with a third of world population being infected with 
Mycobacterium tuberculosis (Khan et al., 2006). Although it is a curable and 
preventable disease. Worldwide TB is the second most common cause of death in 
adults attributable to a single infectious agent (World Health Organization, 2015). 
In 2010, it was estimated that in Sudan there were 209 cases of active TB per 
100.000 of the population with an annual incidence of new cases of 119/100.000, 
resulting in approximately 37.000 new cases each year. Hence, Sudan shoulders 
about 15% of TB burden in the Eastern Mediterranean Region and has the second 
highest active TB prevalence of the countries in this region. In addition, the 
estimated death rate related to TB, including HIV infected TB patients, was 
24/100.000 per year (Federal Ministry of Health, Sudan, 2011). 
The health authority of Sudan subscribes to the strategies for TB prevention 
and treatment recommended by the WHO including The therapeutic regimens given 
under direct observation  short course therapy (DOTS) programme.  Despite the 
efforts that had been undertaken by health authorities still some patients fail to 
adhere to TB treatment and eventually default before completing the treatment. As 
defined by the WHO, patients who fail to collect their TB treatment for 2 consecutive 
months are reported as defaulters (World Health Organization, 2002).  
The role of human behavior in health and illness has been increasingly 
recognized (Suleiman et al., 2014). In any cultural context, a precondition of health-
seeking behavior is the recognition and interpretation of symptoms by individuals 




In the case of TB, personal experiences, perceived etiology of the disease, 
associated beliefs and attitudes could be important for appropriate health- seeking 
behavior, i.e. completing treatment. Hence, health education and counselling to TB 
patients may increase successful treatment completion (Ayisi et al.,2011, Rubel and 
Garo, 1992).  
Many studies have addressed behavioral, biological, socio-demographic 
factors, and patient knowledge factors that were associated with TB treatment 
default or leading to delays in seeking TB treatment (Carolyn et al., 2009). Thus, 
understanding of patient knowledge, opinion, cultural believes and behavioral 
patterns, in addition to knowledge of health staff and their practice and their 
association with defaulters from TB treatment is crucial.    
 The present study was conducted to identify patient related determinants 
(including knowledge and awareness, opinion about TB services and behavioral 
factors) of treatment defaulting among TB patients.  
Materials and Methods 
This was an observational case control study where the  patients defaulting 
from treatment were considered as ‘cases’ and those completing treatment as 
‘controls’.  
Setting 
This study was conducted in KhartoumState. In 1993, the Ministry of Health 
in Khartoum State established a tuberculosis control program.  The decentralized 
healthcare system in Khartoum is divided into seven districts and 19 health areas. Its 
health facilities include 43 hospitals, 147 health centers, 185 NGOs centers, 235 
dispensaries and 365 primary health care units. TB services are delivered in primary 
health care along with all other routine health services. A registered nurse is 




the primary health care unit. This primary health care unit is the basic unit of 
management of the program and also the unit of reporting. Personnel at the primary 
health care unit responsible for tuberculosis services include a medical assistant, a 
laboratory technician and a clerk.  The program provides care through the DOTS 
strategy (Directly Observed Treatment with Short course chemotherapy) as 
recommended by WHO. TB patients receive their treatment through 53 TB treatment 
units distributed all over the State (Suleiman and Sodemann, 2009). 
Population  
The interview process was done in the period from 1th of May 2011 to 15th of 
July 2011, but in order to reach the target defaulted group for the interviews we used 
the clinics records for the patients registered in the period from May 2010 to May 
2011. The inclusion criteria for both cases and controls were; patients age more than 
15 years and clinically and laboratory diagnosed as tuberculosis, registered at the 
treatment units in Khartoum States. Cases were those patients identified as TB 
treatment defaulting during the data collection period. Following identification of 
each case (defaulter) without exclusion criteria, the next 2 subsequent patients 
without exclusion criteria, who had completed their treatment without defaulting, 
and requested to come for follow up, either to do the final sputum smear or to collect 
the smear results, in the same TB treatment unit or the near one in the same area, 
were taken as control into the study. The patients were excluded from the study if 
they were: too ill for interview, had a psychiatric illness, or gave incorrect address 
and could not be traced.  
Definition of variables 
The following definitions were applied according to the World Health 




Pulmonary TB: a patient with tuberculosis disease involving the lung 
parenchyma. Extra-pulmonary TB: a patient with tuberculosis of organs other than 
the lungs (e.g. pleura, lymph nodes, abdomen, genitourinary tract, skin, joints and 
bones, meninges). A patient in whom both pulmonary and extra-pulmonary TB has 
been diagnosed was classified as pulmonary TB(World Health Organization, 2002). 
Categories of treatment outcomes’ Treatment default: is defined as an 
interruption of TB treatment for two or more consecutive months during the intended 
treatment period (World Health Organization, 2002). Adherence to TB treatment 
may be defined as the extent to which the patient's history of therapeutic drug-taking 
coincides with the prescribed treatment (Urquhart, 1996). Complementary and 
alternative medicine (CAM): is a medical intervention which is not taught widely at 
medical schools or is not generally available in hospitals, seek folk remedies 
treatment:  are those patients who seek alternative treatment other than TB 
recommended therapeutic chemotherapy (herbal, traditional and spiritual treatment) 
(Hirofumi et al., 2006). 
Data Collection 
Information on demographic factors, disease related factors and treatment 
related factors were retrieved from patients' medical records. In addition, a face to 
face interview was held, using a standardized questionnaire by trained interviewers 
to elicited information on the various factors possibly associated with treatment 
defaulting. All TB patients who had defaulted prior to data collection period were 
identified and their address had been retrieved from patient records. Then, the 
interviewers used the following sequence of contact attempts:calls – first to the 
patient and thereafter to known family members or friends -  home visits - first to 




Before the start of data collection the interviewers had been trained on how to 
interview the respondents, and had been given instructions on how to fill the 
questionnaire. After that, pretesting was conducted by interviewing few patients. 
Based on the pretesting results the questionnaire was used without any major 
changes. 
The data collected included demographic and clinical variables 
(age,gender,site of TB infection, co-infection with HIV), patient’s knowledge of TB 
and its treatment, the patient’s rating of the TB treatment services provided and 
behavioral factors (Rubel and Garo,1992, (Finlay et al., 2012, Chuah, 1991, 
Marlucia et al., 2012, Comolet et al., 1998, Jaggarajamma et al., 2007, Nyi et al., 
2001, Pardeshi ,2010, Muture et al., 2011). The abbreviated list of questions asked 
is detailed in Table1 and 2. 
Statistics 
 The sample size was calculated according to Fleiss (1981) (Fleiss, 1981) using 
a two sided type one error of 0.05 and a power of 80% and the ability to detect an 
odds ratio of 2.0 with a exposure frequency of 30% in the control group and a ratio 
of cases to controls of 1:2. This yielded a sample size of 105cases and 210 controls.  
 Data were reviewed for consistency and completeness. Data analysis was 
performed in SPSS(Statistical package of Social Sciences) version 16. The 
Demographic characteristics of cases and controls were compared using test for 
qualitative  variables and student’s t tests for continuous variables.  Univariate and 
multivariate analysis were conducted. Descriptive statistics were calculated for all 
dependent variables. Logistic regression was used to calculate the odds ratio and its 
95% confidence interval. Variables that were related to treatment default with a p-
value less than 0.20 were entered in a multivariate model, using a backward approach 





 Ethical approval was obtained from the Ministry of Health Khartoum State ' 
ethical Committee. Permission was granted by public committee leaders in the 
localities through official letters. Informed verbal consent was secured from every 
eligible patient included in this study before the interview. Privacy and 
confidentially was maintained. Prior to the arrival of the data collection team the 
respondents had been informed regarding all relevant aspects of the study , including 
the purpose of the study, interview process and potential benefits. The interviewers 
introduced themselves to respondents and outlined the scope of interview and its 
approximate length to the potential respondents at the beginning of each interview. 
The respondents had been informed that the participation was entirely voluntary, and 
that privacy and confidentially will be maintained during data processing and 
reporting. Potential respondents also were informed that they had the right to refuse 
to participate, or to end the interview at any time. 
Results 
Patients 
         There were 2727 TB patients who attended TB treatment clinics during study 
period. Out of these, 2399 patients (86%) had completed their treatment while 328 
patients (14%) had interrupted it. Out of these, 185 patients had defaulted prior to 
the data collection period. Hence, 143 patients were potentially eligible as cases. Of 
these, 15 had given a wrong address and 12 had moved out of Khartoum State and 
could not be interviewed. A further 11patients refused the interview. Hence, 105 
cases were traced and interviewed. In addition 210 patients who had completed their 
treatment were included (controls).  
Among cases, 70.5% were males and 29.5% were females compared to 60.9% 




respectively 32.8 years and 34.6  years for cases and controls. 53.3% of the study 
cases were aged 15 to 30 years and 46.7% were more than 30 years old compared to 
respectively 47.6% and 52.4 % for controls. Among cases, 61% were living in urban 
area and 39% in rural area compared to respectively 80.5% and 19.5% for controls. 
Also about 61% of cases were ready to stop taking treatment according to the health 
care workers advice and 39% can stop taking treatment due to other factors such as 
feeling better compared to respectively 81.4% and 18.6% for controls. However, 
29.5% of these cases were treated differently by their families, friends and 
colleagues of having TB compared to controls (11.0%). Hence, cases felt that the 
medical center in which they were treated had more attendants than controls (59% 
vs 42.9%). Compared to controls, cases were less often received less health 
education (41.9% vs 11.9%) while more of them did not hear about TB disease 
before they had it (44.9% vs 27.1%.The demographic and TB characteristics are 
given in tables 1and 2. 
Patient’s knowledge and opinion 
         The distribution of factors related to knowledge of TB and it’s treatment as 
well as the opinion and attitudes of cases and controls is given in tables 1 and 2. 
Univariate odds ratios and their 95% confidence intervals are given in Tables 3 and 
4. In general, cases were more likely to lack adequate knowledge of TB such as; 
had never heard about TB before had it (OR: 1.93, 95% CI: 1.18-3.17), when to 
stop TB medication (OR: 2.81, 95% CI: 1.66-4.74), treatment duration (OR: 2.96, 
95%CI: 1.62-5.41) and can TB be cured (OR: 2.54, 95%CI: 1.13-5.71). Hence, 
cases were more living in the rural areas (OR:2.64 and 95%CI: 1.57- 4.44) and 
having more social problems because they had TB. Especially, cases reported 
feeling more ashame(OR:1.88,95%CI:1.04-3.39) and embarrassment because of 




their families, friends and colleagues(OR:3.41, 95%CI: 1.86-6.22). The perception 
of health services was similar. However, cases had often received less counselling 
on TB and its treatment(OR:5.34, 95% CI:3.02-9.44) and felt there were too many 
patients when visiting the TB center(OR:1.92,95%CI:1.20-3.09),tables3and4.  
Risk factors for defaulting 
` In the multivariate analysis the variables that remained in the model were 
residential locality( P value: 0.011, OR:2.16; 95% CI: 1.19-3.90),  ‘lack of 
knowledge on when to stop TB medication’(P value: 0.023, OR: 2.00; 95%CI:1.10-
3.64 ),  “had never heard about TB before had it(P value:0.041, OR: 1.81; 
95%CI:1.02-3.20 ), ‘less support by families, friends and colleagues’(P value: 0.001; 
OR: 3.23; 95%CI: 1.62-6.46), ‘too many patients when visiting the TB center’(P 
value: 0.004; OR: 2.24; 95%CI: 1.29 -3.88), and ‘lack of counseling about TB and 
















Table1: Patients knowledge and awareness factors affecting non adherence to TB treatment: 





Age – mean (SD) 
15 - 30 years 































Residential locality  
   City 









Did you hear about 
 TB before you had it?                        













What do you expect if you stop TB treatment? 
    Know the consequences 










Know the consequence if stop TB treatment 
  Not cured 
   Relapse  
  Start treatment again  














    Known 









Mentioned the treatment duration 
  6 months duration  









Can TB be cured? 
    Yes 









When should you stop taking treatment? 
   When a health worker tells me 









Are you ashamed to have TB? 
 Yes 









Do you try to hide that you have TB? 
 Yes 









Do your family , friends and colleagues treat you different 
because of TB? 
  Yes 












How do you feel about being observed taking treatment? 
  Embarrassed 













Table2 :Patients opinion about TB services and behavior factors affecting non 
adherence to TB treatment: 
Patient behavior and opinion 








Do you smoke? 
 Yes 









Do you use alcohol? 
  Yes   









Do you have AIDS? 
 Yes  









Do you use intravenous drugs? 
  Yes 









Do use other drugs? 
  Yes 





































How do you rate the health center appearance? 
 Suitable 












How do rate the number of patients at the TB 
center? 
 Suitable 












What was your average waiting time at the TB 
center? 
 <60 minutes 












Are you satisfied with the given TB treatment? 
  Yes 












Did you receive health education about the 
disease TB and its treatment? 
 Yes 




















Table 3: Distribution of Patients knowledge and awareness factors: 
95% CI 
 






   15 - 30 years  vs. 






   Male vs. 





Site of tuberculosis 
    Pulmonary vs. 






Residential locality  
   City vs 
















What do you expect if you stop TB treatment 
Know the consequences vs 
Don' know the consequences 
 




  Known vs 





Can TB be cured? 
  Yes  vs 







When should you stop taking treatment? 
 When a health worker tells me vs 






Are you ashamed to have TB? 
 Yes vs 





Do you try to hide that you have TB? 
 Yes vs 







Do your family , friends and colleagues treat you 
different because of TB? 

















Table 4 :Distribution of Patients opinion about TB services and behavior factors: 
Patient opinion about TB services and 
beahviour factors 
OR 95 %CI 
 
Do you smoke? 
 Yes vs 





Do you use alcohol? 
  Yes  vs 





Do you have AIDS? 
  Yes vs 





Do you use intravenous drugs? 
  Yes vs 





Do use other drugs? 






What is your opinion on TB services? 
 Good vs 







How do you rate the health workers attitude? 
  Receptive vs 







How do you rate the health center appearance? 
  Suitable   vs 







How do rate the number of patients at the TB center? 
 Suitable vs 







What was your average waiting time at the TB 
center? 








Are you satisfied with the given TB treatment? 
  Satisfied   vs 







Did you receive health education about the disease 
TB and its treatment? 
   Received  health education   vs 












Table 5:Multivariate results: Patients knowledge and awareness, opinion about TB 
services and behavior factors leading to TB default 
Factor P value Odds Ratio 
(OR) 
95%  CI 
Living in rural areas 0.011 2.16 1.19-3.90 
When should you stop taking 
treatment? 
 
0.023 2.00 1.10-3.64 
Did you hear about TB before 
you had it?                        
 
0.041 1.81 1.02-3.20 
Do your family, friends and 
colleagues treat you different 
because of TB? 
 
0.001 3.23 1.62-6.46 
How do rate the number of 
patients at the TB center? 
 
0.004 2.24 1.29-3.88 
Did you receive health education 
about the disease TB and its 
treatment? 
 




















The present study showed that patients with less opportunity to receive health 
education and counseling about TB and its treatment and those living in the rural 
areas are at higher risk of defaulting TB treatment. Other potentially modifiable 
factors associated with TB treatment default identified in this study were lack of 
support by families, friends and colleagues, and overcrowding of the TB centers and 
its associated issues of long waiting times. Our study observed a default rate of 14% 
among TB treatment patients in Khartoum State. This high default rate was similar 
to rates reported in previous studies conducted in Khartoum State [(Federal Ministry 
of Health, Sudan, 2011, Suleiman and Sodemann, 2009). This observed rate is much 
higher than the World Health Organization’s recommended target rate of 3% (World 
Health Organization, 1994). Similar high default rates were reported in other 
developing countries e.g. in Ethiopia and India with default rates of 23% and 10%, 
respectively[(Damte  et al., 2013, Pardeshi ,2010). Such high default rates has a 
negative impact on the treatment outcome and may lead to spread of disease, 
treatment failure, drug resistance and death (Muture et al., 2011). 
In the present study a substantial proportion of cases 44(42%), and controls 
(12%), did not receive health education and counseling when diagnosed with TB. 
While the intention of the TB-control program in Khartoum State is to provide 
adequate health education and counseling to patients diagnosed with TB, the fact 
that this did not happen in a substantial proportion of patients may be explained by 
shortage of health education personnel, increased health care burden, lack of training 
and supervision of health staff by the TB coordinators. This may indicate that the 
program and its allocated resources deserve a re-assessment.  
Our observation that patients with less opportunity to receive health education 




results of previous studies conducted in both developed and developing countries 
(World Health Organization (WHO),2002,  Muture et al., 2011, Marlucia et al., 
2012). However, Nyi from Malaysia did not find an association between health 
education and counseling  and TB treatment default ( Nyi et al., 2001). 
In general, a large proportion of participants in this study had low 
knowledge about TB, duration of treatment, and whether TB is curable or not. The 
knowledge and behavioral factors contributing to TB default may vary in different 
communities and populations. Part of this can be attributed to patients’ traditions 
and believes. In addition, health services, health staff receptiveness and patients’ 
opinions towards those services are also contributing factors. Moreover, TB is a 
disease largely present in settings of the poor with limited resources. 
The association of TB treatment default with lack of family, friends and 
colleague support, rural residence and overcrowding of the TB centers has been 
recognized before as it was in this study (World Health Organization (WHO), 
2002, Rubel and Garo, 1992,  Marlucia et al., 2012, and Ifebunandu et al., 2013). 
However, our findings were in contrast to those reported by Nyi and Chuah from 
Malaysia (Chuah , 1991, Nyi et al., 2001). 
In our study population, HIV infection and intravenous drug users (IVDU) 
were rare, as might be expected among the population of Khartoum state 
(unpublished data). With regard to HIV infection status, it was interesting to note 
that about 15% of TB patients were not screened, while the intention of the TB 
control program is to perform the HIV testing in all TB patients. This is another 
indication for the need of reassessment of the TB control program in Khartoum 
state. 
Surprisingly, behavioral factors including cigarette smoking, alcohol abuse, 




in this study, in contrast to some earlier studies  (Muture et al., 2011,  Caylà et al., 
2009).  
The findings of this study might help health providers and policy makers in 
Sudan and other developing countries in planning and developing health policies to 
strengthen TB control programs in general. Of special importance seems that there 
is insufficient staff dedicated to counseling and education of the patients as well as 
their social support networks. Also more efforts should be taken to enhance the 
community participation and upgrading of the health personnel’s communication and 
counseling skills. 
Some methodological aspects of this study need attention: Firstly, this study 
was conducted in Khartoum State, capital of Sudan which is the most populated state 
in Sudan. The population in this state could be safely stated to represent the whole 
country as most of the inhabitants come from various parts of Sudan. In addition, the 
TB patients included in this study were selected from all tuberculosis treatment units 
(health centers and hospitals) in the state. Thus, the generalization of the study 
findings to the total tuberculosis population in the state and Sudan could be done and 
seems logical as well as in the communities with similar settings.  Secondly, recall 
bias was minimized by reviewing the patient medical records and cross checking for 
each study variable and using a standardized questionnaire during the interview. 
Thirdly, the reliability of information gathered from each subject could not be 
counterchecked but questions about sensitive issues were carefully dealt with to 
maximize the reliability of the responses obtained.  Fourthly, possible confounders 
were taken into consideration in the design (by restricting the diagnosis criteria) and 
by using logistic regression. Lastly, the major problem we faced during this study 
was how to reach the defaulting patients (cases) for this study. This problem was 




contact information was reviewed. Then, study personnel used the following 
sequence of contact attempts: calls – first to the patient and thereafter to known 
family members or friends -  home visits - first to patient and thereafter to known 
family members or friends. Interestingly, it appeared during the study that many of 
the defaulting patients did not have access to mobile telephones, a risk factor not 
previously described nor evaluated in this study. The interviewers made an average 
of three attempts to contact each defaulter before deciding that a defaulter was a non-
respondent.  
Conclusions: 
          This study confirms that health education and counseling to patients and their 
families on TB disease and it's treatment are of paramount importance and are 
strongly associated with treatment default, which is related to treatment failure and 
microbial resistance to antibiotics. Hence adequate counseling is highly 
recommended. In addition, fostering social support (family and community) and 
adequate training of the health care providers to adopt a warm and respectful 
approach towards patients and their families are also important. Also, reducing the 
number of patients attending health units e.g by increasing number of treatment 
centers may help reduce TB treatment default.  
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Backgrounds: Tuberculosis (TB) is a major public health problem in Sudan 
and in many African countries. The objective of this study is to provide health 
authorities and patients with insight into the perceived factors affecting TB treatment 
default. 
 Methods: The data was collected by means of focus group discussions (FGD). Six 
FGD were conducted (3 for defaulted patients and 3 for health personnel). Overall, 
27 TB defaulted patients and 24 health care providers were randomly selected. 
 Results: Participants reported that lack of knowledge about TB, high cost of 
transportation, difficulty for making a daily visit to health facilities for DOT 
programme due to distance of the facilities from their residences, rural residency, 
social circumstances, TB-related stigma, lack of family support, patient movement 
or giving wrong address, seeking traditional healers and treatment-related factors 
such as side-effects of drugs, the attitude of health care providers, the long delay in 
obtaining medications, and weakness and challenges facing defaulter tracing teams. 
There were consistent findings from interviews among patients and health care 
providers.  
Conclusions: The study revealed several challenges and barriers leading to TB 
treatment default. Our findings may help in improving interaction between patients, 
families, health personnel and policy makers.   
 









       Tuberculosis (TB) is a major public health problem in Sudan and in many 
African countries [1]. In 2010 It was estimated that in Sudan there were 209 cases 
of active TB per 100.000 of population with an annual incidence of new cases of 
119/100.000, resulting in approximately 37.000 new cases each year in Sudan. 
Hence, Sudan shoulders about 15% of TB burden in the Eastern Mediterranean 
Region and has the second highest active TB prevalence of the countries in this 
region. In addition, the estimated death rate related to TB, including HIV infected 
TB patients, was 24/100.000 per year [2].  
The TB Control Programme in Khartoum State, Sudan adopted treatment 
under direct observation short course therapy (DOTS) as recommended by WHO in 
1993 [3].  Despite the efforts that had been undertaken by health authorities still 
some patients fail to adhere to TB treatment and eventually default before 
completing the intensive stage of treatment. As defined by the WHO, patients who 
fail to collect their TB treatment for 2 consecutive months are reported as defaulters 
[4].The TB Control Programme in Khartoum State estimates the default rate to be 
more than 14%. This high default rate to TB therapy can prolong infectiousness 
leading to increased transmission, an increased risk of drug resistance, relapse and 
death [5-9,10]. Thus the identification of risk factors leading to this high TB 
treatment default rate in Khartoum State is essential.  
                In general few studies of TB defaulting treatment  in Sudan were 
conducted. These studies dealt only with socio-economic and TB disease  related 
factors leading to TB Treatment default. To our knowledge no study was conducted 
in Khartoum State, to explore in depth the opinions, experiences and believes of 
patients and health care providers on TB disease, services and other possible factors 




Khartoum State, to explore the TB patient and health care provider’s views about 
the factors prevent TB treatment continuation. 
Materials and Methods: 
Setting 
This study was conducted in Khartoum State, the capital city of Sudan. In 
1993, the Ministry of Health in Khartoum State established a tuberculosis control 
program.  The decentralized healthcare system in Khartoum is divided into seven 
districts and 19 health areas. Its health facilities include 43 hospitals, 147 health 
centers, 185 NGOs centers, 235 dispensaries and 365 primary health care units. TB 
services are delivered in primary health care along with all other routine health 
services. A registered nurse is designated responsible for treatment and follow up 
for continuation of treatment in the primary health care unit. This primary health 
care unit is the basic unit of management of the program and also the unit of 
reporting. Personnel at the primary health care unit responsible for tuberculosis 
services include a medical assistant, a laboratory technician and a clerk.The program 
provides care through the DOTS strategy (Directly Observed Treatment with Short 
course chemotherapy) as recommended by WHO. TB patients receive their 
treatment through 53 TB treatment units distributed all over the state [11-12]. 
Model of the Study Protocol: 
           The humans of the study were selected from all tuberculosis patients 
(defaulters and controls) registered at tuberculosis centers and health professionals 
working in TB treating units in all provinces in Khartoum state from May 2010 to 
May 2011. A total of six focus group discussions were conducted in large three cities 
in Khartoum State: Khartoum, Omdurman and Khartoum North to capture  believes, 
culture, geographical and financial differences in various communities. A twenty 




(FGD). Each group contained, on average of 8 to 10 participants. In order to further 
explore the possible leading factors for defaulting we subsequently conducted 
another 3 (FGD) with a total of 24 health professional representing  53 TB treatment 
units in Khartoum State. The inclusion criteria of participants: patients of more than 
18 years old and who were receiving treatment for at least one month. Because they 
were perceived to be more experienced in having TB  and good knowledge regarding 
tuberculosis treatment barriers. 
Data collection: 
A qualitative research using the technique of Focus Group Discussion (FGD) 
methodology was conducting in Khartoum State from May 2010 to May 2011. Data 
from the participated patients and health care professionals was collected during the 
period from 1st of May 2011 to 15th of July 2011. A total of six  focus group 
discussions were held. All interviews were performed by the first Author who 
moderated the discussion in Arabic language. Few days before the FGD discussion 
the moderator visited the health units to ensure the  privacy and logistic arrangement 
for the comfortable rooms for the these discussions. Also he informed the selected 
health care professionals telephonically about the study. Each session lasted 
approximately two and half hours with 20 minutes break in between using structured 
questionnaire with ended question to collect the necessary information. All 
interviews took place in privacy rooms and the discussions were recorded on 
notebook and audiotapes. We ensure that the all participants felt confident and tell 
reported their opinions freely. Before each FGD session, the moderator welcomed 
with the participants and explained to them the objectives of the study. The 
discussion was started with general information then focused on the TB disease, 
patients knowledge, treatment services, staff receptiveness, health education, the 




The same questions were  covered in each session.  This discussion provides an 
opportunity  for more in depth interaction of patients and beliefs about TB disease 
and reasons leading to treatment default . In addition, it was able the participants to 
give the insight and ideas on further improvement of the TB compliance. In the 
interview discussion for the health care professionals we explore their experiences 
with the barriers leading to TB default and the shortcoming of the medical services 
at TB units. The recordings were transcribed and translated into English language 
by the first author. 
Data Analysis: 
After the FGD sessions, all recordings of data from defaults patient’s 
interviews and data from health care professional’s interviews were transcribed 
verbatim and translated into English language. Then the data were summarized, 
coding  and analysis was done based on the theme  arising from the data.  The 
analysis of data including the patient’s perception about TB disease, the treatment 
services, patient knowledge, family and community supports, staff receptiveness, 
barriers leading to default and their suggestions to overcome these barriers. Also the 
data from health professionals interviews were coded and analyzed using the same 
contents theme. After coding, the grouping, condensing, categorizing   and 
summarizing of these data were done. The findings of the in-depth interviews and 
FGD described the possible barriers leading to TB default were concluded and 
reported in the results section below. 
Ethical Considerations 
 Ethical approval was obtained from Ministry of Health Khartoum State, 
Ethical Committee. Informed verbal consent was secured from every eligible patient 
and health care provider included in this study before the interview. Privacy and 




relevant aspects of the study , including the purpose of the study, the process of FGD 
and potential benefits. The participants in all 6 FGD felt confident and happy to be 
involved in this discussion and were speaking freely. 
Results: 
The characteristics of participants: 
Six sessions of focus group discussion (FGD) were conducted to investigate 
the factors influencing non adherence to TB treatment. Three sessions were targeted 
at TB default patients while the other 3 sessions involved health care providers. The 
sessions aimed to address related experiences of stakeholders participated in TB 
treatment. The participating defaulted patients were made up of 21 males and 6 
females. The mean age and standard deviation (SD) of patients were 36.2 and 8.1 
respectively. All respondents were Muslims, with the majority came from urban area 
(74.1%) and almost all were of low socioeconomic status. Six doctors, and 18 nurses 
participated in the interviews with mean age and SD of 37.7 and 7.6 respectively. 
The health care professionals interviewed were mainly from urban areas (75%) and 
majority of them  had worked in primary health care centers(79.2%). About Fifty 
four percent of them had long working experiences with TB control programme in 
Khartoum state compared to only (16.7%) with less than 10 years of working 
experiences. All of them worked in various health care facilities including health 











Table 1.The characteristics of participants (patients): 
Variables FGD (defaulted patients(27) 
Total (n = 27 ) n (%) 
Age  
   Between 15 and 30 years 





   Male 





    Illiterate 





      Urban  





    Married 
    Single  





 Occupation  
   Had no job 






Table 2.The characteristics of participants (health care providers): 
Variables FGD health care professionals (24)  
Total (n = 24) n (%) 
Age  
   Between 15 and 30 years 





   Male 





      Doctor general practitioner 




Experience in TB management and follow up 
   More than 20 years 
   10-20years 





Place of working 
   Specialized hospital(2 hospitals) 
   Health centers 
 
5 (3 doctors and 2 nurses)(20.8) 
19 (3 doctors, 4 nurses 12 medical 
officers)(79.2) 
Area of working 
   Urban  








The results of interviews: 
The relatives variables identified from the results analysis can be categorized 
in five large groups: patients’ knowledge about TB disease; behaviour related 
factors including traditions and norms; socio demographic factors; the health 
services including the health care providers’ attitude and treatment related factors 
and believe in traditional healers and their methods. 
Patient’s knowledge about TB disease 
The results analysis of interviews of FGD revealed that most of the patients 
had known TB disease, either from family members, relatives or lived with a contact 
(someone who has TB). Even though, most of TB defaulted patients were aware that 
TB is a serious disease, more than 60% of them had limited information about the 
causes of disease, clinical presentation and mode of transmission. These results were 
confirmed by health care providers (about 66.7% of TB default patients had lack of 
knowledge). The possible causes of TB mentioned by respondents included: TB is 
an inherited, drinking cold water, witchcraft, and heavy works such as making 
bricks. However,, 2 of them mentioned that TB is caused by germs.  
 The participants listed various symptoms and signs of TB including: dry 
cough, fever, tiredness, and back pain.  Almost all the interviewed TB patients 
reported that they presented to the health centers with productive cough, fever, 
weakness, anorexia, and or shortness of breath.  However, around 40% of them 
explained that they didn’t know about TB before having it table1,3 and 4.  
I heard about TB from my eldest brother, when he had infected with TB 6 years ago (39 
years old illiterate man ). 
   I  did  not know about TB before I had it (35 years old women).  
The TB disease can be transmitted by shaking hand with an infected person(male opinion). 
My father told me that I got TB since I was a child, my grandmother had similar symptoms, 




TB got me because I worked hard, Iam a farmer (male opinion) 
We got TB from cold drink, we used to drink cold water in the market especially during 
summer seasons, and it was very serious (4 male participants). 
Similar results were mentioned by health care providers, (during my practical 
experience for more than 20 years working in TB programme in various health units and the last 
6 years in this hospital, I had met a good number of TB patients who came seeking medical advice 
who lacked knowledge of the TB disease including causes, mode of transmission, clinical 
presentation , and treatment. Among patients I met, some preferred seeking treatment from 
traditional healers.  (One medical practitioner doctor).  
 
The behavioural  and socio demographic factors: 
The analysis of FGDs revealed that the most social factors leading to default 
TB treatment were financial (low family income (81.5%), had no job (55.6), the 
transportation cost (77.8%) and cost of drugs), distant health unit (70.4%) and lack 
of family support (70.4%). All FGD endorsed the financial burden as the strongest 
factor affecting access and patients’ adherence to treatment. The participants 
mentioned that although, the treatment services were offered free of charge by the 
state TB program, still  some  patients may face obstacles of accessing this free 
services; such as far distances,  cost of transportation  in addition to other social 
reasons such as the fact that women in some rural communities need to be escorted 
to the health unit. The interviewee said these obstacles may force some of them to 
buy their medication for one or two months only from any near private health 
facilities. Thus the social and financial factors significantly affected treatment 
seeking behavior:  they find it much easier to seek care from traditional healers than 
going to a distant public health care facility especially in rural areas and among 
illiterate patients (63%). Cost of drugs, consultation, and hospital admission were 




living expenses, as well as the risk of losing job table1, 3and 4.Similar reasons were 
revealed from the analysis of health care providers’ discussions.  
I faced a very embarrassing situation, that I had no money.  Frankly speaking, how will we 
survive if we have no money in our hands, no treatment, no transportation,  no food  and without 
job (one male opinion)  
To collect my free medication from the health unit, I had to travel for 2 hours daily, 
specially during the first 2 months and I needed a companion to go with me, also I have to stay for 
more than an hour to collect the medication. The cost of transportation is more than 20 Sudanese 
pounds; my husband told me that he cannot afford this. Then he brought a herbal medication from 
his friends (41 years old, one  woman). 
Distance and travelling cost: 
 A group of  participants  stated that the challenge for TB patients is  
geographical distance and  they had to come on  daily basis to take their medication 
under direct supervision  at health center, These challenges faced mainly those lived 
in rural communities or those who lived far from the health center.The health care 
professional mentioned the relation of distance (83.3%), and transportation cost 
(66.7%) to treatment default.  
Patient movement or changing address: 
About 63% of participant mentioned that they moved or changed  address 
during TB treatment duration which was confirmed by the health care providers. In 
addition, (83.3%) of health care providers stated that wrong address or incomplete 
information and patient movement were associated factors for non adherence to 
treatment.. 
(From my experience, I would like to tell this story, one day  I went to trace a defaulted 
patient,  I took his address from patient records, I found that he was shifted to another house  not  
far from here. The patient mentioned that  the main reason to discontinue his  treatment because 




with daily living expenses as there was no body to help him. Now he used  herbal remedies brought 
from a traditional healer(30 years one medical assistant in a health center). 
Lack of family support and stigma: 
The participants discussed that patients with TB disease need family and 
community support (financial, psychological and moral support)  to adhere to 
treatment especially during the first two months. Some patients mentioned that 
sometimes they felt guilty as this will affect their family income especially if a 
family member left his work to accompany him to the health unit.   
(the family support is important factor to continue the treatment, I  faced stress from my  brothers. This discourage 
me from taking drugs)(one female opinion).  
Many patients believed that they were predisposed to stigma (63%) because 
of TB.  These believes prevented them to attend social events and occasions. (My 
relatives and friends believed that I was infectious, as I had TB disease ,and they  tried to avoid 
me. (one male opinion).  
Other respondents stated that no significant changes in the behavior of peoples 
towards them, no precautions were taken against them, and social support of family 
and friends was continued as normal which helped them taking treatment.The health 
care professional emphasized that TB patients feel stigmatized by closed relatives or 
friends due lack of knowledge about TB in the community. This encouraged some 
patients to hide that they had TB even form their spouses. (TB may affect patient 
interaction with others, specially females  could not get married as she had TB disease(2 males , 
health care providers).These circumstances may lead  patients to delay  seeking  
treatment.(I got TB few months ago, I did not tell anybody, even my family member, TB was 
infectious disease, nobody will respect me and all will try to avoid me(one male opinion). Other 
few participants stated that they told their families and close friends about TB infection, they 
provided them support and encouragement during the treatment duration. (I accept that I got TB 
infection, without complain,  I told my family and old friends, about my TB infection. They told me 




Some health care providers mentioned that till now there are separate clinics 
in some health centers for treating TB patients, this make them feel stigmatized.   
Health services,  treatment related factors and attitude of health care 
providers: 
There were divergent views among patients regarding the barriers leading to 
TB default, especially the health services and treatment related factors  (side effect 
of drugs, barriers related to health center for  DOTS programme, and  health 
professional attitude). 
The treatment factors: 
About 63% of defaulted patients were not on DOTS programme. They 
mentioned that DOTS with daily supervision of treatment for the first two months 
(initial phase) was a challenge to them especially during this phase. During the initial 
phase many patients were ill, weak and suffered from the severity of the disease. 
This meant that they needed to visit the TB clinic with  a family member. Thus not 
merely the patients bearing the burden of TB, but involved their families and 
relatives. 
“I had to come every day for injections and to swallow the medication in front of the nurse. I 
came daily with my brother because Iam ill,  I  tell you the truth, we had to hurry  to reach here 
early in the morning, sometimes  without even having breakfast. We cannot afford to come every 
day. It was very difficult to me and my family. In addition, we sold all properties, now we need 
financial support but no body to help us, so how can we continue the treatment for 2months?” 
(41 year-old female”: 
  The DOTS programme was compounded by several challenges: 
geographical distance, transportation cost and daily attendance, especially for 
women and those coming from rural areas. Those who had no cars used public 




I had to wake up early at 5:30 A.M every day to catch a car to travel for more than 25 KM 
to the health unit and then returning back home. I was asked to continue treatment for 2 months. 
If there was a rain I had to stay with my relative in Khartoum North. The transportation cost me 
a lot. All this cost provided from my relatives as I had no job during this period. Also the far 
distance made me  uncomfortable, and sweat  a lot, in addition, the dust  and smoke exhausted by 
the car made us feel dirty . I tried this for a month before deciding to discontinue the treatment, 
especially after I felt better. (39 male patient from a rural area) . 
The health care providers expressed their well awareness of TB treatment and 
emphasized  the availability of health services at DOTS health centers. At the same 
time they admitted the shortage of health staff, and lack of training. All health care 
providers stated that DOTS programme is an important factor for treatment 
adherence and cure. However, some reported that coming daily to the TB clinic 
especially in the intensive phase of treatment was physically and financially 
demanding for sick patients.. (from my experience, seeking medical treatment is related to the 
patients knowledge, as treatment of TB may continue for more than 6months,  this needs 
commitment. DOTS programme helps patients to continue their treatment, offers opportunity for 
interaction between  patients and health personnel, to increased their information. But still coming 
on daily bases was difficult for sick,  poor patients,  and those coming from far. Thus some patients 
may discontinue treatment after short period, especially when he feels better or finds alternative 
treatment.(one male health care provider) 
(Some patients seek medical advice too late, one day We got a very sick patient, he was diagnosed 
with TB.  He told me that he thought that it was a normal cough, although he complained of it  for 
more than 6 weeks.  (one male medical doctor) 
 
Side effects to treatment: 
More than 77% of defaulted patients experienced side effects to TB 
medication and mentioned the  burden of TB drugs and their  side effects being the  




patients and health care providers included headache, rash, nightmares, burning 
abdomen, feeling of hunger, vomiting and generalized body weakness.  
 Since I have started to swallow tablets and to be injected on daily basis, my 
body was harmed. Few days later I developed itching, hungry and burning abdomen. 
I mentioned this to the nurse. He said to me these symptoms will subside and gave 
me another medication but the side effects never subsided. When I told the nurse that 
I still suffer from the same side effects,  he always retort and did not believe what I 
said, and considered me as annoying  patient. Then I decided to discontinue 
treatment(44 years male). These results were reinforced by 6  health care providers.  
Other health care providers reported that  some patients seek medical treatment when 
they feel ill, and stop treatment when feeling better. Additionally, they mentioned 
that medications side effect were a leading cause of default(75%). 
The attitude of health care providers: 
The majority of defaulted patients in the study were not happy about attitude 
and approach of health professionals(81.5%). The participants mentioned that the 
health care provider should be receptive, friendly, follow a warm approach when 
educating patients. The health care provider mentioned that their main roles are 
diagnosis and treatment of the disease, but also they used to provide their patients 
with some information on TB disease. All of them followed friendly approach with 
patients and increased interaction with them to enhance continuation of treatment. 
They all emphasized the importance of having a health educators at each health unit. 
  I visited the health unit many time: at the first visit they told me that I have a chest infection. 
After 15 days I came back with the same symptoms and then referred me to the TB unit. They told 
me that I had TB disease. The nurse asked me to come tomorrow for treatment. When I came next 
day I stayed for more than 1 hour,  after that the nurse called me , please come in , today you will  
start TB  treatment. He didn’t give me enough information about the disease and its treatment , he 




beside me. This approach embarrassed  me  and I felt  this disease as stigma in the community. 
(48 years women).  
The health care providers mentioned that they try to support their patients and 
families but still some patients cannot accept their infection with TB and may hide 
it even from their close relatives, and eventually discontinue the treatment.    
The TB treatment default tracing team: 
           A key barriers raised during the interviews discussion by a proportion of 
patients and the health care providers was the weakness of defaulters tracing team-. 
Interestingly, this factor had not been included in the questions asked by the 
moderator. Some patients  mentioned they discontinued the treatment for months 
and had not been called or visited by the health professional, while  few patients 
mentioned that had received calls from the health units. One patient said he had been 
visited once by his treating nurse, he explained that his house lie near to the health 
unit, also he had a friendship with this nurse. 
            The health care providers mentioned that the TB control programme had  
problems in  tracing TB defaulters. This was attributed to shortage of staff, lack of 
transportation and communication means, incomplete patients address information 
and staff related difficulty such as female health professionals inability to trace 
defaulted patient due to cultural factors.(we feel and know the importance of communication 
with our patients, the tracing of defaulted patients, but how can we achieve this? There was no 
default tracing team at the health unit, no car or any mean of transportation, sometimes had no 
means of communication with these patients, either due to wrong or incomplete address for the 
patients or the telephone at health center was out of service(44 years male nurse). 
“how can I visit the patient’s home, Iam a female and my husband cannot accept that (32years 







About 63% of defaulted TB patients admitted that according to their culture 
and norms, going to the traditional healers or taking herbal drugs was preferable to 
visiting health centers.  As per patients and health care providers,  other reasons for 
seeking traditional healing were: lack of knowledge, cost of travelling, daily collection of 
medication, misbelieves about, lack of social support, waiting time at health facility, 
health care providers attitude, stigma, high expectation of immediate healing and 
improvement, medications’ Side effects, injectable treatment, and duration of 
treatment. 
  (I preferred to go take herbal treatment as the traditional healer was more friendly and well known 
to me, and I trust him as well.(one female patient). 
(I got a cough for 4 weeks, I had to wake up early to visit a far health center, It costed me more 
than 30 pounds daily for transportation and breakfast. After one week my elder brother asked me 
to go with him to a famous traditional healer, who claimed to be having long experience in treating 
many diseases. He was a simple man, friending had a good sense of humor, accept any amount of 
money and even other gifts. He prepared for me herbal medicine.(one man opinion).  
(Illiterate, Poor patients cannot afford treatment completion regardless the source of the treatment 
(one male, health care provider). 
(The norms and traditional in our community had negative impact on TB treatment, some patients 
started treatment at the health unit,  few days  may go to seek other advice either from private 
sectors or go to traditional healers. Therefore, health education,  and involvement of community 
organizations is mandatory to increase awareness of patients, and their families about TB disease 
and the treatment compliance. One male medical doctors)  
The traditional healer in our village was friendly, gave drug with little money, no waiting time, no cost of travelling, 










Table 3. The barriers leading to TB treatment default according to health care professionals 
FGD: 
The factors  Opinions of health care 
professionals  
Total (n = 24) n (%) 











Distance to clinic 
 Between 1 and 5 kilometers 











 Less than 3 Sudanese pound(SD) 




Time to clinic 
Up to 60minutes  




Family income =(mean, SD) 
Less than 1000 Sudanese pound(SP) 




those with family support 









Response to treatment 
    Good 
    Not good 
 
24(100) 
Side effects to TB treatment 
   Had side effects 




Try to hide that had TB disease(stigma) 
   Yes 





    Those on Dots vs 
     Not DOTS 
 
24(100) 
Seek folk remedies 
       Yes 
       No 
 
24(100) 





Table 4. The barriers leading to TB treatment default according to patients 
The  factors defaulted patients  
Total (n = 27 ) n (%) 
adherence patients  Total (n 
= 9) n (%) 


















Distance to clinic 
 Between 1 and 5 kilometers 

















 Less than 3 Sudanese pound(SD) 







Time to clinic 
Up to 60minutes  







Family income =(mean, SD) 
Less than 1000 Sudanese pound(SP) 








those with family support 








   Good knowledge 





Presenting  symptoms to the clinics(productive cough, 
fever, weakness, anorexia, and or shortness of breath) 
Yes 
No  









Response to treatment 
    Good 






Side effects to TB treatment 
   Had side effects 








    Those on Dots vs 







Try to hide that had TB disease(stigma) 
   Yes 







Seek folk remedies 
       Yes 







Health care providers approach 
   Receptive 












The present qualitative study revealed five major factors that most TB 
treatment defaulting patients mentioned when assessing the TB services offered by 
the TB Control Programme in Khartoum State. These factors were: 1) patients’ 
knowledge about the disease TB; 2) behavior related factors that included traditions 
and norms; 3) sociodemographic factors, especially income versus cost and 
distances to the TB center; 4) the health services provided itself, including the health 
care providers attitude and treatment related factors and;  5) believe in traditional 
healers and their methods. These factors represent opinions of three samples of TB 
treatment defaulting patients and three samples of health care providers who worked 
for a long period in TB units in Khartoum State. 
The barriers reported by TB treatment defaulting patients and health care 
providers who participated in this study were not well known and not familiar to 
both the Khartoum community and the policy makers of the TB control program in 
Khartoum state, although they were reported previously in many international 
studies [3,13-15]. In addition, this the first larger qualitative wide study that explored 
the opinions and experiences of the patients and treating staff themselves about the 
barriers related to interruption of TB treatment. Moreover the results highlight the 
attitude of health care workers towards the patients, patients knowledge about TB 
disease and its treatment, the economic effects, including cost of travelling, food and 
loss of work and the believe in traditional healers. Interestingly, there was another 
barrier raised by the participants in the six focus group discussions, i.e. the poor 
availability of communication and transportation for the treatment default tracing 
team.  
TB is a disease prevalent among poor communities and when diagnosed needs 




program will need to come on daily basis to take their treatment in presence of the 
nursing staff at the TB clinic. This create challenges, identified in this study, 
including the cost of travelling, especially for those who lived in rural areas. Another 
barrier, reported by the participants concerned especially females who, as 
necessitated by the traditions and norms of the Khartoum society, need companion 
to visit the TB units. Our findings consolidate the previous results in the developing 
and developed countries ([5,17-20]. The patients tried to overcome these challenges 
by seeking help from their relatives and non-governmental charity organizations. 
Although the TB services are offered on free base to all patients, these still barriers 
to the accessibility and acceptability to these services. One way to improve 
accessibility could be the integration of TB services in the primary health care 
centers scattered all over the state. The absence of specialized knowledge on 
diagnosis and treatment of TB could be amended be e.g. weekly visits of a TB center 
specialist. In addition, it would be important to further study and measure patient 
satisfaction with the TB services that includes their and their relative’s opinion 
regarding the DOTS program. For example those who live far from the TB units 
may take their treatment under supervision of one their family members, with e.g. a 
confirmatory texting message. 
TB is a familiar disease worldwide, nevertheless, a large number of patients 
lack knowledge about the disease. This due to illiteracy, and the insufficient 
education and counseling given to the patients. Also we observed that patients 
seeking treatment from traditional healers are more likely to default their TB 
treatment. These findings are similar to results of other studies in developing 
countries with low resources in Africa and Asia which carry the highest burden of 




 We found that the patient’s perception regarding the health care provider 
attitude is an important determinant factor for adherence to TB treatment. However, 
the health provider attributed the influence of this factor to shortage of staff and high 
work load, lack of health education given to the patients, and self-stigmatization 
among patients. Therefore we recommend that health personnel to follow a warm 
approach with their patients and assure them that TB is curable. This approach will 
create good rapport between health providers and their patients. Hence, encourage 
patients adherence to treatment.  These findings are in line with results reported by 
other studies [3,13,15,21-22,24]. Although our findings in contrast with that 
mentioned by Nyi form Malaysia [25] and Ayé from Tajikistan[4].  
This study confirmed that waiting time, side effect of treatment and patient 
movement are associated with TB defaults. These findings match previous studies 
in developed and developing countries [3, 10,12,13]. Although our findings are in 
contrast with that reported by Nyi [25].  
Although the intention of the National TB Control Programme was to have an 
effective tracing team, the interesting barrier related to treatment default which 
raised by most of the participants in this study was the weakness of TB default 
tracing team. This needs special attention and deserve an assessment of TB control 
programme. This weakness was attributed to shortage of staff, lack of transportation 
and communication means and cultural barriers. These findings in line with the 
result reported by other international studies(south Africa) [26].  
The findings of this study might help the policy makers in Khartoum state, 
Sudan and other developing countries in planning and policy development to 
strengthen TB control programs in general. Moreover the barriers need special 
attention including: health education, travel cost, family support, waiting time, 




of the community members, patients, families, treating staff, and governmental and 
non-governmental organizations. These efforts may help patients socially and 
financially. These will help strengthening interaction between the patients, their 
families and treatment staff. In addition, more attention should be paid to staff 
training, regarding the  health education, supervision  and receptiveness. 
Overall the findings of present study raise important issues on TB treatment 
default in Sudan since we could not identify previous detailed studies on this subject 
in this area. These results can help in decreasing the TB treatment default. Thus, 
decreasing treatment failure, multi drugs resistant, TB relapse and inhibit spreading 
of tuberculosis in the community.  
Some methodological aspects of this study need attention: First, the major 
problem we faced during the study was how to reach the defaulting patients. This 
problem was tackled in 3 steps. First, the patient medical records were traced and 
identified and all contact information was reviewed. Then, study personnel first tried 
to telephone the patient and, failing that, to telephone known family members or 
friends. If telephone contact failed or if there was no telephone number on record, 
home visits were made, first to the patient and then to known family members or 
friends. Secondly, this study was qualitative study which help in identifying the 
perception, opinions and problems of different patients and health care providers. 
Thirdly, the qualitative study may help in improving the treatment and strengthening 
the TB control programme.  Fourthly, the results of focus group discussion included 
the patients opinions and the long experience of health care providers. Lastly, to 
reduce the recall bias, we interviewed three groups of  patients who were recently 







The study highlighted several challenges and barriers leading to TB treatment 
default. Our findings may help the interaction between patients, families,  health 
personnel  and policy makers.  We believe that the findings are applicable to current 
situation of TB management and control in Sudan and other developing countries. 
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Setting:Although tuberculosis is a treatable disease,the high frequency of treatment 
default remains a challenge.The use of mobile phones structurally in a TB program 
has the potential to lower the frequency of default.However, it’s impact on treatment 
outcome in Sudan has not yet been evaluated.  
Objective:To evaluate the potential use of cell phones for lowering treatment 
default. 
Design:We conducted a controlled intervention pilot study during the period from 
1th of May 2017 to 31th of March 2018,in eight TB treatment units in Khartoum 
state,Sudan.Newly diagnosed patient with positive sputum smear on DOTS therapy 
were enrolled in intervention and control groups.SMS reminder were sent to the 
intervention group.Assessments were done at the beginning and at the end of the 
treatment. 
Results:One hundred and forty-eight patients were enrolled, seventy-four patients 
in each group.The participants in the two groups were similar in demographic 
characteristics and behavioral and knowledge related factors about TB disease at 
baseline.The patients in the intervention group had a lower default rate(6.8%),higher 
documented cure rate(78.4%),better knowledge compared to control group.SMS 
reminder was useful and facilitated good interaction between patients and health 
personnel. 
Conclusions:Mobile texting seemed useful and was highly accepted by participants. 
Further evaluation of it’s potential benefit was warranted. 
 







  Tuberculosis (TB) is the ninth leading cause of death worldwide and the 
leading cause from a single infectious agent, ranking above HIV/AIDS1. Moreover, 
it continues to be a major global cause of death and morbidity, disproportionately 
affect the poorest communities 2,3. Thus WHO recommend directly observed 
treatment short course (DOTS) strategy 4,5. This strategy aims to detect   individuals 
with sputum smear-positive tuberculosis, initiation of anti-tuberculosis 
chemotherapy  and  adherence to treatment and decrease defaulting rate.  Treatment 
of active pulmonary TB patients remains the most effective strategy to stop the 
spread of the disease 6,7. Defaulting from treatment may remain the major challenge 
to control TB. In addition, it increases the risk of drug resistance, relapse, and death 
and may prolong infectiousness 8,9. 
Sudan shoulders about 15% of TB burden in the Eastern Mediterranean 
Region and has the second highest active TB prevalence of the countries in this 
region 10. In line with WHO, Sudan adopted DOTS strategy since 1993. Despite the 
efforts that had been undertaken by health authorities still some patients fail to 
adhere to TB treatment and eventually default before completing the treatment. 
There are many factors  leading to  high default rate in  Khartoum state. These 
include: socio-demographic factors; behavioural factors, disease and treatment 
relating factors; lack of knowledge and stigma and default tracing team 
problems.The default tracing is major challenge to TB control programme in 
Khartoum State, this due to wide area of the State, shortage of staff, shortage of 
transport facilities for default tracing teams 8,11. As defined by the WHO, patients 
who fail to collect their TB treatment for 2 consecutive months are reported as 




The use of mobile phones has substantially increased throughout the world 
over the last decade and also in Sudan. The global expansion in cell phone use 
presents new opportunities to incorporate mobile phones into health care delivery 
services 13-15.The World Health Organization (WHO) has defined mHealth as 
‘medical and public health practice supported by mobile devices, such as mobile 
phones, personal digital assistants and other wireless devices 16.  
Thus we conducted an intervention comparative study in Khartoum province, 
Khartoum state aiming to determine the approach of use of mobile phone in 
improving adherence and decreasing the default rate among patients receiving TB 
medication under DOTS program.  
Material and methods 
Study design 
      To evaluate the potential use of cell phones for improving adherence to 
treatment, we conducted a controlled intervention pilot study in TB patients on a 
DOTS program. Those TB patients who owned a cell phone or had shared access to 
such a devise formed the intervention group. These patients received the current 
standard of care with the addition of informative text messages. TB patients on the 
same DOTS program who did not have access to a cell phone received the current 
standard of care and were the control group. The trial was conducted in Khartoum 
state. We conducted this study to determine the effect of cell phone usage in 
decreasing TB treatment default. 
Setting 
    This study was conducted in Khartoum province, Khartoum State. The patients 
were recruited form 8 TB treatment units. A registered nurse is responsible for 
promoting and checking treatment adherence as well as for tracing the patient in case 




a medical doctor or a specially trained medical assistant, a laboratory technician and 
a clerk.  The tuberculosis control program has been described in detail elsewhere 11. 
 
Patient eligibility 
   All TB patients who participated in a DOTS program and were registered at the 
participating centers were eligible. Inclusion criteria were: newly diagnosed, smear 
positive pulmonary TB, age over 15 years and the provision of informed consent. 
Exclusion criteria were: psychiatric illness, limited vision, extrapulmonary or 
relapsing TB. 
Patient accrual 
     Patients who had access to a cell phone were considered the intervention group. 
After each such patient who consented to participate the next patient(s) without 
access to a cell phone were asked to participate in the control group. 
Standard of care 
     All patients were in a DOTS program according to the TB control program 
strategy in Khartoum State. This strategy coincides with WHO 
recommendations.  The DOTS program consists of 6 months of TB treatment. In the 
first 2 months (intensive phase) patients receive 4 drugs: isoniazid, rifampicin, pyra-
zinamide and ethambutol. Here after, patients receive 4 months of isoniazid and 
rifampicin (continuation phase). All patients came on a daily basis to the TB center 
to take their medication in the presence of health care personnel 17. All patients who 
interrupted their treatment were traced by the routine methods carried out by the TB 
control program in Khartoum State. 
Intervention 
      The patients in the intervention group received standard of care, with the addition 




the end of treatment. The content of the text messages is displayed in Table 1. Also, 
these patients received a telephone call at least once during the first week of their 
treatment. In case of treatment interruption, the patients received cell phone 
messages to encourage them to come back and continue their treatment. Moreover, 
on top of the usual tracing activities performed by the TB control program, they 
received telephone call, additional text messages and, if need a home visit. 
Data collection methods 
     The data collection was done by 2 trained persons who recorded demographic, 
disease related factors and treatment related variables from the medical records. In 
addition, a face to face interview was done, using a semi- structured questionnaire, 
to elicit information on the various factors possibly associated with treatment 
default. (figure 1).  
Definition of outcomes 
       Treatment default was defined as a patient who failed to collect his TB treatment 
for 2 consecutive months. A documented cure was defined as a patient who was 
smear- or culture-negative in the last month of treatment and on at least one previous 
occasion18.  
    Knowledge of TB disease and its treatment was defined as “the facts, feelings, 
and experiences reported by the patient 19. This was implemented using the following 
5 questions: do you hear about TB disease before you had it?, do you know duration 
of treatment?, what you expect if you stop treatment?, can TB be cured?, when to 
stop TB treatment? and do you know the cause of TB?.  








Sample size was calculated by using the WHO calculator for a controlled 
study. The default rate among TB patients reported by the National TB control 
program in Sudan was 11%. We expected an improvement in default rate to 5% (or 
less). Hence, with A  type I error – two-sided of 0.05 and a 80% of power, the 
sample size was calculated to be 138 patients. We reviewed 148 patients (74 in 
each group) 20.  
All calculations were done based on the intention to treat principle. Data 
analysis was performed in SPSS (Statistical package of Social Sciences) version 
21. Chi-square tests were performed for qualitative variables and Student’s t tests 
for continuous (outcome) variables. In addition, the defined outcomes were related 
to group of assignment, adjusted for potentially confounding variables using 
logistic regression analysis.  
Ethical Considerations:  
        Ethical approval was obtained from Ministry of Health of Khartoum State 
ethical Committee. Informed verbal consent was secured from every eligible patient 
included in this study before the interview. All participants were informed that the 
interview was entirely voluntary. Privacy and confidentially were maintained during 
data processing and reporting. Also, patients who participated were informed that 
they had the right to end the initial interview at any time, or refuse participation 









































The patients assigned according to 
inclusion and exclusion criteria 
The cases, all newly 
diagnosed TB patients with 
positive sputum smear results 
- Received mobile text 
message, or calls 
- Usual follow up  
The cases, all newly 
diagnosed TB patients with 
positive sputum smear results 
- No mobile text 
message, or calls 
- Usual follow up  
Base line data: 
-socio demographic data, 
disease, investigation and 
treatment, 
-the intervention process 
 
Base line data: 
-socio demographic data, 
disease, investigation and 
treatment,   
-  Standard process 
 
Clinical data: 











Between the period 1th of May 2017 to 31th of March 2018, a total of 169 
consecutive patients who initiated TB treatment based on the inclusion and exclusion 
criteria were assessed for eligibility to participate in this study. Of these, 148 were 
enrolled in the study and 21 patients met an exclusion criterion. The demographic 
characteristics of the intervention and control groups are given in Table 2. Patients 
in the intervention and control group were well matched, and none of the differences 
were statistically or clinically significant. The participants in two groups were also 
similar in behavioral related factors and knowledge about TB disease at baseline 
(Table 3 and 4).  
Adherence to intervention and control group assignment 
 All 74 patients in the intervention group received text messages and telephone 
calls during the study period. Out of them 70 patients responded to our SMS’s and 
texted or called back. A total of 61(82.4%) patients of the intervention group were 
able to read and send SMS’s, while 13(17.6%) patients shared the mobile phone with 
their families as they were not able to use it or read the messages themselves. There 
were 72(97.3%) patients in the intervention group who rated the SMS’s as very 
useful, useful or may be useful while only 2 (2.7%) patients rated the SMS’s as not 
useful.  
 There were 70(82.4%) patients asked for counselling assistant, while 
36(48.6%) patients provided a request regarding information about side effect of 
drugs and 24(32.4%) patients asked for Medication and social support.  
 None of the 74 patients in the control group received the SMS messages. 
However, the responsible treatment center tried to call or trace the 8 patients who 




Adherence to the TB treatment protocol 
The patients in the intervention group had a lower default rate (6.8%; 5 out of 
74 patients) compared to those in the control group (10.8%; 8 out of 74 patients). 
This difference was not statistically significant (P-value 0.563; OR: 1.673, 95% C.I. 
0.521-5.374).  
The patients in the intervention group had higher cure rate 58 /74 (78.4.0%) 
compared to 44 (59.5) of the 74 patients in the control group (P-value 0.020; OR: 
2,472, 95% CI:1.133 – 5.434).  
Knowledge of TB disease and its treatment between the groups  
 At the beginning of treatment, knowledge of TB disease and its treatment, 
were similar between the groups, with odds ratios varying between 0.78 to 1.32 
(Table 5). 
At the end of treatment, the knowledge in the intervention group was better 
than in the control group for all 5 variables, and was statistically significant in 3 of 
them (Table 5). 
Knowledge of TB disease and its treatment in relation to treatment default and 
documented cure.  
There was no statistically significance found between the patient’s knowledge 
and treatment default among the intervention group for all 5 knowledge variables. 
In the control group a single variable (‘know when to stop’) was statistically 
significant, (OR: 7.421; 95% CI: 1.374- 40.085; P < 0.015 ).   
In the intervention group the relationship between patient’s knowledge and 
documented cure was statistically significant, namely ‘duration of treatment’ (OR: 
6.136; 95% CI: 1.417- 26.581; P < 0.019)and when to stop treatment (OR: 4.371; 
95% CI: 1.211-15.784; P < 0.028). In a multivariate analysis the variable ‘when to 




1.050-4.870; P < 0.037). In the control group, no statistically significant relationship 
was found between all 5 knowledge variables and documented cure.  
DISCUSSION 
The present study explored the use of mobile phone services to decrease 
default rates in newly diagnosed patients with smear positive results for 
Mycobacterium Tuberculosis (TB) who received treatment under a DOTS program. 
We found that patients in the intervention group had a lower default rate (albeit not 
statistically significant), a statistically significant higher documented cure rate and 
better knowledge than those in the control group at end of the treatment period, 
regarding the duration of treatment, what to expect if treatment is stopped and when 
to stop TB treatment. Also, it was observed that there was à statistically significant 
relationship between patient knowledge (know when to stop TB treatment) and TB 
treatment default among patients in the control group. In addition, there was a 
statistically significant association between the patients’ knowledge and 
documented cure rate (duration of treatment and when to stop treatment) among the 
intervention group. Moreover, the use of mobile phone services created good 
opportunities for interaction between health personnel and patients in the 
intervention group who often responded by texting or calling back, asking about 
drug side effects and requesting for help and social support. Finally, most patients 
in the intervention group were positive about the mobile services. 
The TB treatment default rate observed in the control group in this study was 
(10.8%) which is high compared to WHO target maximal default rate of (3%) 21. 
However, it is lower than those reported (14%) in recent studies conducted in the 
same geographical area 8,11. A potential cause could be the relative high education 
of residents from Khartoum state and the patients who participated in the study, 




between SMS text messages reminders and default rate and documented cure rate 
confirms the results of previous studies conducted in both developed and developing 
countries 24,25,26,27. However, our findings were in contrast to that reported by Sabine 
M H form Uganda and Cameron that SMS reminder did not show any difference 
between intervention and control group 28,29. Our observation that the SMS 
recipients, texted or called asking help and social support were similar to those 
reported in India and Uganda, in which study the recipient also were favorable about 
the use of mobile services 30,31. 
TB is a chronic disease and its treatment lasts for more than 6 months. In 
addition, the treatment needs multiple drugs that are to be taken once daily for this 
period.  After starting treatment patients usually feel better since symptoms and signs 
improve or disappear. Hence some patients may discontinue, forget or stop their 
treatment. Such a default in finishing appropriate treatment is a danger for the spread 
of the disease, as well as induces multi-resistant TB bacteria strains. Texting can be 
sent every morning to remind patients to take treatment. The patient can reply with 
SMS confirming taking medication. Moreover, short message service (SMS) are 
cheap and quick means of communication between health personnel and TB patients. 
In fact, the availability and wide spread use of mobile phones is an encouraging fact 
that would help implemented texting successfully in a TB control program. 
However, there are challenges facing the use of this communication means that need 
consideration. For example, mobile phones   needs electric charging and patients 
may live in the absence of such facilities. In addition, the telecommunication 
network may be weak in some areas.  
 Although, we conducted a pilot study and did not do formal calculation of the 
actual cost of the mobile services, the observations in the present study show 




rate and increased knowledge of the patients. We believe that a properly powered 
and funded study is warranted to explore this possibility. Moreover, mobile phone 
services may be in general of help for health personnel and patients to have an 
improved interaction.  
Some methodological aspects of this study require attention. First, our study 
was conducted in Khartoum State, which is the most populated state in Sudan. Most 
of the inhabitants come from various parts of Sudan so it is likely that subjects 
included in the study may represent the whole country. Second, recall bias was 
minimized by using a semi standardized questionnaire during the interview and by 
cross-checking patients’ responses for each study variable against their medical 
records. Third, the reliability of the information gathered from each patient could 
not be counter-checked but questions about sensitive issues were carefully handled 
to maximize the accuracy of the responses obtained. Fourth, the sample size was 
calculated using previous reports of default rates in Sudan. However, the observed 
frequency of default was substantially lower in the control group. Hence, the power 
to find a similar relative effect was reduced. Fifth, for this pilot study we used a 
controlled but not randomized design. However, the demographic characteristics of 
both groups were similar, most importantly for education and by using logistic 
regression analysis. Finally, a major challenge during the study was how to reach 
the defaulting patients in the two groups. This was tackled in 3 steps. First, the 
patient medical records were traced and identified and all contact information was 
reviewed. All patients who interrupted their treatment were traced by the routine 
methods carried out by the TB control program in Khartoum State. Then, for the 
control group patients study personnel first tried to telephone the patient and, failing 
that, to telephone known family members or friends. If telephone contact failed or if 




and then to a known family members or friends.  If the patient was not traced in the 
intervention group, the patient text-messages. Moreover, they received a telephone 
call, additional text messages and, if need a home visit. Interestingly, all defaulting 
patients responded. They came back and continued their treatment (only 3 of them 
needed home visits two among the control group and one among the intervention 
group).  
Conclusions: 
 We believe that our data shows promising results to lower treatment default 
in patients with TB using mobile services that included both texting and if required 
calls. Hence, we recommend the conduction of a properly powered randomized 
clinical trial in a region with similar social conditions to establish its clinical 
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Table 1: messages sent to the patient through SMS text: Please beep or sent 
SMS to 00249990284733. 
Please don’t worry: TB is a curable disease 
TB patients present with cough for more than 2 weeks, night sweeting, and 
fatigability  
Taking TB treatment regularly will enhance cure, shortening duration of 
symptoms and prevent complications of the disease 
Please follow the advice and instructions given by the treating health personnel 
Please try to take your meals regularly, this improve the immunity against the 
disease 
 Please do not forget to take your TB medicine regularly  to reduce the risk for 
further spread of TB 
 Please do not forget to take your TB medicine to prevent infecting your family 
and friends 
 Do not forget your appointment: please come back to the clinic tomorrow. 
Come with your remaining TB medicine and TB card. 
If you have any questions or need any help please do not hesitate to contact us 
or to send SMS. 
Please try to  Use your own cup and plate  
Please try to Cover your mouth and nose when sneezing or coughing  
For good ventilation: Keeping the windows open 
If you feel with any side effect of medication please inform your treating health 
personnel or send SMS 
Please try to inform your doctor if you would like to travel anywhere and don’t 
for get to take your medication with you. 




 Table2: Sociodemographic characteristics. 
Sociodemographic Factors Cases (n=74) Control ( n=74 ) P-value 
Age – mean (SD) 
   15 - 30 years 










   Male 










   Single vs 










   Literate  











   City 











  Sudanese 











  White work 











  1000-2000SB 










  Muslim 











  On foot 
Bicycle 
 Public transportation 



























Distance to Health unit 
  Less than one KM -to 10KM 










Time to health center 
  Less than 1hour 














      Table3: Behavioural Characteristics: 
 














































































































































What do you expect 
if stop treatment 
Know 






















When to stop TB 
treatment 
When advised  






















































Table 5: Bivariate analysis of knowledge related factors between  intervention 





At the beginning of the study At the end of the study 
Odds ratio 
(OR) 
   95% C .I Odds ratio (OR)    95% C .I 



















What do you expect if 
stop treatment 
 
0.893 0.461-1.728 2.536 1.099-5.853 









When to stop TB 
treatment 
 




Causes of TB 
Germs 
Others  




























































In the research presented in this dissertation, we explored the risk factors 
associated with TB treatment default using three different study designs: a case-
control study, focus group discussions, and an intervention study. Our objective was 
to identify determinants of treatment default among TB patients in Khartoum State, 
Sudan. Based on our process evaluation and the findings of our studies, several 
recommendations were made. It is hoped that these recommendations will help 
policy makers and health care providers make changes that will improve treatment 
adherence, leading to a reduction in TB default. 
     This chapter presents a discussion of our research findings, which focus on the 
predictors of TB treatment default. A number of TB treatment barriers were 
identified which were related to treatment default among TB patients in Khartoum 
state. 
Reasons for treatment default in Khartoum State: 
      The WHO guidelines for monitoring and evaluating TB treatment outcomes have 
been used to assess TB control programme outcomes across Sudan. Tuberculosis 
continues to be a major public health problem in Sudan, particularly in Khartoum 
State, despite the fact that there has been a reduction in tuberculosis-related 
mortality, and a decline in incidence and prevalence (2). In fact, Sudan ranks 3rd of 
the 10 highest-burden countries in the Eastern Mediterranean region (3). The results 
of a TB survey conducted in Sudan in 2014 indicated a prevalence of 159/100,000. 
The survey results pointed to a higher prevalence of TB in the young, in males, and 
among those living in urban settings (1.4). Over the last decade, the number of 
notified TB cases has remained relatively constant. In 2018, the total number of 
reported cases in Sudan was 20117 with a total incidence rate of 71/100.000 
population; a MDR incidence of 2.6/100.000 population; a TB incidence rate among 




(4-6). In 2009, the National Tuberculosis Control Programme (NTBCP) reported the 
following treatment outcomes: a treatment success rate of 82%, a treatment default 
rate of 9.9%, a death rate of 2.2%, a treatment failure rate of 0.6% and a transferred-
out rate of 4.9%) (7). Similar results were achieved by the tuberculosis control 
programme (TBCP) in Khartoum state in 2018. These results included an incidence 
rate of 85/100.000 population. In terms of treatment outcomes, figures showed a 
success rate of 84.8%, a default rate of 12%, a death rate of 2.1, a treatment failure 
of 0.8% and a transferred-out rate of 1.3% (8).   
 Defaulting from treatment remains the major challenge for TB control 
programmes in Khartoum State.  Over the last decade, the default rate has remained 
high at around 14%, as reported by various studies conducted in Khartoum State (9-
11).  In 2015, the World Health Organization (WHO) launched the End TB Strategy 
with the aim of ending the global TB pandemic by 2035. However, meeting the 
targets set by the WHO in order to achieve this goal will be challenging, bearing in 
mind the current levels of treatment default in Sudan. This is because treatment 
default contributes to the spread of TB (12,13). In addition, it increases the risk of 
treatment failure, relapse, acquisition of drug resistance, prolonged infectiousness, 
and death [2,3,7,12,13]. Furthermore, if left untreated, a contagious person is 
expected to infect up to 15 people every year (14). The identification of risk factors 
leading to treatment default in Khartoum State is therefore crucial.  
The research presented in this dissertation constitutes the first in-depth study 
conducted in Sudan to identify the determinant factors associated with TB treatment 
default. Using three different study designs, we studied multiple variables that could 
potentially be associated with non-adherence to TB treatment. These variables 
included sociodemographic factors, disease- and treatment-related factors, 




care providers, and patient opinions. This approach reflects the fact that health is no 
longer considered simply as a biomedical problem; rather, it is influenced by social, 
cultural, physiological, economic and political factors that can determine the 
decision of the individuals concerned (15,16). Hence, our study differs from 
previous studies - which targeted only the TB disease and treatment outcomes - by 
also taking into account patient opinions  and the doctor patient interaction. We hope 
that these findings will help the NTBCP, policy makers and health care providers in 
Sudan (and other countries with similar settings) to improve their performance. 
Ultimately, we hope that these findings will lead to better TB treatment adherence. 
Main findings: 
Case-control study: 
   The default rate in Khartoum state stands at 14%.  We found the following 
factors to be significantly associated with TB treatment default: residential locality 
(rural area); patient relocation or change of address; absence of support from family, 
friends and colleagues; occupation (blue collar work), not being part of a DOTS 
programme; suffering from adverse treatment effects; having a history of TB 
(relapse, multidrug-resistant TB or treatment failure); not having heard about TB 
before contracting it; lack of knowledge about when to stop TB medication; stigma; 
visiting an overcrowded TB centre; and lack of  counselling about TB and its 
treatment (Chapters 3-5).  
Focus Group Discussions: 
The results from the interviews of six focus group discussions (FGDs) (three 
for defaulted patients and three for health personnel) were consistent in terms of 
identifying the determinant factors leading to TB treatment default. These results 





The intervention study:  
The patients in the intervention group had a lower default rate (6.8%), a higher 
documented cure rate (78.4%), and better knowledge about TB treatment compared 
to the control group. Our results showed than an SMS reminder was useful in terms 
of encouraging treatment adherence and facilitated good interactions between 
patients and health personnel (Chapter 7). 
Comparison of our findings with previous literature: 
 The results of our case control study showed that 14% of TB patients in 
Khartoum State were treatment defaulters (11). This high default rate is similar to 
figures that have been reported in other developing countries in Africa and Asia, as 
outlined in our systematic review (16-18). These findings were confirmed in our 
intervention study which showed that the patients in the intervention group had a 
lower default rate (6.8%) compared to those in the control group (10.8%).  
Furthermore, patients in the intervention group had a higher cure rate (78.4%) 
compared to  patients in the control group (59.5%) (Chapter 7). 
We identified several factors associated with TB treatment default. These 
predictors included sociodemographic factors, TB disease- and treatment-related 
factors, patient knowledge, and behavioural factors. Similar factors predictors were 
identified in the focus group discussions, where we explored the opinions of both 
TB patients and health care providers. The results from the intervention study were 
also consistent with these findings (Chapters 3-7).   
For the most part, our findings regarding factors which are associated with TB 
default are similar to those reported in studies carried out in developing countries 
with low resources in Africa and Asia which carry the highest burden of TB (16-18), 




some previous studies, we did not find an association between certain 
sociodemographic or disease-related factors and TB default [21]. 
  Surprisingly, some factors previously thought to be related to TB treatment 
default (e.g. age, sex, religion, family income, family size, house size and 
nationality) were not found to be statistically significantly  associated with default 
in our studies or in the systematic review (24,25). Furthermore, other behavioural 
factors - including cigarette smoking, alcohol abuse, and feeling shame - were not 
associated with TB default in our study, in contrast to the findings of some earlier 
studies (16,27). However, there are relatively few papers that have specifically 
investigated the association between these factors and TB treatment default (17-19). 
In our research, patient awareness about TB and its treatment was 
significantly associated with TB default, especially among those with a low 
education level. Highly educated individuals, whether employers or employees, had 
a very good awareness of the disease, and so did those living in urban areas. Results 
showed that patients with a low education level are more likely to change their 
address or stop their treatment prematurely when feeling better, without informing 
their care providers. Moreover, they may be more likely to seek traditional or herbal 
medicine. Our study highlights the importance of health care workers providing 
health education to their patients, by showing that a lack of this information had a 
negative impact on patients’ adherence to their TB treatment. We recommend that 
health workers provide health education and counselling for both TB patients and 
their families. These efforts should encourage patients and their families to adhere 
to TB treatment and ensure family support during the treatment period. The fact that 
more than 66% of TB patients are illiterate or receive less than 6 years of schooling 




 TB patients living in rural areas are more liable to default TB treatment. 
Poverty, poor nutrition, illiteracy and lack of knowledge represent major risk factors 
for TB disease and are associated with noncompliance to treatment among displaced 
individuals and refugees who live in camps, where TB medical services are provided 
in clinics managed by non-governmental organizations. These clinics are not fully 
equipped in terms of  laboratory services, trained health personnel and the 
availability of medication for drug resistant TB (DR TB) (18,33-36). Our findings 
were similar to results of previous studies suggesting that TB is associated with low 
socioeconomic status (18,28-31). In Sudan, for example, it has been shown that more 
than 80% of TB cases had a family income of less than 100 dollars per month (6).  
We therefore suggest that both governmental and non-governmental organizations 
should ensure that social and financial support is provided to TB patients who are 
out of work or of low socioeconomic status.  
The stigma surrounding TB has long been recognized as an important factor 
leading to TB treatment default, especially among those with a lower level of 
education, or those who live in rural areas. The psychological effects of stigma on 
TB patients include increased levels of stress and anxiety, decreased levels of self-
confidence, and other issues related to self-identity. Stigma can also have a negative 
impact on TB patients and their families socially and economically. Social stigma of 
TB may force some patients to give up their work,  and its effects for some may be 
lifelong. Moreover, stigma can make TB patients more likely to feel shame, hide 
their disease, and decrease their motivation to seek medical care. In addition, 
stigmatized patients may be more likely to turn to herbal and traditional medicines.  
In summary, social stigma can lead to a worsening of patient’s condition, disease 
complications,  treatment default, treatment failure, drug resistance, and the spread 




Overcoming TB stigma needs active interventions using non-traditional 
health education methods. To ensure the success of a health education initiative, it 
is important to have an ambitious plan which communicates and reinforces specific 
messages, such as the fact that TB is a curable and preventable disease. Moreover, 
it is important that these health education messages are designed and targeted with 
specific groups - such as TB patient, their families, students, and the wider 
community – in mind. The education plan needs to be implemented by well-trained 
health staff. Furthermore, it is crucial that various outreach methods are employed, 
including social media, movies, drama, public talks, and brochures. In this way, 
health care staff as well as various non-governmental organizations can encourage 
community participation and contribute to the health education of TB patients, their 
families, and the wider community. 
It has been shown that receiving treatment under the DOTS programme 
significantly enhances adherence to TB treatment. Adopting the DOTS programme 
is usually associated with free services (TB diagnosis and medication), and enhanced 
accessibility to services through primary health care centres (PHCC) (37). However, 
there are still some challenges facing the implementation of DOTS programme, such 
as inequity of health services utilization, especially in rural areas. Our findings on 
this confirmed the results of previous studies (28,35).  
In order to encourage adherence to treatment, the Ministry of Health (MOH) 
in Khartoum State adopted a DOTS strategy when it was recommended by the WHO 
in 1993 (35). Adopting DOTS ensured that TB patients would be receiving their 
treatment under the supervision of health care workers. Moreover, DOTS increased 
the accessibility of TB services; the Ministry of Health established more than 50 TB 
units (microscopic and treatment centres) distributed all over the state, according to 




remains high. One objective of the TB control programme in Khartoum State is to 
provide tracing teams in all TB units, which are responsible for contacting defaulting 
patients, encouraging them to come back to continue their treatment, and visiting 
them at their home if they do not reply, so as to identify any barriers and give advice 
on how to overcome them when they first start to default. The fact that this does not 
appear to be happening, at least during our study period, may indicate that the 
programme (and its allocated resources) need to be reassessed (36). The introduction 
of a revised retrieval system in Saudi Arabia has been shown to significantly 
improve the retrieval of non-attenders and reduce the dropout rate (37). There are 
several possible reasons why default tracing is a major challenge to TB control in 
Khartoum State, including the wide area of the state, a shortage of available staff, 
the inadequacy of the patient referral system from one TB health unit to another, a 
shortage of transport means for default tracing teams, and a reliance on landline 
telephones and irregular home visits (36). To overcome the obstacles facing the 
DOTS programme  in Khartoum State, we recommend that future research 
investigates both social and economic aspects of patient care. We further recommend 
that the family situation and the opinions of both patients and their families are 
further explored and taken into account when it comes to policy decisions regarding 
treatment. In this way, TB health services will be respectful of, and responsive to, 
individual patient preferences, needs and values. This will ensure that the patient’s 
values will guide all clinical decisions. Our recommendations are in line with the 
WHO post-2015 global tuberculosis strategy framework. This framework, built on 
the foundations of the DOTS treatment strategy, consists of three strategic pillars 
and components, the first of which focuses on integrated, patient-centred care and 




the year 2030, and the overall vision is of a world that will be free of TB disease, 
with zero deaths and zero suffering due to tuberculosis (11,12).  
The TBCP in Khartoum State does not use new technology for the follow-up 
of TB patients during the treatment period despite the fact that the use of mobile 
phones has substantially increased throughout the world over the last decade, also in 
Sudan. The global expansion in mobile phone use presents new opportunities to 
incorporate mobile phones into health care delivery services (38-40). Our 
intervention study findings provide the basis for solid recommendations which we 
hope will provide new opportunities to increase health education and improve 
doctor-patient interaction. In turn, we hope that this will help to improve treatment 
outcomes such that there will be a higher cure rate and a lower default rate. We 
suggest that the adoption of mobile phone use (or other new technology) by the 
TBCP will help the policy makers in planning, enhance communication with TB 
patients and facilitate follow-up. Our findings are similar to those reported in 
previous studies (41-44). 
The receptiveness of the health care providers in Khartoum State and the 
approach they adopted was significantly associated with TB treatment default. These 
finding confirmed the results of previous studies conducted in developing countries 
(19,45). Several factors, including lack of training, work overload and overcrowding 
at health units, patients’ behaviour, and a shortage of health services and facilities 
(including health education materials) may affect the attitude of health staff. The 
interaction between health care staff and their patients is important, as it offers an 
opportunity to increase patient awareness about TB. Moreover, this interaction 
allows the doctor to assess/determine the social circumstances and economic status 
of patients and their families. Having access to this information may mean that some 




doctor to discuss a suitable treatment plan tailored to each patient, which will 
increase the likelihood of the patient adhering to the treatment (46-48).  
Our studies explored in depth several factors associated with TB default 
related to patients, their families and community. We identified more variables 
associated with TB treatment default than those identified in our systematic review 
(which included the results of 53 articles).  Our research included three types of study 
design (observational, focus group discussion and intervention), in contrast to the 
single study designs of the research included in the systematic review. Moreover, 
our findings across the three studies were similar and consistent, while the results of 
the research included in the systematic review may be controversial.  
In summary, we believe that our studies have identified the important factors 
associated with TB default. With this knowledge, more focus can be placed on 
helping patients most at risk of treatment default adhere to their treatment plan. Our 
findings are applicable not only to the current situation regarding TB management 
and control in Sudan, but also to those in a similar situation in other developing 
countries. 
Methodological considerations: 
Selection of our study populations:  
Our case control study was conducted in Khartoum State, which is the most 
populated state in Sudan. Its population can be assumed to represent the whole 
country, as most of the inhabitants come from various parts of Sudan. The TB 
patients included in this study were selected from all of the TB treatment units 
(health centres and hospitals) in the state. The population of the three patient focus 
group discussions were selected from all tuberculosis patients (defaulters and 
controls) registered at tuberculosis centres in Khartoum State, in order to capture 




The inclusion criteria for participants specified that patients had to be at least 18 
years old and receiving treatment for at least one month; it was thought that these 
patients would provide better insight into TB treatment barriers. In order to further 
explore the driving factors for defaulting, we subsequently conducted another three 
focus group discussions with a total of 24 health professionals representing 53 TB 
treatment units in Khartoum State. The health professionals who participated were 
all experienced in treating TB patients.  
      The participants in our intervention study were randomly selected from the 
health units in Khartoum State (using the same selection criteria). Patients who had 
access to a cell phone were allocated to the intervention group, if they agreed to 
participate. For every patient placed in the intervention group, the following patient 
without access to a cell phone was allocated to the control group, if they agreed to 
participate. 
In summary, we suggest that our findings from the three study designs can be 
generalized to the total TB population in the state, to Sudan as a whole, and to other  
communities with similar settings.  
Potential bias: 
Recall bias was minimized by the use of a semi standardized questionnaire 
during the interviews and by cross-checking patients’ responses for each study 
variable against their medical records. While the reliability of the information 
gathered from each patient could not be counter-checked, questions about sensitive 
issues were carefully handled in order to maximize the accuracy of the responses 
obtained. Moreover, potential confounding variables were taken into consideration 
in the design (by restricting the diagnosis criteria) and in the analysis (by using 





Tracing of default patients: 
  The major problem we faced during the study was how to reach the defaulting 
patients (cases). This problem was tackled in three steps. First, the patient medical 
records were traced and identified and all contact information was reviewed. Then, 
study personnel first tried to telephone the patient and, failing that, to telephone 
known family members or friends. If telephone contact failed, home visits were 
made, first to the patient and then to known family members or friends. Interestingly, 
we found that many of the defaulting patients did not have access to any phone 
(mobile or landline), a risk factor not previously described or evaluated in our study. 
The interviewers made an average of three attempts to contact each defaulter before 
recording the defaulter as a non-respondent.  
Study design: 
Our three study designs allowed us a more in-depth investigation of the 
determinant factors associated with TB treatment default. Firstly, we conducted a 
case control study. In this study, the participants (cases and controls) were 
interviewed using a questionnaire. Secondly, we conducted the focus group 
discussions, in order to ascertain the opinions of TB patients and health care 
providers. The barriers reported by TB treatment defaulting patients and health 
care providers who participated in this study were not well known and not familiar 
to either the Khartoum community or the policy makers of the TB control program 
in Khartoum State, despite being previously reported in many international studies 
(3,13-15). It is important to note that this is the first large scale qualitative study 
exploring the opinions and experiences of both patients and the staff treating them 
about the barriers related to the interruption of TB treatment. Our results shed 




knowledge about TB disease and its treatment, the economic impact of TB 
(including the cost of travelling to treatment centres, food, and potential loss of 
work) and the belief in traditional healers. Interestingly, there was another barrier 
raised by the participants in the six focus group discussions, i.e. the poor availability 
of communication tools and transportation for the treatment default tracing 
teams. Finally, in order to further investigate risk factors associated with TB default, 
we conducted an intervention study about the structural use of mobile phones in 
a TB program as a potential way of lowering the frequency of default. However, the 
impact of this intervention on treatment outcomes in Sudan has not yet been 
evaluated. We therefore conducted a controlled intervention pilot study to 
evaluate the potential role of cell phone use in lowering treatment default. 
Future implications:  
The results of our studies have the potential to positively impact TB patient care in 
the following ways:  
Implications for patient health care 
- The intervention study investigated the use of modern communication 
technology (SMS via cell phone) by the NTCP for the follow-up of TB 
patients. We found that the use of cell phones achieved positive outcomes 
such as: a higher cure rate, a decrease in the default rate and an increase in 
patient knowledge about TB. Our results show that there is considerable 
promise in using cell phone technology to improve the efficiency and quality 
of TB treatment. While recognising that there are many advantages to using 
cell phones in place of landline telephones, other alternative means of 
communication should also be considered. These might include the use of 




observed therapy to follow-up patients taking TB medication, or the use of 
reminders to help patients take the correct dose at the right time. 
- Our studies are the first to investigate the default tracing team in Khartoum 
State, and Sudan as a whole.  Based on our results, we recommended that 
improvements are made to the default tracing teams, building capacity by 
providing additional training for health personnel, and increasing the 
availability of transportation and communication tools. 
- Our findings show that some patients may default during the referral process 
from one TB clinic to another. There is therefore a need to update the 
guidelines regarding the referral system of TB patients, and improve the 
communication methods in order to ensure information is effectively shared 
between the TB health units. 
- There was a substantial group of TB patients in Khartoum State who had not 
been screened for HIV status, despite the fact that it is the core policy of the 
NTB programme to screen all TB patients for HIV. It is therefore of vital 
importance to expand the provision of HIV testing services in all TB clinics. 
- Our study indicates that DRTB patients require additional and special 
attention from the health care providers over the long treatment duration 
period, due to the fact that DRTB is associated with a high default rate. 
- The default rate is higher among the patients who live in rural locations.  
These patients also tend to have a low education level. It is important, then, 
that the health care provider can focus on these patients and tailor a treatment 
strategy to their specific needs, with the idea that this will increase the 
likelihood of treatment adherence.  
- Our study indicates that special attention is needed for the displaced people 




in Khartoum State. The NTP program needs to develop an intervention plan 
that includes training for health personnel, capacity building for the health 
units, and provision of drugs and investigation services. 
- Building on the DOTs programme and adopting a patient-centred approach to 
care will help to achieve the END TB strategy. Such an approach takes into 
account each patient’s personal situation and social status. A decision can then 
be made about whether a home-based or a hospital-based treatment plan 
would be best.  
- Our findings show that lack of knowledge and stigma were strong determinant 
factors for TB treatment default. It is therefore of vital importance that health 
care workers provide health education to all TB patients, their families, and 
the wider community. In order to communicate this effectively, we 
recommend that health care workers adopt a receptive and welcoming 
approach to their patients. Furthermore, it is necessary for the NTB to update 
the guidelines for health education to include the use of non-traditional health 
education methods which offer good opportunities for interaction between 
patients and their health care providers. 
- We strongly recommend that the NTB programme actively encourages more 
community participation. This can be achieved by co-ordinating with 
governmental and non-governmental organisations and charity associations to 
get them involved in the provision of health services for TB patients. 
- Finally, we advocate periodic updates of TB guidelines in light of 








      Based on the findings presented in this thesis, we have several suggestions for 
further research: 
- We conducted a pilot of an intervention study to investigate the use of mobile 
phone use in decreasing the rate of TB treatment default. This was the first study 
conducted in Khartoum State to evaluate the use of such devices. Based on our 
findings, we highly recommend that the NTBP conducts a randomized controlled 
trial study to evaluate the role of mobile phone use  on TB treatment adherence.  
- Ours was the first study conducted in Khartoum State (or Sudan as a whole) to 
investigate the determinants factors for TB treatment default. We used three 
different study designs, and explored several different variables, some of which 
had not been studied in the area before, e.g. the evaluation of the DOTS 
programme and the TB default tracing team. Further prospective research could 
provide in-depth insight regarding the determinant factors for TB treatment 
default. 
- In the light of our study findings, we recommend the reassessment and 
evaluation of NTCP strategies. 
- We suggest that future research opportunities include an investigation of the 
feasibility, affordability and benefits of adopting a patient-centred approach, 
a comparison of home-based versus hospital-based DOTS, and further 
exploration of the obstacles which prevent daily attendance at TB health units.  
Conclusions: 
 Our research identified determinant factors influencing TB treatment 
default.  We believe that the findings are applicable to the current situation of TB 




This thesis addresses some important issues in TB control in Khartoum State 
as well as the rest of Sudan (and other locations in similar settings with limited 
resources). In summary, our recommendations are as follows: 
- Implement capacity building of TB programme staff and provide ongoing training 
in relation to certain elements of TB control programmes such as case 
classification, treatment monitoring, record keeping, outcome recording, patient 
follow-up and quality control. 
- Use advanced communication tools to increase awareness of TB in patients and 
their families and increase the provision of counselling. It is important to determine 
which groups in particular should be targeted and to encourage community 
participation.  
- Improve the coordination between the different departments in the Ministry of 
Health and other related sectors e.g. the Ministry of Education.  
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The impact of the research 
Tuberculosis (TB) is the major causes of illness and death worldwide for more 
than three decades. It is  classified among the top ten causes of global cause of death, 
particularly in developing countries. Our  objective was to identify factors associated  
with discontinue treatment among TB patients in Khartoum State, Sudan. Based on 
our findings, relevant suggestions and recommendations can be made with the aim 
to help the patient, families, communities, policy makers and health care providers 
make changes that will improve treatment compliance and treatment outcomes, and 
leading to a reduction in TB dropout  among tuberculosis patients in Khartoum State 
and Sudan.  
The results of our studies have the potential to positively impact TB patient care as  
the findings of our research identified several factors leading to discontinue TB 
treatment  
Impact for patient health care, health care providers, TB control program and 
the future research: 
The results of these studies show that the patients lack of knowledge, those with 
with low level of education, and stigma such as feeling shame were strong factors 
for discontinue TB treatment. It is therefore of vital importance that health care 
workers provide health education to all TB patients, their families, and the wider 
community. In order to communicate this effectively, we recommend that health 
care workers adopt a receptive and welcoming approach to their patients. 
Furthermore, it is necessary for the national TB program (NTBC) to update the 
guidelines (plans, procedures and strategies) for health education to include the use 
of non-traditional health education methods which offer good opportunities for 




Moreover, Our study indicates that special attention is needed for the 
poor patients, displaced individuals and refugees with a high dropout rate 
living in camps, rural and remote areas around the big cities in Khartoum State 
where TB medical services are provided in clinics managed by non-
governmental organizations. The national TB control program needs to 
develop an intervention plan that includes training for health personnel, 
provision of equipment and tools, and availability of drugs and laboratory 
services.  
Due to lack of resources for the national TB control program in 
Khartoum State, we strongly recommend that the NTB programme actively 
encourages more community participation. This can be achieved by co-
ordinating with governmental and non-governmental organisations and 
charity associations to get them involved in the provision of health services 
for TB patients. In addition, these nongovernmental organization can 
participate in overcoming the stigma by active intervention using non-
traditional health education methods. To ensure the success of a health 
education initiative, it is important to have a motivated plan which 
communicates and emphasizes specific messages, such as the fact that TB is 
a treatable and preventable disease. Furthermore, it is essential that various 
outreach methods are employed, including social media, movies, drama, 
public talks, and brochures. 
Also, Our study evaluated the use of new communication technology 
(short message services (SMS via mobile phone) by the NTCP for the follow-
up of TB patients. We found that the use of mobile phones achieved positive 
results such as: a higher cure rate, a decrease in the dropout rate and an 




considerable promise in using mobile phone technology to improve the 
efficiency and quality of TB treatment. While recognising that there are many 
benefits to using mobile phones in place of landline telephones, other 
alternative means of communication should also be considered. These might 
include the use of voice messages for those who cannot read SMS messages, 
the use of video-observed therapy to follow-up patients taking TB drugs, or 
the use of reminders to help patients take the correct dose at the right time.  
Our studies are the first to evaluate the team tracing the patients who 
discontinue treatment in Khartoum State, and Sudan as a whole.  Based on our 
results, we recommended that improvements are made to the retrieval tracing 
teams, by providing additional training for health personnel, and increasing 
the availability of transportation and communication tools. This team will try 
to encourage the non- attender TB patients to come back to continue their 
treatment and reduce dropout rate. The team follow sequence of contact 
attempts including phone call and home visit. Moreover, we found that some 
patients may discontinue their treatment during the referral process from one 
TB clinic to another. There is therefore a need to play special attention 
regarding the referral system of TB patients, and improve the communication 
methods in order to ensure information is effectively shared between the TB 
health units. 
As TB is a chronic disease that need treatment with multiple drugs for 
more than six month duration. This had social, financial and psychological 
effects for TB patients, their families and the community. Discontinue 
treatment or taking treatment irregular may enhance the spreading of the 
disease, In addition, it increases the risk of treatment failure, disease may 




illness, and death. Furthermore, if left untreated, an infected person is 
expected to spread infection up  to 15 people every year. Hence identification 
of risk factors leading to discontinue treatment in Khartoum State is therefore 
essential. Thus our study indicates that TB patients specially those had drug 
resistant require additional and special attention from the health care providers 
over the long treatment duration period, due to the fact that patients with drug 
resistant are associated with a high dropout  rate. 
Our study reported  that there was a substantial group of TB patients in 
Khartoum State who had not been screened and tested for HIV status, despite 
the fact that it is the core policy of the NTB programme to screen all TB 
patients for HIV. It is therefore of vital importance to expand the provision of 
HIV testing services in all TB clinics. 
Our research identified several  factors influencing discontinue TB 
treatment.  We believe that the findings are applicable to the current situation 
of TB management and control in Sudan and in other developing countries. 
Based on the findings presented in this thesis, we have several suggestions for 
further research to assess in depth the factors associated with discontinue TB 
treatment not evaluated in our studies. Also, in the light of our study findings, 
we recommend the reassessment and evaluation of NTCP strategies. 
Furthermore, we recommend to evaluate use of mobile phone use in 













Tuberculosis (TB) is the major causes of illness and death worldwide for more 
than three decades. In 1993, the World Health Organization (WHO) declared TB 
infection to be a global public health problem . TB continues to cause high morbidity 
and mortality rates, and is classified among the top ten causes of global mortality, 
particularly in developing countries.   
Since then, many efforts have been undertaken by experts in international 
organisations to control TB disease. The WHO launched the “Directly Observed 
Treatment; Short-course (DOTS)” strategy in 1994 as the essential, most cost-
effective means of tuberculosis control. The success of this strategy later 
underpinned the development and implementation of the “Stop TB Strategy” (2006–
2015). This was incorporated in the subsequent “End TB Strategy” by the year 2035 
which launched by the WHO as a post-2015 global TB strategy.  
TB continues to be a major public health problem in Sudan, particularly in 
Khartoum State. Sudan ranks the 3rd of the 10 highest burden countries in the Eastern 
Mediterranean region. It alone carries about 15% of TB burden in the region 
In Khartoum State , the total number of TB cases detected in 2010 was 6670; an 
incidence rate of 119/100.000 population (population of the state was 5.558.647 in 
the year 2010). The annual risk for TB was 1.8 %, hence the programme was able 
to detect 2196 new smear positive cases (83.5% of the target) and achieve a cure 
rate of 48.4% from the detected cases. The treatment success rate increased from 
66% in 2011 to reach 81.0% and 84.0% in 2017 and 2018, respectively (of all 
registered new smear positive cases). These figures come close to the target set 
(85%).  
TB shows high morbidity and mortality, and has proven difficult to eliminate, 




that poor compliance associated with TB treatment remains a challenge for the 
national TB control programmes in developing countries and in Sudan, including 
Khartoum State . Treatment compliance is as crucial as the early detection of disease 
for achieving a high cure rate . Despite all of the efforts taken by the TB control 
programme, there is still a high TB treatment default rate (14%) in Khartoum State , 
as compared to the WHO benchmark (of less than 3%). Irregular, interrupted or 
incomplete TB treatment increases the risk of disease spread, treatment failure, 
relapse of disease, acquisition of drug-resistant TB, prolonged infectiousness, and 
death .   
In this thesis we presented studies conducted to investigate the factors leading 
to defaulting TB treatment. Thus the relevant suggestions and recommendations can 
be made with the aim of reducing treatment default, and improving TB treatment 
adherence and treatment outcomes among tuberculosis patients in Khartoum State 
and Sudan.  
The factors leading to treatment default among TB patients 
In chapter 2 we reported the Patient characteristics associated with non-
adherence to Tuberculosis treatment. This results were obtained by conducting a 
systematic review study which included the reveiw of 53 eligible studies. The 
elegible studies included different sudy designs and were conducted in both  
developed and developing countries  The results of this systematic review show that 
family income, moving of patient or giving wrong address, tuberculosis relapse or 
MDR TB, intensive phase of treatment, history of default, long course treatment 
regimen, response to treatment, homeless, stigma, seeking traditional healers, staff 
receptiveness, DOTS, poor knowledge or lack of health education were consistently 




In chapter 3, 4 and 5 we reported the determinants of treatment defaulting among 
adults TB patients (15 years and above) in Khartoum State, Sudan. The findings 
obtained by conducting a case control study where the  patients defaulting from 
treatment were considered as ‘cases’ and those completing treatment as ‘controls’ 
between May 2010 to May 2011. The data collection for the case control study was 
carried out  from 1th of May 2011 to 15th of July 2011. The aim of this study was to 
identify determinants of treatment defaulting among TB patients in Khartoum State, 
Sudan.  
There were 2727 TB patients who attended TB treatment clinics during study 
period. Out of these 2399 patients (86%) had continued their treatment while 328 
patients (14%) had interrupted it. Of these, 185 had resumed treatment before data 
collection and 143 had not and were eligible as cases. Of the 143, 27 could not be 
traced and 11 declined to participate. Thus, 105 cases and 210 controls were included 
and interviewed.   
The results of this study conclude some factors influence defaulting  of TB 
treatment. These factors included socio-demographic  factors such as: residential 
locality (rural area), patients moving or changing address, and absence of family 
support and occupation (blue collar work); Disease- and treatment-related factors 
such as: not being on a DOTS programme, having side-effects from treatment, and 
having a history of TB (relapse, multidrug-resistant TB or treatment failure); Patient 
knowledge and behavioral factors such as: “had never heard about TB before had 
it”, lack of knowledge on when to stop TB medication, less support by families, 
friends and colleagues, too many patients when visiting the TB center, and lack of 
counseling about TB and its treatment. 
             In chapter 6 we reported the barriers Leading to Treatment Default among 




conducting a qualitative research using the technique of Focus Group Discussion 
(FGD) during the period from 1st of May 2011 to 15th of July 2011. Six FGD were 
conducted (3 for defaulted patients and 3 for health personnel). Overall, 27 TB 
defaulted patients and 24 health care providers were randomly selected. The 
objective of this study is to provide health authorities and patients with insight into 
the perceived factors affecting TB treatment default. 
          The Participants included in this study  reported several barriers leading to TB 
treatment default such as:  lack of knowledge about TB, high cost of transportation, 
difficulty for making a daily visit to health facilities for DOT programme due to 
distance of the facilities from their residences, rural residency, social circumstances, 
TB-related stigma, lack of family support, patient movement or giving wrong 
address, seeking traditional healers and treatment-related factors such as side-effects 
of drugs, the attitude of health care providers, the long delay in obtaining 
medications, and weakness and challenges facing defaulter tracing teams. There 
were consistent findings from interviews among patients and health care providers.  
In chapter 7 we reported the use of  Mobile health to improve adherence to 
tuberculosis treatment in Khartoum State, Sudan. The findings were obtained by 
conduticng a controlled intervention pilot study during the period from 1th of May 
2017 to 31th of March 2018,in eight TB treatment units in Khartoum state.  Short 
message services (SMS) reminder were sent to the intervention group. The aim of 
this study was to evaluate the potential use of cell phones for lowering treatment 
default. However, it’s impact on treatment outcome in Sudan has not yet been 
evaluated before.  
        There was 148 TB patients enrolled in this study, seventy-four patients in each 
group. The patients in the intervention group had a lower default rate(6.8%),higher 




reminder was useful and facilitated good interaction between patients and health 
personnel. 
The findings presented in chapter 3,4,5,6 and 7 constitutes the first in-depth 
study conducted in Khartoum State and  Sudan to explore  the  factors associated 
with TB default related to patients, their families and community. We identified 
more variables associated with TB treatment default than those identified in our 
systematic review (which included the results of 53 articles).  Our research included 
three types of study design (observational, focus group discussion and intervention), 
in contrast to the single study designs of the research included in the systematic 
review. Moreover, our findings across the three studies were similar and consistent, 
and confirmed the findings of the previous studies conducted in developed and 
developing countries.  
In summary, we believe that our studies have identified the important factors 
associated with TB default. With this knowledge, more focus can be placed on 
helping patients most at risk of treatment default adhere to their treatment plan. Our 
findings are applicable not only to the current situation regarding TB management 
and control in Sudan, but also to those in a similar situation in other developing 
countries. 
       In chapter 8  we presented a discussion of our research findings reported in the 
previous chapters, which focus on the predictors of TB treatment default. Also we 
discussed future implications of these findings on  the TB patient care and health 
care providers. In addition, we identified the research needs and priority areas for 
enhancing adherence of TB treatment and strengthening activities, strategies and 
policies of the national TB control programme (NTP) in Khartoum State, Sudan 

































































TUBRCULOSIS TREATMENT DEFAULTER STUDY 
The questions will be answer by the clients  
Date: ___ / ___ / ___         locality: _______________ health area: _______________ 
area: _______________   interviewer: _______________ 
Patient  File No______________  Patient Telephone No_________________________           
We wish to learn about your opinion  regarding tuberculosis treatment (TB) as well as 
determinant factors for TB treatment defaulting. The information you provide will be used to 
improve TB treatment. 
Your answers will not be released to anyone and will remain anonymous. Your name will not be 
written on the questionnaire or be kept in any other records. Your participation is voluntary and 
you may choose to stop the interview at any time. 
Thank you for your assistance. 
Interviewer: Please write the answer  number in the box of selected answer(s). Do not read 
responses unless the directions indicate. 
1. Study Serial No: …………………………………………….……….………. 
2. Patient status                                  1. Defaulter                                       (     ) 
                                                           2. Complaint 
A- Socio- demographic questions:  ِ  
3.How old are you? Age in completed years (on 1.6.2011) ……………….  
      --------------------------------------------------------------------------- 
4. What is the interviewee gender? 
 1. Male  
 2. Female 
5. What is your marital status ? 
        1.Married 
        2.Single 
 3.Divorced 
 4.Widower 
6.What is the highest level of education you have completed? 
 1. No school 
 2. Elementary 
3. intermediate 
 4. High school 
 5. University 
 6. Post-graduate 
 7. Religious schooling only 
 8. Literacy classes only 
7. What is the type of your residency  
 1. City 




 3. Camp 
 4. Other(define----------------------------------------------------------------------) 
8.What is your Nationality? 
        1.Sudanese  
        2.None- Sudanese (define -----------------------------------------------------------
-) 
9. What is your current occupation? 
 1.Employee 
 2.Laborer 
 3.retired  
 4.Student 
 5.house wife 
 6.non work 
 7.employer 
 8.self-employed 
 9.others ( define)  ----------------------------------------------------------- 
10. What is the number of your family members , (including yourself)? 
 1. 1– 3  
 2. 4-7 
 3. more than 7 
11. What is the number of rooms in your house? 
 1. 1 – 2  rooms 
 2. 3 – 4  rooms 
 3. more than 4 rooms 
 4. no house(homeless) 
12.Did you find any kind of support from your family while you have TB disease? 
 1. yes 
 2. No 
13.What is your Family income per  month(Sudanese pound) ?  
  1.<1000SP 
  2.1000-1999SP 
  3.2000-2999Sp 
  4. > 3000SP 
14.What is your Religious? 
 1.Muslim 
 2.Non Muslim 
 3.No religious 
15.Did you change your address(patient movement) during treatment  ?  
       1.yes 
       2.No 
16.Did you inform the health centre personnel that you change your address)  ?  
       1.yes 
       2.No 
17. What means of transport do you use to get to the  health centre? 
       1.Foot  
       2.Bicycle 
      3. Public transport 
      4.your own car 
18. The costs incurred when visiting the  health centre is? 
       1.Cheap 




       3. Reasonable 
 3. No money spent to reach the health centre 
19. How far do you live from the nearest health clinic or hospital(Tuberculosis treatment clinic)? 
1.       Less than 2km (kilometers) 
2.       3–5 km  
3.  6–10 km 
      4.    More than 10 km 
20. How long does it take to reach the nearest health clinic or hospital(Tuberculosis treatment clinic)? 
-----------------------------------------------------------------------------------------------------------------------  
 
B-TB knowledge and awareness 
21.Do you hear about TB before you had it? 
        1.Yes  
        2.No      
22. In your opinion, what you expect if you stop TB treatment? (Please check all 
that are relevant) 
 1. Can't be cured 
 2. Relapse 
 3. Dying 
 4. Start treatment again 
 5. Don' know 
23. Do you aware with the treatment duration? 
 1. Yes 
 2. No 
 3. Don' know 
 24. mention the treatment duration? 
  -----------------------------------------------------------------------------------------------  
25. Can TB be cured? 4. Yes 
              1.Yes 
 2.No 
              3.Don' know 
26.When you should stop taking your treatment?  ِ  
 1. When I have side effect 
 2. When there is no improvement 
 3. When health workers tell me to stop treatment 
 4. When Iam feeling better 
 5. I Don' know 
C. Disease and Treatment related Factors: 
27. Did  you receive BCG  vaccination against TB? 
 1.yes 
 2.No 














4. not done 
31.What was the treatment regimen given to you? 
 1-CAT1 
 2- CAT2 
32.Do you taking your treatment under direct observation therapy(DOTS)? 
 1.yes 
 2.No 
33. Did  you think that you feel better after taking treatment(Response to 
treatment) 
        1. Good response 
        2. Not good response 
        3.No response 
34.. What was the result of sputum smear after 2 month of starting treatment? 
 1.Positive 
 2.Negative 
35.Did you feel any kind of side effect due to TB treatment?  




36. What is the Site of disease?                                        
 1. Pulmonary 
 2. Extra pulmonary  
37. What was type of  Diagnosis and disease status? 




 2. Relapsing disease 
 3. MDRTB 
 4.Treatment Failure 
38.Do you have Chronic disease ? 
 1.yes 
 2.No 
 39.If yes define 
 1- DM 
2- Hypertension 
3- Cardiac Diseases 
4- Renal diseases 
5- Cancer 
6- Other(define) ------------------------------------------------------------------------ 
40.During your course illness Did you receive any kind of treatment other than anti 
tuberculosis drugs?  
1.yes 
2.No 





42. Do you smokes?                    
 1.yes 
 2.No 
43.Do you use Alcohol? 
 1.yes 
 2.No 
44.Do you  have HIV (+ve ) disease? 
 1.yes 
 2.No 
45.Do you use intravenous drugs(IVDU)?  
 1.yes 
 2.No 
46.Do you use any other types of drugs?  
1.yes 
2.No 










48. Do you feel shame to have TB? 
 1. Yes, why (                                                                                  ) 
 2. No why (                                                                                  ) 
 3. I don't know 
49. Do you try to hide your TB disease  from the others? 
 1.Yes 
 2.No 
 3. don't know  
50. Did some  of your family , friends and colleagues treat you different when they  
found out that you  have TB? 
 1.Yes 
 2.No 
 51.If yes specify 
 1- Friends 
 2- Family members  
 3- colleagues 
52. How do you fell about being observed taking treatment? 
 1.I Do not mind 
 2.Feel embarrassed 
F:Patients Opinion about TB services: 
53. What do you think about TB center services offered 
 1. Excellent 
 2. Good 
 3. Fair 
 4. Not suitable 
 5. Bad 
54. What do you think about attitude of TB health care workers to ward 
patients(staff receptiveness)? 
 1. receptive 
 2. Unreceptive 
55. What do you think about TB center appearance? 
 1. Excellent 
 2. Good 
 3. Fair 
 4. Not suitable 
 5. Bad 
56. What do you think about number of people seeking treatment in TB center? 
 1. Too many  




 3. Suitable 
 4. Few 
 5. Very few 
57. What do you think about your waiting time in TB center ?  
 1. <15 minutes 
 2. 15 – 30  minutes 
 3. 30 – 1 hour 
 4. 1-2 hours 
 5. more than 2 hours 
58.Do you satisfy with TB treatment given  ?  
       1.yes 
       2.No 
59.Were you given information on the dangers of interrupting treatment  ?  
       1.yes 
       2.No 
 
Name of interviewer: …………………………………………………………………. 
Designation & Health Center: ………………………………………………………… 
 




























































Use of Mobile health to improve adherence to TB treatment  
The questions will be answer by the clients  
Date: ___ / ___ / ___         locality: _______________ health area: _______________ 
area: _______________   interviewer: _______________ 
    
We wish to learn about your opinion  regarding tuberculosis treatment (TB), the information you 
provide will be used to improve TB treatment. 
Your answers will not be released to anyone and will remain anonymous. Your participation is 
voluntary and you may choose to stop the interview at any time. 
Thank you for your assistance. 
Interviewer: Place an X in the box of the selected answer(s).Do not read responses unless the 
directions indicate. 
1. Study Serial No: …………………………………………….……….………. 
2. Patient status                                  1. Owner mobile phone 
                                                           2. Do not have mobile phone 
A- Socio- demographic questions:  ِ  
3.How old are you? Age in completed years (on 1.6.2017) ……………….  
      --------------------------------------------------------------------------- 
4. What is the interviewee gender? 
 3. Male  
 4. Female 
5. What is your marital status ? 
        1.Married 
        2.Single 
 3.Divorced 
 4.Widower 
6.What is the highest level of education you have completed? 
      1. No school 
 2.Elementary 
     3.intermediate 
 4.High school 
 5.University 
 6.Post-graduate 
 7.Religious schooling only 
 8.Literacy classes only 






  3.Camp 
  4.Other 
8.What is your Nationality? 
        1.Sudanese  
        2.None- Sudanese 
(identify……………………………………………………) 





 5.house wife 
 6.non worker 
 7.employer 
 8.self-employed 
 9.others ( define)  ----------------------------------------------------------- 
10.What is your Family income per  month(Sudanese pound) ?  
  1.<1000SP 
  2.1000-1999SP 
  3.2000-2999Sp 
  4. > 3000SP 
11.What is your Religious? 
 1.Muslim 
 2.Non Muslim 
 3.No religious 
12.Did you change your address(patient movement) during treatment  ?  
       1.yes 
       2.No 
13.Did you inform the health centre personnel that you change your address)  ?  
       1.yes 
       2.No 
14. What means of transport do you use to get to the  health centre? 
       1.Foot  
       2.Bicycle 
      3. Public transport 
      4.your own car 
15. The costs incurred when visiting the  health centre is? 
       1.Cheap 
       2.Expensive 
       3. Reasonable 
      4. no cost 
16. How far do you live from the nearest health clinic or hospital(Tuberculosis 
treatment clinic)? 




5.       3–5 km  
6.  6–10 km 
      4.    More than 10 km 
17. How long does it take to get to the nearest health unit or hospital to be 
treated (a treatment unit for TB patients) 
 
B-TB knowledge and awareness 
18.Do you hear about TB before you had it? 
        1.Yes  
        2.No      
19. In your opinion, what you expect if you stop TB treatment? (Please check all 
that are relevant) 
 1.Can't be cured 
 2.Relapse 
 3.Dying 
 4.Start treatment again 
 5.Don' know 
20. Do you aware with the treatment duration? 
 1.Yes 
 2.No 
 21. Mention the treatment duration please 
  
22. Can TB be cured? 
              1.Yes 
 2.No 
              3.Don' know 
23.When you should stop taking your treatment?  ِ  
 1. When I have side effect 
 2.When there is no improvement 
 3.When health workers tell me to stop treatment 
 4.When Iam feeling better 
 5. I Don' know 
C Disease and Treatment related Factors: 
24. What was the result of sputum smear at the beginning of the disease ? 
 1.Positive 
 2.Negative 
25. Did  you think that you feel better after taking treatment(Response to 
treatment) 




        2. Not good 
        3.no response 
26.. What was the result of sputum smear after 2 month of starting treatment? 
 1.Positive 
 2.Negative 
27.Did you feel any kind of side effect due to TB treatment?  




28.What was the results of sputum smear at the end of treatment ? 
 1.positive 
 2.negative 
 29. The treatment outcome at the end of treatment duration 
       1.cured 
 2.completment of treatment 
 3.default 
 4.transfer out 
 5.failure 
 6.died 
30.During your course illness Did receive any kind of treatment other than 
anti tuberculosis drugs?  
1.yes 
2.No 





32. Do you smokes?                    
 1.yes 
 2.No 
33.Do you use Alcohol? 
 1.yes 
 2.No 






35.Do you use intravenous drugs(IVDU)?  
 1.yes 
 2.No 
 36.Do you use any other types of drugs? 
 1.yes 
 2.No 
 37.If yes specify the type of drug?  
 1.Cannbis 
 2.benzene 
 3. Spirit 
 4.others 
E. Stigma: 
38. Do you feel shame to have TB? 
 4. Yes, why (                                                                                  ) 
 5. No why (                                                                                  ) 
 6. I don't know 
39. Do you try to hide your TB disease  from the others? 
 1.Yes 
 2.No 
 3. don't know  
40. Did some  of your family , friends and colleagues treat you different when 
they  found out that you  have TB? 
 1.Yes 
 2.No 
 41. If yes specify 
 1.friends 
 2.family members 
 3.colleagues  
42. How do you fell about being observed taking treatment? 
 1.I Do not mind 
 2.Feel embarrassed 
F:Satisfaction about TB services: 
43. What do you think about TB center services offered 
















46. What do you think about number of people seeking treatment in TB 
center? 
 1.Too many  
 2.Many  
 3.Few 
 4.Very few 
47. What do you think about your waiting time in TB center ?  
 1. 15 minutes 
 2. 15 – 30  minutes 
             3.  30 – 1 hour 
 4. more than 2 hours 
48. Do you satisfy with TB treatment given  ?  
       1.yes 
       2.No 
49.Were you given information on the dangers of interrupting treatment  ?  
       1.yes 
       2.No 
 
Name of interviewer: …………………………………………………………………. 
Designation & Health Center: ………………………………………………………… 
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